Johnson, Bruce
eCommons Login: BEJ1
first name: Bruce
last name: Johnson
coauthor of: Nishino Hatabu, Mizuki
coauthor of: Jackman, David M
coauthor of: Janne, Pasi
coauthor of: Dahlberg, Suzanne
coauthor of: Sholl, Lynette
full name: Bruce Evan Johnson, M.D.
has faculty rank: Full Professor
has network: selected publications
has network: research areas
has network: coauthor of
has network: similar to
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 46357
person in primary position: Professor of Medicine, Emeritus
physical neighbor: Canellos, George
physical neighbor: Grier, Holcombe
physical neighbor: Iglehart, James
physical neighbor: Kantoff, Philip
physical neighbor: Loda, Massimo
similar to: Sequist, Lecia
similar to: Shaw, Alice
similar to: Christiani, David
similar to: Gainor, Justin
similar to: Costa, Daniel
type: Agent
type: Person
selected publications: Authorship 1781651
selected publications: Authorship 1817810
selected publications: Authorship 1813056
selected publications: Authorship 1793526
selected publications: Authorship 1812708
selected publications: Authorship 1848389
selected publications: Authorship 1780525
selected publications: Authorship 1746445
selected publications: Authorship 1750311
selected publications: Authorship 1844373
selected publications: Authorship 1743043
selected publications: Authorship 1739454
selected publications: Authorship 1737057
selected publications: Authorship 1725384
selected publications: Authorship 1723991
selected publications: Authorship 1666625
selected publications: Authorship 1710275
selected publications: Authorship 1703300
selected publications: Authorship 1700291
selected publications: Authorship 1700293
selected publications: Authorship 1687544
selected publications: Authorship 1665927
selected publications: Authorship 1660261
selected publications: Authorship 1647767
selected publications: Authorship 1631478
selected publications: Authorship 1568342
selected publications: Authorship 1623146
selected publications: Authorship 1620622
selected publications: Authorship 1596985
selected publications: Authorship 1615736
selected publications: Authorship 1587622
selected publications: Authorship 1613469
selected publications: Authorship 1608745
selected publications: Authorship 1614669
selected publications: Authorship 1599193
selected publications: Authorship 1557521
selected publications: Authorship 1553245
selected publications: Authorship 1572040
selected publications: Authorship 1523202
selected publications: Authorship 1528227
selected publications: Authorship 1530510
selected publications: Authorship 1526182
selected publications: Authorship 1516053
selected publications: Authorship 1508133
selected publications: Authorship 1502068
selected publications: Authorship 1486320
selected publications: Authorship 1483808
selected publications: Authorship 1481139
selected publications: Authorship 1437296

eCommons Login
tag name: catalyst:eCommonsLogin
type: DatatypeProperty

coauthor of
tag name: prns:coAuthorOf
type: ObjectProperty

end date
tag name: prns:endDate
type: DatatypeProperty

Faculty Rank
type: Class

full name
tag name: prns:fullName
type: DatatypeProperty

author list
tag name: prns:hasAuthorList
type: DatatypeProperty

has faculty rank
tag name: prns:hasFacultyRank
type: ObjectProperty

has network
tag name: prns:hasNetwork
type: ObjectProperty

published in
tag name: prns:hasPublicationVenue
type: DatatypeProperty

information resource reference
tag name: prns:informationResourceReference
type: DatatypeProperty

is primary position
tag name: prns:isPrimaryPosition
type: DatatypeProperty

latitude
tag name: prns:latitude
type: DatatypeProperty

longitude
tag name: prns:longitude
type: DatatypeProperty

photo
tag name: prns:mainImage
type: ObjectProperty

maximum weight
tag name: prns:maxWeight
type: DatatypeProperty

journal title abbreviation
tag name: prns:medlineTA
type: DatatypeProperty

MeSH DescriptorUI
tag name: prns:meshDescriptorUI
type: DatatypeProperty

MeSH semantic group name
tag name: prns:meshSemanticGroupName
type: DatatypeProperty

minimum weight
tag name: prns:minWeight
type: DatatypeProperty

number of authors
tag name: prns:numberOfAuthors
type: DatatypeProperty

number of connections
tag name: prns:numberOfConnections
type: DatatypeProperty

number of publications
tag name: prns:numberOfPublications
type: DatatypeProperty

Person ID
tag name: prns:personId
type: DatatypeProperty

person in primary position
tag name: prns:personInPrimaryPosition
type: ObjectProperty

physical neighbor
tag name: prns:physicalNeighborOf
type: ObjectProperty

position in department
tag name: prns:positionInDepartment
type: ObjectProperty

position in division
tag name: prns:positionInDivision
type: ObjectProperty

predicate node
tag name: prns:predicateNode
type: ObjectProperty

principal investigator name
tag name: prns:principalInvestigatorName
type: DatatypeProperty

publication date
tag name: prns:publicationDate
type: DatatypeProperty

similar to
tag name: prns:similarTo
type: ObjectProperty

sort order
tag name: prns:sortOrder
type: DatatypeProperty

start date
tag name: prns:startDate
type: DatatypeProperty

uniqueness weight
tag name: prns:uniquenessWeight
type: DatatypeProperty

year
tag name: prns:year
type: DatatypeProperty

Academic Article
type: Class

Article
type: Class

Document
type: Class

PubMed Identifier
tag name: bibo:pmid
type: DatatypeProperty

Address
type: Class

address line 1
tag name: vivo:address1
type: DatatypeProperty

address line 2
tag name: vivo:address2
type: DatatypeProperty

address line 3
tag name: vivo:address3
type: DatatypeProperty

city
tag name: vivo:addressCity
type: DatatypeProperty
type: FunctionalProperty

postal code
tag name: vivo:addressPostalCode
type: DatatypeProperty
type: FunctionalProperty

state or province
tag name: vivo:addressState
type: DatatypeProperty
type: FunctionalProperty

selected publications
tag name: vivo:authorInAuthorship
type: ObjectProperty

author rank in publication
tag name: vivo:authorRank
type: DatatypeProperty
type: FunctionalProperty

Authorship
type: Class

Department
type: Class

Division
type: Class

Grant
type: Class

research areas
tag name: vivo:hasResearchArea
type: ObjectProperty

research activities
tag name: vivo:hasResearcherRole
type: ObjectProperty

HR job title
tag name: vivo:hrJobTitle
type: DatatypeProperty

Information Resource
type: Class

linked author
tag name: vivo:linkedAuthor
type: ObjectProperty

linked information resource
tag name: vivo:linkedInformationResource
type: ObjectProperty

mailing address
tag name: vivo:mailingAddress
type: ObjectProperty

middle name or initial
tag name: vivo:middleName
type: DatatypeProperty
type: FunctionalProperty

positions
tag name: vivo:personInPosition
type: ObjectProperty

phone
tag name: vivo:phoneNumber
type: DatatypeProperty

Position
type: Class

position in organization
tag name: vivo:positionInOrganization
type: ObjectProperty

preferred title
tag name: vivo:preferredTitle
type: DatatypeProperty
type: FunctionalProperty

Researcher Role
type: Class

researcher role of
tag name: vivo:researcherRoleOf
type: ObjectProperty

contributes to
tag name: vivo:roleContributesTo
type: ObjectProperty

sponsor award id
tag name: vivo:sponsorAwardId
type: DatatypeProperty
type: FunctionalProperty

predicate
tag name: rdf:predicate
type: ObjectProperty

type
tag name: rdf:type
type: ObjectProperty

label
tag name: rdfs:label
type: DatatypeProperty

Concept
type: Class

Agent
type: Class

first name
tag name: foaf:firstName
type: DatatypeProperty
type: FunctionalProperty

last name
tag name: foaf:lastName
type: DatatypeProperty
type: FunctionalProperty

Organization
type: Class

Person
type: Class

Management of small cell lung cancer.
PubMed Identifier: 11901913
author list: Johnson BE
published in: Clinics in chest medicine
information resource reference: Management of small cell lung cancer. Clin Chest Med. 2002 Mar; 23(1):225-39.
journal title abbreviation: Clin Chest Med
publication date: 2002-03-01T00:00:00
year: 2002
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase II study of imatinib in patients with small cell lung cancer.
PubMed Identifier: 14676110
author list: Johnson BE, Fischer T, Fischer B, Dunlop D, Rischin D, Silberman S, Kowalski MO, Sayles D, Dimitrijevic S, Fletcher C, Hornick J, Salgia R, Le Chevalier T
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Phase II study of imatinib in patients with small cell lung cancer. Clin Cancer Res. 2003 Dec 01; 9(16 Pt 1):5880-7.
journal title abbreviation: Clin Cancer Res
publication date: 2003-12-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255.
PubMed Identifier: 15492241
author list: Tracy S, Mukohara T, Hansen M, Meyerson M, Johnson BE, Jänne PA
published in: Cancer research
information resource reference: Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255. Cancer Res. 2004 Oct 15; 64(20):7241-4.
journal title abbreviation: Cancer Res
publication date: 2004-10-15T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Long-term mortality with multiple treadmill exercise test abnormalities: comparison between patients with and without cardiovascular disease.
PubMed Identifier: 18926161
author list: Aijaz B, Babuin L, Squires RW, Kopecky SL, Johnson BD, Thomas RJ, Allison TG
published in: American heart journal
information resource reference: Long-term mortality with multiple treadmill exercise test abnormalities: comparison between patients with and without cardiovascular disease. Am Heart J. 2008 Oct; 156(4):783-9.
journal title abbreviation: Am Heart J
publication date: 2008-07-11T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome.
PubMed Identifier: 15983396
author list: Carbone DP, Ciernik IF, Kelley MJ, Smith MC, Nadaf S, Kavanaugh D, Maher VE, Stipanov M, Contois D, Johnson BE, Pendleton CD, Seifert B, Carter C, Read EJ, Greenblatt J, Top LE, Kelsey MI, Minna JD, Berzofsky JA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome. J Clin Oncol. 2005 Aug 01; 23(22):5099-107.
journal title abbreviation: J Clin Oncol
publication date: 2005-06-27T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials.
PubMed Identifier: 19671843
author list: Jackman DM, Miller VA, Cioffredi LA, Yeap BY, Jänne PA, Riely GJ, Ruiz MG, Giaccone G, Sequist LV, Johnson BE
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials. Clin Cancer Res. 2009 Aug 15; 15(16):5267-73.
journal title abbreviation: Clin Cancer Res
publication date: 2009-08-11T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1058273
type: Authorship
author rank in publication: 2
linked author: Johnson, Bruce
linked information resource: BRAF Adds an Additional Piece of the Puzzle to Precision Oncology-Based Treatment Strategies in Lung Cancer.

BRAF Adds an Additional Piece of the Puzzle to Precision Oncology-Based Treatment Strategies in Lung Cancer.
PubMed Identifier: 29648886
author list: Planchard D, Johnson BE
published in: Archives of pathology & laboratory medicine
information resource reference: BRAF Adds an Additional Piece of the Puzzle to Precision Oncology-Based Treatment Strategies in Lung Cancer. Arch Pathol Lab Med. 2018 07; 142(7):796-797.
journal title abbreviation: Arch Pathol Lab Med
publication date: 2018-04-12T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Plasma leptin and prognosis in patients with established coronary atherosclerosis.
PubMed Identifier: 15519013
author list: Wolk R, Berger P, Lennon RJ, Brilakis ES, Johnson BD, Somers VK
published in: Journal of the American College of Cardiology
information resource reference: Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol. 2004 Nov 02; 44(9):1819-24.
journal title abbreviation: J Am Coll Cardiol
publication date: 2004-11-02T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development.
PubMed Identifier: 15837727
author list: Kelloff GJ, Hoffman JM, Johnson B, Scher HI, Siegel BA, Cheng EY, Cheson BD, O'shaughnessy J, Guyton KZ, Mankoff DA, Shankar L, Larson SM, Sigman CC, Schilsky RL, Sullivan DC
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res. 2005 Apr 15; 11(8):2785-808.
journal title abbreviation: Clin Cancer Res
publication date: 2005-04-15T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Response to treatment and survival of patients with non-small cell lung cancer undergoing somatic EGFR mutation testing.
PubMed Identifier: 17285735
author list: Sequist LV, Joshi VA, Jänne PA, Muzikansky A, Fidias P, Meyerson M, Haber DA, Kucherlapati R, Johnson BE, Lynch TJ
published in: The oncologist
information resource reference: Response to treatment and survival of patients with non-small cell lung cancer undergoing somatic EGFR mutation testing. Oncologist. 2007 Jan; 12(1):90-8.
journal title abbreviation: Oncologist
publication date: 2007-01-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies.
PubMed Identifier: 16730237
author list: Ji H, Li D, Chen L, Shimamura T, Kobayashi S, McNamara K, Mahmood U, Mitchell A, Sun Y, Al-Hashem R, Chirieac LR, Padera R, Bronson RT, Kim W, Jänne PA, Shapiro GI, Tenen D, Johnson BE, Weissleder R, Sharpless NE, Wong KK
published in: Cancer cell
information resource reference: The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies. Cancer Cell. 2006 Jun; 9(6):485-95.
journal title abbreviation: Cancer Cell
publication date: 2006-05-25T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1064697
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma.

A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma.
PubMed Identifier: 29753120
author list: Burt BM, Richards WG, Lee HS, Bartel S, Dasilva MC, Gill RR, Jaklitsch MT, Johnson BE, Swanson SJ, Bueno R, Sugarbaker DJ
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma. J Thorac Oncol. 2018 09; 13(9):1400-1409.
journal title abbreviation: J Thorac Oncol
publication date: 2018-05-09T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

The BATTLE trial: personalizing therapy for lung cancer.
PubMed Identifier: 22586319
author list: Kim ES, Herbst RS, Wistuba II, Lee JJ, Blumenschein GR, Tsao A, Stewart DJ, Hicks ME, Erasmus J, Gupta S, Alden CM, Liu S, Tang X, Khuri FR, Tran HT, Johnson BE, Heymach JV, Mao L, Fossella F, Kies MS, Papadimitrakopoulou V, Davis SE, Lippman SM, Hong WK
published in: Cancer discovery
information resource reference: The BATTLE trial: personalizing therapy for lung cancer. Cancer Discov. 2011 Jun; 1(1):44-53.
journal title abbreviation: Cancer Discov
publication date: 2011-06-01T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

The impact of initial gefitinib or erlotinib versus chemotherapy on central nervous system progression in advanced non-small cell lung cancer with EGFR mutations.
PubMed Identifier: 22733536
author list: Heon S, Yeap BY, Lindeman NI, Joshi VA, Butaney M, Britt GJ, Costa DB, Rabin MS, Jackman DM, Johnson BE
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: The impact of initial gefitinib or erlotinib versus chemotherapy on central nervous system progression in advanced non-small cell lung cancer with EGFR mutations. Clin Cancer Res. 2012 Aug 15; 18(16):4406-14.
journal title abbreviation: Clin Cancer Res
publication date: 2012-06-25T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Everolimus and erlotinib as second- or third-line therapy in patients with advanced non-small-cell lung cancer.
PubMed Identifier: 22968184
author list: Papadimitrakopoulou VA, Soria JC, Jappe A, Jehl V, Klimovsky J, Johnson BE
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Everolimus and erlotinib as second- or third-line therapy in patients with advanced non-small-cell lung cancer. J Thorac Oncol. 2012 Oct; 7(10):1594-601.
journal title abbreviation: J Thorac Oncol
publication date: 2012-10-01T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.
PubMed Identifier: 22980975
author list: Imielinski M, Berger AH, Hammerman PS, Hernandez B, Pugh TJ, Hodis E, Cho J, Suh J, Capelletti M, Sivachenko A, Sougnez C, Auclair D, Lawrence MS, Stojanov P, Cibulskis K, Choi K, de Waal L, Sharifnia T, Brooks A, Greulich H, Banerji S, Zander T, Seidel D, Leenders F, Ansén S, Ludwig C, Engel-Riedel W, Stoelben E, Wolf J, Goparju C, Thompson K, Winckler W, Kwiatkowski D, Johnson BE, Jänne PA, Miller VA, Pao W, Travis WD, Pass HI, Gabriel SB, Lander ES, Thomas RK, Garraway LA, Getz G, Meyerson M
published in: Cell
information resource reference: Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell. 2012 Sep 14; 150(6):1107-20.
journal title abbreviation: Cell
publication date: 2012-09-14T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America.
PubMed Identifier: 12237922
author list: Jänne PA, Freidlin B, Saxman S, Johnson DH, Livingston RB, Shepherd FA, Johnson BE
published in: Cancer
information resource reference: Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America. Cancer. 2002 Oct 01; 95(7):1528-38.
journal title abbreviation: Cancer
publication date: 2002-10-01T00:00:00
year: 2002
type: Academic Article
type: Article
type: Document
type: Information Resource

A model to select regimens for phase III trials for patients with advanced-stage non-small cell lung cancer.
PubMed Identifier: 12631588
author list: Freidlin B, Breathnach OS, Johnson BE
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: A model to select regimens for phase III trials for patients with advanced-stage non-small cell lung cancer. Clin Cancer Res. 2003 Mar; 9(3):917-22.
journal title abbreviation: Clin Cancer Res
publication date: 2003-03-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1073978
type: Authorship
author rank in publication: 50
linked author: Johnson, Bruce
linked information resource: Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine.

Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine.
PubMed Identifier: 29903880
author list: Aguirre AJ, Nowak JA, Camarda ND, Moffitt RA, Ghazani AA, Hazar-Rethinam M, Raghavan S, Kim J, Brais LK, Ragon D, Welch MW, Reilly E, McCabe D, Marini L, Anderka K, Helvie K, Oliver N, Babic A, Da Silva A, Nadres B, Van Seventer EE, Shahzade HA, St Pierre JP, Burke KP, Clancy T, Cleary JM, Doyle LA, Jajoo K, McCleary NJ, Meyerhardt JA, Murphy JE, Ng K, Patel AK, Perez K, Rosenthal MH, Rubinson DA, Ryou M, Shapiro GI, Sicinska E, Silverman SG, Nagy RJ, Lanman RB, Knoerzer D, Welsch DJ, Yurgelun MB, Fuchs CS, Garraway LA, Getz G, Hornick JL, Johnson BE, Kulke MH, Mayer RJ, Miller JW, Shyn PB, Tuveson DA, Wagle N, Yeh JJ, Hahn WC, Corcoran RB, Carter SL, Wolpin BM
published in: Cancer discovery
information resource reference: Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine. Cancer Discov. 2018 09; 8(9):1096-1111.
journal title abbreviation: Cancer Discov
publication date: 2018-06-14T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening.
PubMed Identifier: 22882882
author list: McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Tramontano AC, Cipriano LE, Bouzan C, Gazelle GS
published in: Risk analysis : an official publication of the Society for Risk Analysis
information resource reference: Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening. Risk Anal. 2012 Jul; 32 Suppl 1:S117-24.
journal title abbreviation: Risk Anal
publication date: 2012-07-01T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting.
PubMed Identifier: 18281673
author list: Eberhard DA, Giaccone G, Johnson BE
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting. J Clin Oncol. 2008 Feb 20; 26(6):983-94.
journal title abbreviation: J Clin Oncol
publication date: 2008-02-20T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Selecting patients for epidermal growth factor receptor inhibitor treatment: A FISH story or a tale of mutations?
PubMed Identifier: 16145056
author list: Johnson BE, Jänne PA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Selecting patients for epidermal growth factor receptor inhibitor treatment: A FISH story or a tale of mutations? J Clin Oncol. 2005 Oct 01; 23(28):6813-6.
journal title abbreviation: J Clin Oncol
publication date: 2005-09-06T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Update: NCCN small cell and non-small cell lung cancer Clinical Practice Guidelines.
PubMed Identifier: 16280105
author list: Ettinger D, Johnson B
published in: Journal of the National Comprehensive Cancer Network : JNCCN
information resource reference: Update: NCCN small cell and non-small cell lung cancer Clinical Practice Guidelines. J Natl Compr Canc Netw. 2005 Nov; 3 Suppl 1:S17-21.
journal title abbreviation: J Natl Compr Canc Netw
publication date: 2005-11-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 113379
type: Authorship
author rank in publication: 2
linked author: Johnson, Bruce
linked information resource: Imatinib in small cell lung cancer.

Factors associated with smoking abstinence among smokers and recent-quitters with lung and head and neck cancer.
PubMed Identifier: 22093155
author list: Cooley ME, Wang Q, Johnson BE, Catalano P, Haddad RI, Bueno R, Emmons KM
published in: Lung cancer (Amsterdam, Netherlands)
information resource reference: Factors associated with smoking abstinence among smokers and recent-quitters with lung and head and neck cancer. Lung Cancer. 2012 May; 76(2):144-9.
journal title abbreviation: Lung Cancer
publication date: 2011-11-16T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib.
PubMed Identifier: 16818686
author list: Jackman DM, Yeap BY, Sequist LV, Lindeman N, Holmes AJ, Joshi VA, Bell DW, Huberman MS, Halmos B, Rabin MS, Haber DA, Lynch TJ, Meyerson M, Johnson BE, Jänne PA
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib. Clin Cancer Res. 2006 Jul 01; 12(13):3908-14.
journal title abbreviation: Clin Cancer Res
publication date: 2006-07-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/1075095
PubMed Identifier: 16857820
author list: Jänne PA, Johnson BE
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Effect of epidermal growth factor receptor tyrosine kinase domain mutations on the outcome of patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors. Clin Cancer Res. 2006 Jul 15; 12(14 Pt 2):4416s-4420s.
journal title abbreviation: Clin Cancer Res
publication date: 2006-07-15T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Effect of epidermal growth factor receptor tyrosine kinase domain mutations on the outcome of patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.

Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancer.
PubMed Identifier: 17228019
author list: Jackman DM, Yeap BY, Lindeman NI, Fidias P, Rabin MS, Temel J, Skarin AT, Meyerson M, Holmes AJ, Borras AM, Freidlin B, Ostler PA, Lucca J, Lynch TJ, Johnson BE, Jänne PA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancer. J Clin Oncol. 2007 Mar 01; 25(7):760-6.
journal title abbreviation: J Clin Oncol
publication date: 2007-01-16T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Gefitinib for recurrent non-small-cell lung cancer: all things are not created equal.
PubMed Identifier: 18779608
author list: Dahlberg SE, Gray RJ, Johnson BE
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Gefitinib for recurrent non-small-cell lung cancer: all things are not created equal. J Clin Oncol. 2008 Sep 10; 26(26):4233-5.
journal title abbreviation: J Clin Oncol
publication date: 2008-09-10T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Radiographic assessment and therapeutic decisions at RECIST progression in EGFR-mutant NSCLC treated with EGFR tyrosine kinase inhibitors.
PubMed Identifier: 23254265
author list: Nishino M, Cardarella S, Dahlberg SE, Jackman DM, Ramaiya NH, Hatabu H, Rabin MS, Jänne PA, Johnson BE
published in: Lung cancer (Amsterdam, Netherlands)
information resource reference: Radiographic assessment and therapeutic decisions at RECIST progression in EGFR-mutant NSCLC treated with EGFR tyrosine kinase inhibitors. Lung Cancer. 2013 Mar; 79(3):283-8.
journal title abbreviation: Lung Cancer
publication date: 2012-12-14T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Heart rate recovery and prognosis in heart failure patients.
PubMed Identifier: 18797918
author list: Kubrychtova V, Olson TP, Bailey KR, Thapa P, Allison TG, Johnson BD
published in: European journal of applied physiology
information resource reference: Heart rate recovery and prognosis in heart failure patients. Eur J Appl Physiol. 2009 Jan; 105(1):37-45.
journal title abbreviation: Eur J Appl Physiol
publication date: 2008-09-17T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period.
PubMed Identifier: 18988293
author list: McMahon PM, Kong CY, Weinstein MC, Tramontano AC, Cipriano LE, Johnson BE, Weeks JC, Gazelle GS
published in: Cancer
information resource reference: Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period. Cancer. 2008 Dec 15; 113(12):3440-9.
journal title abbreviation: Cancer
publication date: 2008-12-15T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
PubMed Identifier: 19551884
author list: Caglar HB, Baldini EH, Othus M, Rabin MS, Bueno R, Sugarbaker DJ, Mentzer SJ, Jänne PA, Johnson BE, Allen AM
published in: Cancer
information resource reference: Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery. Cancer. 2009 Sep 15; 115(18):4156-66.
journal title abbreviation: Cancer
publication date: 2009-09-15T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1090374
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: 2018 ASCO Presidential Address: "Delivering Discoveries: Expanding the Reach of Precision Medicine".

2018 ASCO Presidential Address: "Delivering Discoveries: Expanding the Reach of Precision Medicine".
PubMed Identifier: 30161020
author list: Johnson BE
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: 2018 ASCO Presidential Address: "Delivering Discoveries: Expanding the Reach of Precision Medicine". J Clin Oncol. 2018 10 10; 36(29):2899-2903.
journal title abbreviation: J Clin Oncol
publication date: 2018-08-30T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Adjuvant chemotherapy for surgically resected non-small cell lung cancer.
PubMed Identifier: 22502967
author list: Heon S, Johnson BE
published in: The Journal of thoracic and cardiovascular surgery
information resource reference: Adjuvant chemotherapy for surgically resected non-small cell lung cancer. J Thorac Cardiovasc Surg. 2012 Sep; 144(3):S39-42.
journal title abbreviation: J Thorac Cardiovasc Surg
publication date: 2012-04-13T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1092758
type: Authorship
author rank in publication: 10
linked author: Johnson, Bruce
linked information resource: Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer.

Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer.
PubMed Identifier: 30224342
author list: Dagogo-Jack I, Martinez P, Yeap BY, Ambrogio C, Ferris LA, Lydon C, Nguyen T, Jessop NA, Iafrate AJ, Johnson BE, Lennerz JK, Shaw AT, Awad MM
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer. Clin Cancer Res. 2019 01 01; 25(1):158-165.
journal title abbreviation: Clin Cancer Res
publication date: 2018-09-17T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Patient-reported receipt of and interest in smoking-cessation interventions after a diagnosis of cancer.
PubMed Identifier: 21692055
author list: Cooley ME, Emmons KM, Haddad R, Wang Q, Posner M, Bueno R, Cohen TJ, Johnson BE
published in: Cancer
information resource reference: Patient-reported receipt of and interest in smoking-cessation interventions after a diagnosis of cancer. Cancer. 2011 Jul 01; 117(13):2961-9.
journal title abbreviation: Cancer
publication date: 2011-01-10T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Tumoral cavitation in patients with non-small-cell lung cancer treated with antiangiogenic therapy using bevacizumab.
PubMed Identifier: 22743083
author list: Nishino M, Cryer SK, Okajima Y, Sholl LM, Hatabu H, Rabin MS, Jackman DM, Johnson BE
published in: Cancer imaging : the official publication of the International Cancer Imaging Society
information resource reference: Tumoral cavitation in patients with non-small-cell lung cancer treated with antiangiogenic therapy using bevacizumab. Cancer Imaging. 2012 Jun 29; 12:225-35.
journal title abbreviation: Cancer Imaging
publication date: 2012-06-29T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1095471
type: Authorship
author rank in publication: 6
linked author: Johnson, Bruce
linked information resource: Success of genomic profiling of non-small cell lung cancer biopsies obtained by trans-thoracic percutaneous needle biopsy.

Success of genomic profiling of non-small cell lung cancer biopsies obtained by trans-thoracic percutaneous needle biopsy.
PubMed Identifier: 30261097
author list: Gill RR, Murphy DJ, Kravets S, Sholl LM, Janne PA, Johnson BE
published in: Journal of surgical oncology
information resource reference: Success of genomic profiling of non-small cell lung cancer biopsies obtained by trans-thoracic percutaneous needle biopsy. J Surg Oncol. 2018 Dec; 118(7):1170-1177.
journal title abbreviation: J Surg Oncol
publication date: 2018-09-27T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Small cell lung cancer clinical practice guidelines in oncology.
PubMed Identifier: 16813728
author list: Johnson BE, Crawford J, Downey RJ, Ettinger DS, Fossella F, Grecula JC, Jahan T, Kalemkerian GP, Kessinger A, Koczywas M, Langer CJ, Martins R, Marymont MH, Niell HB, Ramnath N, Robert F, Williams CC
published in: Journal of the National Comprehensive Cancer Network : JNCCN
information resource reference: Small cell lung cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2006 Jul; 4(6):602-22.
journal title abbreviation: J Natl Compr Canc Netw
publication date: 2006-07-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Beta2-adrenergic receptor genotype and pulmonary function in patients with heart failure.
PubMed Identifier: 17099033
author list: Snyder EM, Turner ST, Johnson BD
published in: Chest
information resource reference: Beta2-adrenergic receptor genotype and pulmonary function in patients with heart failure. Chest. 2006 Nov; 130(5):1527-34.
journal title abbreviation: Chest
publication date: 2006-11-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Human phenylethanolamine N-methyltransferase genetic polymorphisms and exercise-induced epinephrine release.
PubMed Identifier: 18349382
author list: Ji Y, Snyder EM, Fridley BL, Salavaggione OE, Moon I, Batzler A, Yee VC, Schaid DJ, Joyner MJ, Johnson BD, Weinshilboum RM
published in: Physiological genomics
information resource reference: Human phenylethanolamine N-methyltransferase genetic polymorphisms and exercise-induced epinephrine release. Physiol Genomics. 2008 May 13; 33(3):323-32.
journal title abbreviation: Physiol Genomics
publication date: 2008-03-18T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma.
PubMed Identifier: 18543326
author list: Jackman DM, Kindler HL, Yeap BY, Fidias P, Salgia R, Lucca J, Morse LK, Ostler PA, Johnson BE, Jänne PA
published in: Cancer
information resource reference: Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma. Cancer. 2008 Aug 15; 113(4):808-14.
journal title abbreviation: Cancer
publication date: 2008-08-15T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.
PubMed Identifier: 19671850
author list: Rodig SJ, Mino-Kenudson M, Dacic S, Yeap BY, Shaw A, Barletta JA, Stubbs H, Law K, Lindeman N, Mark E, Janne PA, Lynch T, Johnson BE, Iafrate AJ, Chirieac LR
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population. Clin Cancer Res. 2009 Aug 15; 15(16):5216-23.
journal title abbreviation: Clin Cancer Res
publication date: 2009-08-11T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial.
PubMed Identifier: 20570559
author list: Herbst RS, Sun Y, Eberhardt WE, Germonpré P, Saijo N, Zhou C, Wang J, Li L, Kabbinavar F, Ichinose Y, Qin S, Zhang L, Biesma B, Heymach JV, Langmuir P, Kennedy SJ, Tada H, Johnson BE
published in: The Lancet. Oncology
information resource reference: Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial. Lancet Oncol. 2010 Jul; 11(7):619-26.
journal title abbreviation: Lancet Oncol
publication date: 2010-07-01T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

A pulmonary hypertension gas exchange severity (PH-GXS) score to assist with the assessment and monitoring of pulmonary arterial hypertension.
PubMed Identifier: 22245407
author list: Woods PR, Taylor BJ, Frantz RP, Johnson BD
published in: The American journal of cardiology
information resource reference: A pulmonary hypertension gas exchange severity (PH-GXS) score to assist with the assessment and monitoring of pulmonary arterial hypertension. Am J Cardiol. 2012 Apr 01; 109(7):1066-72.
journal title abbreviation: Am J Cardiol
publication date: 2012-01-14T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1110364
type: Authorship
author rank in publication: 46
linked author: Johnson, Bruce
linked information resource: A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.

A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.
PubMed Identifier: 30388455
author list: Jerby-Arnon L, Shah P, Cuoco MS, Rodman C, Su MJ, Melms JC, Leeson R, Kanodia A, Mei S, Lin JR, Wang S, Rabasha B, Liu D, Zhang G, Margolais C, Ashenberg O, Ott PA, Buchbinder EI, Haq R, Hodi FS, Boland GM, Sullivan RJ, Frederick DT, Miao B, Moll T, Flaherty KT, Herlyn M, Jenkins RW, Thummalapalli R, Kowalczyk MS, Cañadas I, Schilling B, Cartwright ANR, Luoma AM, Malu S, Hwu P, Bernatchez C, Forget MA, Barbie DA, Shalek AK, Tirosh I, Sorger PK, Wucherpfennig K, Van Allen EM, Schadendorf D, Johnson BE, Rotem A, Rozenblatt-Rosen O, Garraway LA, Yoon CH, Izar B, Regev A
published in: Cell
information resource reference: A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade. Cell. 2018 11 01; 175(4):984-997.e24.
journal title abbreviation: Cell
publication date: 2018-11-01T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 135106
type: Authorship
author rank in publication: 4
linked author: Johnson, Bruce
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/1169623

Expression of bcl-2 protein is associated with shorter survival in nonsmall cell lung carcinoma.
PubMed Identifier: 12833466
author list: Huang CI, Neuberg D, Johnson BE, Wei JY, Christiani DC
published in: Cancer
information resource reference: Expression of bcl-2 protein is associated with shorter survival in nonsmall cell lung carcinoma. Cancer. 2003 Jul 01; 98(1):135-43.
journal title abbreviation: Cancer
publication date: 2003-07-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

Novel agents in the treatment of lung cancer: conference summary statement.
PubMed Identifier: 15217958
author list: Lynch TJ, Adjei AA, Bunn PA, DuBois RN, Gandara DR, Giaccone G, Govindan R, Herbst RS, Johnson BE, Khuri FR, Perez-Soler R, Rosell R, Rowinsky EK, Sandler AB, Scagliotti GV, Schiller JH, Shapiro GI, Socinski MA, Hart CS
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Novel agents in the treatment of lung cancer: conference summary statement. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 2):4199s-4204s.
journal title abbreviation: Clin Cancer Res
publication date: 2004-06-15T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Farnesyl transferase inhibitors for patients with lung cancer.
PubMed Identifier: 15217969
author list: Johnson BE, Heymach JV
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Farnesyl transferase inhibitors for patients with lung cancer. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 2):4254s-4257s.
journal title abbreviation: Clin Cancer Res
publication date: 2004-06-15T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models.
PubMed Identifier: 17510423
author list: Ji H, Wang Z, Perera SA, Li D, Liang MC, Zaghlul S, McNamara K, Chen L, Albert M, Sun Y, Al-Hashem R, Chirieac LR, Padera R, Bronson RT, Thomas RK, Garraway LA, Jänne PA, Johnson BE, Chin L, Wong KK
published in: Cancer research
information resource reference: Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models. Cancer Res. 2007 May 15; 67(10):4933-9.
journal title abbreviation: Cancer Res
publication date: 2007-05-15T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.
PubMed Identifier: 19949011
author list: Jackman D, Pao W, Riely GJ, Engelman JA, Kris MG, Jänne PA, Lynch T, Johnson BE, Miller VA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer. J Clin Oncol. 2010 Jan 10; 28(2):357-60.
journal title abbreviation: J Clin Oncol
publication date: 2009-11-30T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1120656
type: Authorship
author rank in publication: 3
linked author: Johnson, Bruce
linked information resource: Race, Poverty, and Initial Implementation of Precision Medicine for Lung Cancer.

Authorship 1121240
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: Automated image analysis tool for tumor volume growth rate to guide precision cancer therapy: EGFR-mutant non-small-cell lung cancer as a paradigm.

Automated image analysis tool for tumor volume growth rate to guide precision cancer therapy: EGFR-mutant non-small-cell lung cancer as a paradigm.
PubMed Identifier: 30527314
author list: Nishino M, Wakai S, Hida T, Dahlberg SE, Ozaki M, Hatabu H, Tachizaki H, Johnson BE
published in: European journal of radiology
information resource reference: Automated image analysis tool for tumor volume growth rate to guide precision cancer therapy: EGFR-mutant non-small-cell lung cancer as a paradigm. Eur J Radiol. 2018 Dec; 109:68-76.
journal title abbreviation: Eur J Radiol
publication date: 2018-10-23T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Race, Poverty, and Initial Implementation of Precision Medicine for Lung Cancer.
PubMed Identifier: 30576459
author list: Kehl KL, Lathan CS, Johnson BE, Schrag D
published in: Journal of the National Cancer Institute
information resource reference: Race, Poverty, and Initial Implementation of Precision Medicine for Lung Cancer. J Natl Cancer Inst. 2019 04 01; 111(4):431-434.
journal title abbreviation: J Natl Cancer Inst
publication date: 2019-04-01T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

The Cellular Geography of Therapeutic Resistance in Cancer
end date: 2024-08-31
principal investigator name: JOHNSON, BRUCE E.
start date: 2018-09-24
type: Grant
sponsor award id: U2CCA233195

Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology.
PubMed Identifier: 15886310
author list: Jänne PA, Engelman JA, Johnson BE
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology. J Clin Oncol. 2005 May 10; 23(14):3227-34.
journal title abbreviation: J Clin Oncol
publication date: 2005-05-10T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
PubMed Identifier: 16000607
author list: Johnson BE, Rabin MS
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer. Clin Cancer Res. 2005 Jul 01; 11(13 Pt 2):5022s-5026s.
journal title abbreviation: Clin Cancer Res
publication date: 2005-07-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening.
PubMed Identifier: 16467085
author list: Jänne PA, Borras AM, Kuang Y, Rogers AM, Joshi VA, Liyanage H, Lindeman N, Lee JC, Halmos B, Maher EA, Distel RJ, Meyerson M, Johnson BE
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening. Clin Cancer Res. 2006 Feb 01; 12(3 Pt 1):751-8.
journal title abbreviation: Clin Cancer Res
publication date: 2006-02-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Paraneoplastic syndromes associated with small cell lung cancer.
PubMed Identifier: 16813730
author list: Gandhi L, Johnson BE
published in: Journal of the National Comprehensive Cancer Network : JNCCN
information resource reference: Paraneoplastic syndromes associated with small cell lung cancer. J Natl Compr Canc Netw. 2006 Jul; 4(6):631-8.
journal title abbreviation: J Natl Compr Canc Netw
publication date: 2006-07-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Epidermal growth factor receptor mutation testing in the care of lung cancer patients.
PubMed Identifier: 16857818
author list: Sequist LV, Joshi VA, Jänne PA, Bell DW, Fidias P, Lindeman NI, Louis DN, Lee JC, Mark EJ, Longtine J, Verlander P, Kucherlapati R, Meyerson M, Haber DA, Johnson BE, Lynch TJ
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Epidermal growth factor receptor mutation testing in the care of lung cancer patients. Clin Cancer Res. 2006 Jul 15; 12(14 Pt 2):4403s-4408s.
journal title abbreviation: Clin Cancer Res
publication date: 2006-07-15T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.
PubMed Identifier: 17463250
author list: Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park JO, Lindeman N, Gale CM, Zhao X, Christensen J, Kosaka T, Holmes AJ, Rogers AM, Cappuzzo F, Mok T, Lee C, Johnson BE, Cantley LC, Jänne PA
published in: Science (New York, N.Y.)
information resource reference: MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science. 2007 May 18; 316(5827):1039-43.
journal title abbreviation: Science
publication date: 2007-04-26T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1125605
type: Authorship
author rank in publication: 14
linked author: Johnson, Bruce
linked information resource: Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancer.

Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancer.
PubMed Identifier: 30642457
author list: Horn L, Bauml J, Forde PM, Davis KL, Myall NJ, Sasane M, Dalal A, Culver K, Wozniak AJ, Baik CS, Mutebi A, Zhang P, Wakelee HA, Johnson BE
published in: Lung cancer (Amsterdam, Netherlands)
information resource reference: Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancer. Lung Cancer. 2019 02; 128:74-90.
journal title abbreviation: Lung Cancer
publication date: 2018-12-06T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations.
PubMed Identifier: 18458038
author list: Sequist LV, Martins RG, Spigel D, Grunberg SM, Spira A, Jänne PA, Joshi VA, McCollum D, Evans TL, Muzikansky A, Kuhlmann GL, Han M, Goldberg JS, Settleman J, Iafrate AJ, Engelman JA, Haber DA, Johnson BE, Lynch TJ
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations. J Clin Oncol. 2008 May 20; 26(15):2442-9.
journal title abbreviation: J Clin Oncol
publication date: 2008-05-05T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma.
PubMed Identifier: 19040416
author list: Barletta JA, Perner S, Iafrate AJ, Yeap BY, Weir BA, Johnson LA, Johnson BE, Meyerson M, Rubin MA, Travis WD, Loda M, Chirieac LR
published in: Journal of cellular and molecular medicine
information resource reference: Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma. J Cell Mol Med. 2009 Aug; 13(8B):1977-1986.
journal title abbreviation: J Cell Mol Med
publication date: 2009-08-01T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Impact of graft volume reduction for oversized grafts after lung transplantation on outcome in recipients with end-stage restrictive pulmonary diseases.
PubMed Identifier: 19201337
author list: Shigemura N, Bermudez C, Hattler BG, Johnson B, Crespo M, Pilewski J, Toyoda Y
published in: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
information resource reference: Impact of graft volume reduction for oversized grafts after lung transplantation on outcome in recipients with end-stage restrictive pulmonary diseases. J Heart Lung Transplant. 2009 Feb; 28(2):130-4.
journal title abbreviation: J Heart Lung Transplant
publication date: 2009-02-01T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Predictive value of heart rate recovery and peak oxygen consumption for long-term mortality in patients with coronary heart disease.
PubMed Identifier: 19539069
author list: Aijaz B, Squires RW, Thomas RJ, Johnson BD, Allison TG
published in: The American journal of cardiology
information resource reference: Predictive value of heart rate recovery and peak oxygen consumption for long-term mortality in patients with coronary heart disease. Am J Cardiol. 2009 Jun 15; 103(12):1641-6.
journal title abbreviation: Am J Cardiol
publication date: 2009-04-16T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/1169623
PubMed Identifier: 19619785
author list: Tilleman TR, Richards WG, Zellos L, Johnson BE, Jaklitsch MT, Mueller J, Yeap BY, Mujoomdar AA, Ducko CT, Bueno R, Sugarbaker DJ
published in: The Journal of thoracic and cardiovascular surgery
information resource reference: Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. J Thorac Cardiovasc Surg. 2009 Aug; 138(2):405-11.
journal title abbreviation: J Thorac Cardiovasc Surg
publication date: 2009-08-01T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.

https://connects.catalyst.harvard.edu/Profiles/profile/1170781
PubMed Identifier: 20729419
author list: Nishino M, Jackman DM, Hatabu H, Yeap BY, Cioffredi LA, Yap JT, Jänne PA, Johnson BE, Van den Abbeele AD
published in: AJR. American journal of roentgenology
information resource reference: New Response Evaluation Criteria in Solid Tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy. AJR Am J Roentgenol. 2010 Sep; 195(3):W221-8.
journal title abbreviation: AJR Am J Roentgenol
publication date: 2010-09-01T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource
label: New Response Evaluation Criteria in Solid Tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy.

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.
PubMed Identifier: 21252716
author list: Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M, Yankelewitz D
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011 Feb; 6(2):244-85.
journal title abbreviation: J Thorac Oncol
publication date: 2011-02-01T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.
PubMed Identifier: 22328973
author list: Hammerman PS, Sos ML, Ramos AH, Xu C, Dutt A, Zhou W, Brace LE, Woods BA, Lin W, Zhang J, Deng X, Lim SM, Heynck S, Peifer M, Simard JR, Lawrence MS, Onofrio RC, Salvesen HB, Seidel D, Zander T, Heuckmann JM, Soltermann A, Moch H, Koker M, Leenders F, Gabler F, Querings S, Ansén S, Brambilla E, Brambilla C, Lorimier P, Brustugun OT, Helland A, Petersen I, Clement JH, Groen H, Timens W, Sietsma H, Stoelben E, Wolf J, Beer DG, Tsao MS, Hanna M, Hatton C, Eck MJ, Janne PA, Johnson BE, Winckler W, Greulich H, Bass AJ, Cho J, Rauh D, Gray NS, Wong KK, Haura EB, Thomas RK, Meyerson M
published in: Cancer discovery
information resource reference: Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer. Cancer Discov. 2011 Jun; 1(1):78-89.
journal title abbreviation: Cancer Discov
publication date: 2011-06-01T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1129175
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome.

Authorship 1129696
type: Authorship
author rank in publication: 25
linked author: Johnson, Bruce
linked information resource: Clinical Cancer Advances 2019: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.

M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome.
PubMed Identifier: 30696724
author list: Park H, Dahlberg SE, Lydon CA, Araki T, Hatabu H, Rabin MS, Johnson BE, Nishino M
published in: The oncologist
information resource reference: M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome. Oncologist. 2019 08; 24(8):e749-e754.
journal title abbreviation: Oncologist
publication date: 2019-01-29T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Clinical Cancer Advances 2019: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
PubMed Identifier: 30702028
author list: Pal SK, Miller MJ, Agarwal N, Chang SM, Chavez-MacGregor M, Cohen E, Cole S, Dale W, Magid Diefenbach CS, Disis ML, Dreicer R, Graham DL, Henry NL, Jones J, Keedy V, Klepin HD, Markham MJ, Mittendorf EA, Rodriguez-Galindo C, Sabel MS, Schilsky RL, Sznol M, Tap WD, Westin SN, Johnson BE
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Clinical Cancer Advances 2019: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. J Clin Oncol. 2019 04 01; 37(10):834-849.
journal title abbreviation: J Clin Oncol
publication date: 2019-01-31T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 145264
type: Authorship
author rank in publication: 3
linked author: Johnson, Bruce
linked information resource: Socioeconomic marginality and health services utilization among Central Harlem substance users.

Carcinoma, Small Cell
MeSH DescriptorUI: D018288
MeSH semantic group name: Disorders
number of authors: 230
number of publications: 414
uniqueness weight: 0.822813
type: Concept

Authorship 114869
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.

Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome.
PubMed Identifier: 30984804
author list: Araki T, Dahlberg SE, Hida T, Lydon CA, Rabin MS, Hatabu H, Johnson BE, Nishino M
published in: European journal of radiology open
information resource reference: Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome. Eur J Radiol Open. 2019; 6:128-131.
journal title abbreviation: Eur J Radiol Open
publication date: 2019-03-29T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Proto-Oncogene Proteins B-raf
MeSH DescriptorUI: D048493
MeSH semantic group name: Chemicals & Drugs
number of authors: 664
number of publications: 2211
uniqueness weight: 0.479506
type: Concept

Authorship 1141158
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome.

Carcinoma, Non-Small-Cell Lung
MeSH DescriptorUI: D002289
MeSH semantic group name: Disorders
number of authors: 1102
number of publications: 5718
uniqueness weight: 0.259527
type: Concept

Authorship 1144980
type: Authorship
author rank in publication: 5
linked author: Johnson, Bruce
linked information resource: Tumor Volume Analysis as a Predictive Marker for Prolonged Survival in Anaplastic Lymphoma Kinase-rearranged Advanced Non-Small Cell Lung Cancer Patients Treated With Crizotinib.

Authorship 1144551
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer.

Authorship 1146415
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience.

Tumor Volume Analysis as a Predictive Marker for Prolonged Survival in Anaplastic Lymphoma Kinase-rearranged Advanced Non-Small Cell Lung Cancer Patients Treated With Crizotinib.
PubMed Identifier: 30985604
author list: Hida T, Dahlberg SE, Lydon CA, Hatabu H, Johnson BE, Awad MM, Nishino M
published in: Journal of thoracic imaging
information resource reference: Tumor Volume Analysis as a Predictive Marker for Prolonged Survival in Anaplastic Lymphoma Kinase-rearranged Advanced Non-Small Cell Lung Cancer Patients Treated With Crizotinib. J Thorac Imaging. 2020 Mar; 35(2):101-107.
journal title abbreviation: J Thorac Imaging
publication date: 2020-03-01T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience.
PubMed Identifier: 30735816
author list: El Osta B, Behera M, Kim S, Berry LD, Sica G, Pillai RN, Owonikoko TK, Kris MG, Johnson BE, Kwiatkowski DJ, Sholl LM, Aisner DL, Bunn PA, Khuri FR, Ramalingam SS
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience. J Thorac Oncol. 2019 05; 14(5):876-889.
journal title abbreviation: J Thorac Oncol
publication date: 2019-02-05T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer.
PubMed Identifier: 30922388
author list: Ricciuti B, Kravets S, Dahlberg SE, Umeton R, Albayrak A, Subegdjo SJ, Johnson BE, Nishino M, Sholl LM, Awad MM
published in: Journal for immunotherapy of cancer
information resource reference: Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer. J Immunother Cancer. 2019 03 28; 7(1):87.
journal title abbreviation: J Immunother Cancer
publication date: 2019-03-28T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Lung Neoplasms
MeSH DescriptorUI: D008175
MeSH semantic group name: Disorders
number of authors: 2605
number of publications: 14119
uniqueness weight: 0.173058
type: Concept

Authorship 124125
type: Authorship
author rank in publication: 5
linked author: Johnson, Bruce
linked information resource: Plasma leptin and prognosis in patients with established coronary atherosclerosis.

Quinazolines
MeSH DescriptorUI: D011799
MeSH semantic group name: Chemicals & Drugs
number of authors: 467
number of publications: 1368
uniqueness weight: 0.622703
type: Concept

Emeritus
type: Department
type: Organization

Environmental Health
type: Department
type: Organization

Medicine
type: Department
type: Organization

Pathology
type: Department
type: Organization

Pediatrics
type: Department
type: Organization

Radiology
type: Department
type: Organization

Hematology/Oncology
type: Division
type: Organization

Oncology
type: Division
type: Organization

Beth Israel Deaconess Medical Center
type: Organization

Brigham and Women's Hospital
type: Organization

Boston Children's Hospital
type: Organization

Dana-Farber Cancer Institute
type: Organization

Harvard Medical School
type: Organization

Harvard T.H. Chan School of Public Health
type: Organization

Massachusetts General Hospital
type: Organization

Christiani, David
eCommons Login: DCC5
first name: David
last name: Christiani
full name: David Christopher Christiani, M.D.
has faculty rank: Full Professor
latitude: 42.33570000000000
longitude: -71.10169990000000
photo: https://connects.catalyst.harvard.edu/Profiles/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx
Person ID: 14998
person in primary position: Elkan Blout Professor of Environmental Genetics
type: Agent
type: Person
preferred title: Elkan Blout Professor of Environmental Genetics

Loda, Massimo
eCommons Login: MFL3
first name: Massimo
last name: Loda
full name: Massimo Loda, M.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 50956
person in primary position: Professor of Pathology, Emeritus
type: Agent
type: Person
preferred title: Professor of Pathology, Emeritus

Canellos, George
eCommons Login: GPC1
first name: George
last name: Canellos
full name: George Peter Canellos, M.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 84865
person in primary position: William Rosenberg Professor of Medicine, Emeritus
type: Agent
type: Person
preferred title: William Rosenberg Professor of Medicine, Emeritus

Grier, Holcombe
eCommons Login: HEG3
first name: Holcombe
last name: Grier
full name: Holcombe Edwin Grier, M.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 57897
person in primary position: Professor of Pediatrics, Emeritus
type: Agent
type: Person
preferred title: Professor of Pediatrics, Emeritus

Sholl, Lynette
eCommons Login: LMS22
first name: Lynette
last name: Sholl
full name: Lynette Marie Sholl, M.D.
has faculty rank: Full Professor
latitude: 42.33510370000000
longitude: -71.10616490000000
Person ID: 87212
person in primary position: Professor of Pathology
type: Agent
type: Person
preferred title: Professor of Pathology

Sequist, Lecia
eCommons Login: LVS1
first name: Lecia
last name: Sequist
full name: Lecia Vandam Sequist, M.D.
has faculty rank: Full Professor
latitude: 42.36239000000000
longitude: -71.06931690000000
Person ID: 28331
person in primary position: Landry Family Professor of Medicine in the Field of Medical Oncology
type: Agent
type: Person
preferred title: Landry Family Professor of Medicine in the Field of Medical Oncology

Dahlberg, Suzanne
eCommons Login: SES15
first name: Suzanne
last name: Dahlberg
full name: Suzanne Dahlberg, Ph.D.
has faculty rank: Associate Professor
latitude: 42.33517680000000
longitude: -71.10240210000000
photo: https://connects.catalyst.harvard.edu/Profiles/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx
Person ID: 53598
person in primary position: Associate Professor of Pediatrics
type: Agent
type: Person
preferred title: Associate Professor of Pediatrics

selected publications
maximum weight: 1
minimum weight: 1
number of connections: 303
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/113
predicate: selected publications
type: Network

research areas
maximum weight: 8.24429
minimum weight: 0.00302684
number of connections: 691
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/217
predicate: research areas
type: Network

coauthor of
maximum weight: 6.96768
minimum weight: 0.012602
number of connections: 293
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/363
predicate: coauthor of
type: Network

similar to
maximum weight: 242.809
minimum weight: 43.7515
number of connections: 60
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/494
predicate: similar to
type: Network

Jackman, David M
eCommons Login: DMJ1
first name: David M
last name: Jackman
full name: David M Jackman, M.D.
has faculty rank: Assistant Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 33548
person in primary position: Assistant Professor of Medicine
type: Agent
type: Person
preferred title: Assistant Professor of Medicine

Iglehart, James
eCommons Login: JDI1
first name: James
last name: Iglehart
full name: James Dirk Iglehart, M.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 55207
person in primary position: Anne E. Dyson Professor in Women's Cancers, Emeritus
type: Agent
type: Person
preferred title: Anne E. Dyson Professor in Women's Cancers, Emeritus

Gainor, Justin
eCommons Login: JFG5
first name: Justin
last name: Gainor
full name: Justin Franklin Gainor, M.D.
has faculty rank: Associate Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 64512
person in primary position: Associate Professor of Medicine
type: Agent
type: Person
preferred title: Associate Professor of Medicine

Nishino Hatabu, Mizuki
eCommons Login: MN41
first name: Mizuki
last name: Nishino Hatabu
full name: Mizuki Nishino Hatabu, M.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 64881
person in primary position: Professor of Radiology
type: Agent
type: Person
preferred title: Professor of Radiology

Shaw, Alice
eCommons Login: APT1
first name: Alice
last name: Shaw
full name: Alice Tsang Shaw, M.D., Ph.D.
has faculty rank: Full Professor
latitude: 42.36241700000000
longitude: -71.06893700000000
Person ID: 7296
person in primary position: George P. Canellos, MD, and Jean S. Canellos Professor of Medicine Professor of Medicine
type: Agent
type: Person
preferred title: George P. Canellos, MD, and Jean S. Canellos Professor of Medicine Professor of Medicine

Kantoff, Philip
eCommons Login: PWK1
first name: Philip
last name: Kantoff
full name: Philip Kantoff, M.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 15015
person in primary position: Jerome and Nancy Kohlberg Professor of Medicine, Emeritus
type: Agent
type: Person
preferred title: Jerome and Nancy Kohlberg Professor of Medicine, Emeritus

Costa, Daniel
eCommons Login: DBC4
first name: Daniel
last name: Costa
full name: Daniel Botelho Costa, M.D., Ph.D.
has faculty rank: Full Professor
latitude: 42.34022770000000
longitude: -71.10585400000000
photo: https://connects.catalyst.harvard.edu/Profiles/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx
Person ID: 17541
person in primary position: Professor of Medicine
type: Agent
type: Person
preferred title: Professor of Medicine

Janne, Pasi
eCommons Login: PAJ1
first name: Pasi
last name: Janne
full name: Pasi Antero Janne, M.D.,Ph.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 711
person in primary position: Professor of Medicine
type: Agent
type: Person
preferred title: Professor of Medicine

Authorship 1165201
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium.

MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium.
PubMed Identifier: 31228623
author list: Guo R, Berry LD, Aisner DL, Sheren J, Boyle T, Bunn PA, Johnson BE, Kwiatkowski DJ, Drilon A, Sholl LM, Kris MG
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium. J Thorac Oncol. 2019 09; 14(9):1666-1671.
journal title abbreviation: J Thorac Oncol
publication date: 2019-06-20T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 134937
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer.

Authorship 1175647
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: Assessment of Deep Natural Language Processing in Ascertaining Oncologic Outcomes From Radiology Reports.

Assessment of Deep Natural Language Processing in Ascertaining Oncologic Outcomes From Radiology Reports.
PubMed Identifier: 31343664
author list: Kehl KL, Elmarakeby H, Nishino M, Van Allen EM, Lepisto EM, Hassett MJ, Johnson BE, Schrag D
published in: JAMA oncology
information resource reference: Assessment of Deep Natural Language Processing in Ascertaining Oncologic Outcomes From Radiology Reports. JAMA Oncol. 2019 Oct 01; 5(10):1421-1429.
journal title abbreviation: JAMA Oncol
publication date: 2019-10-01T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Principal Investigator
type: Researcher Role
researcher role of: Johnson, Bruce
contributes to: The Cellular Geography of Therapeutic Resistance in Cancer

Landry Family Professor of Medicine in the Field of Medical Oncology
is primary position: true
position in department: Medicine
position in division: Hematology/Oncology
sort order: 1
type: Position
HR job title: Landry Family Professor of Medicine in the Field of Medical Oncology
position in organization: Massachusetts General Hospital

Assistant Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: Assistant Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Authorship 121480
type: Authorship
author rank in publication: 2
linked author: Johnson, Bruce
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/1075095

Authorship 158316
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/923964

Authorship 1207334
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: From clinical specimens to human cancer preclinical models-a journey the NCI-cell line database-25 years later.

From clinical specimens to human cancer preclinical models-a journey the NCI-cell line database-25 years later.
PubMed Identifier: 31803961
author list: Mulshine JL, Ujhazy P, Antman M, Burgess CM, Kuzmin I, Bunn PA, Johnson BE, Roth JA, Pass HI, Ross SM, Aldige CR, Wistuba II, Minna JD
published in: Journal of cellular biochemistry
information resource reference: From clinical specimens to human cancer preclinical models-a journey the NCI-cell line database-25 years later. J Cell Biochem. 2020 Aug; 121(8-9):3986-3999.
journal title abbreviation: J Cell Biochem
publication date: 2019-12-05T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1218384
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: The impact of quantitative CT-based tumor volumetric features on the outcomes of patients with limited stage small cell lung cancer.

The impact of quantitative CT-based tumor volumetric features on the outcomes of patients with limited stage small cell lung cancer.
PubMed Identifier: 31937336
author list: Kamran SC, Coroller T, Milani N, Agrawal V, Baldini EH, Chen AB, Johnson BE, Kozono D, Franco I, Chopra N, Zeleznik R, Aerts HJWL, Mak R
published in: Radiation oncology (London, England)
information resource reference: The impact of quantitative CT-based tumor volumetric features on the outcomes of patients with limited stage small cell lung cancer. Radiat Oncol. 2020 Jan 14; 15(1):14.
journal title abbreviation: Radiat Oncol
publication date: 2020-01-14T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 152524
type: Authorship
author rank in publication: 4
linked author: Johnson, Bruce
linked information resource: Impact of graft volume reduction for oversized grafts after lung transplantation on outcome in recipients with end-stage restrictive pulmonary diseases.

Authorship 163353
type: Authorship
author rank in publication: 14
linked author: Johnson, Bruce
linked information resource: Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer.

Authorship 1231524
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Training oncologists to carry out clinical trials.

Authorship 1233497
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Expanding the Reach of Targeted Therapy in Lung Cancer.

Expanding the Reach of Targeted Therapy in Lung Cancer.
PubMed Identifier: 32120617
author list: Johnson BE
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Expanding the Reach of Targeted Therapy in Lung Cancer. Ann Oncol. 2017 Oct; 28 Suppl 9:ix5.
journal title abbreviation: Ann Oncol
publication date: 2017-10-01T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Training oncologists to carry out clinical trials.
PubMed Identifier: 32120469
author list: Johnson BE
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Training oncologists to carry out clinical trials. Ann Oncol. 2017 Oct; 28 Suppl 9:ix1.
journal title abbreviation: Ann Oncol
publication date: 2017-10-01T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1235394
type: Authorship
author rank in publication: 38
linked author: Johnson, Bruce
linked information resource: Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma.

Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma.
PubMed Identifier: 32203465
author list: Shih DJH, Nayyar N, Bihun I, Dagogo-Jack I, Gill CM, Aquilanti E, Bertalan M, Kaplan A, D'Andrea MR, Chukwueke U, Ippen FM, Alvarez-Breckenridge C, Camarda ND, Lastrapes M, McCabe D, Kuter B, Kaufman B, Strickland MR, Martinez-Gutierrez JC, Nagabhushan D, De Sauvage M, White MD, Castro BA, Hoang K, Kaneb A, Batchelor ED, Paek SH, Park SH, Martinez-Lage M, Berghoff AS, Merrill P, Gerstner ER, Batchelor TT, Frosch MP, Frazier RP, Borger DR, Iafrate AJ, Johnson BE, Santagata S, Preusser M, Cahill DP, Carter SL, Brastianos PK
published in: Nature genetics
information resource reference: Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma. Nat Genet. 2020 04; 52(4):371-377.
journal title abbreviation: Nat Genet
publication date: 2020-03-23T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 168735
type: Authorship
author rank in publication: 6
linked author: Johnson, Bruce
linked information resource: Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.

The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution.
PubMed Identifier: 32302568
author list: Rozenblatt-Rosen O, Regev A, Oberdoerffer P, Nawy T, Hupalowska A, Rood JE, Ashenberg O, Cerami E, Coffey RJ, Demir E, Ding L, Esplin ED, Ford JM, Goecks J, Ghosh S, Gray JW, Guinney J, Hanlon SE, Hughes SK, Hwang ES, Iacobuzio-Donahue CA, Jané-Valbuena J, Johnson BE, Lau KS, Lively T, Mazzilli SA, Pe'er D, Santagata S, Shalek AK, Schapiro D, Snyder MP, Sorger PK, Spira AE, Srivastava S, Tan K, West RB, Williams EH
published in: Cell
information resource reference: The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution. Cell. 2020 04 16; 181(2):236-249.
journal title abbreviation: Cell
publication date: 2020-04-16T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1241243
type: Authorship
author rank in publication: 23
linked author: Johnson, Bruce
linked information resource: The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution.

Authorship 1248392
type: Authorship
author rank in publication: 47
linked author: Johnson, Bruce
linked information resource: A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors.

A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors.
PubMed Identifier: 32405060
author list: Slyper M, Porter CBM, Ashenberg O, Waldman J, Drokhlyansky E, Wakiro I, Smillie C, Smith-Rosario G, Wu J, Dionne D, Vigneau S, Jané-Valbuena J, Tickle TL, Napolitano S, Su MJ, Patel AG, Karlstrom A, Gritsch S, Nomura M, Waghray A, Gohil SH, Tsankov AM, Jerby-Arnon L, Cohen O, Klughammer J, Rosen Y, Gould J, Nguyen L, Hofree M, Tramontozzi PJ, Li B, Wu CJ, Izar B, Haq R, Hodi FS, Yoon CH, Hata AN, Baker SJ, Suvà ML, Bueno R, Stover EH, Clay MR, Dyer MA, Collins NB, Matulonis UA, Wagle N, Johnson BE, Rotem A, Rozenblatt-Rosen O, Regev A
published in: Nature medicine
information resource reference: A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. Nat Med. 2020 05; 26(5):792-802.
journal title abbreviation: Nat Med
publication date: 2020-05-11T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 182335
type: Authorship
author rank in publication: 3
linked author: Johnson, Bruce
linked information resource: Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology.

Authorship 203895
type: Authorship
author rank in publication: 6
linked author: Johnson, Bruce
linked information resource: Molecular biology, genomics, and proteomics in bronchioloalveolar carcinoma.

Authorship 1259060
type: Authorship
author rank in publication: 31
linked author: Johnson, Bruce
linked information resource: A single-cell landscape of high-grade serous ovarian cancer.

Authorship 1258684
type: Authorship
author rank in publication: 47
linked author: Johnson, Bruce
linked information resource: Author Correction: A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors.

Author Correction: A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors.
PubMed Identifier: 32587393
author list: Slyper M, Porter CBM, Ashenberg O, Waldman J, Drokhlyansky E, Wakiro I, Smillie C, Smith-Rosario G, Wu J, Dionne D, Vigneau S, Jané-Valbuena J, Tickle TL, Napolitano S, Su MJ, Patel AG, Karlstrom A, Gritsch S, Nomura M, Waghray A, Gohil SH, Tsankov AM, Jerby-Arnon L, Cohen O, Klughammer J, Rosen Y, Gould J, Nguyen L, Hofree M, Tramontozzi PJ, Li B, Wu CJ, Izar B, Haq R, Hodi FS, Yoon CH, Hata AN, Baker SJ, Suvà ML, Bueno R, Stover EH, Clay MR, Dyer MA, Collins NB, Matulonis UA, Wagle N, Johnson BE, Rotem A, Rozenblatt-Rosen O, Regev A
published in: Nature medicine
information resource reference: Author Correction: A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. Nat Med. 2020 Aug; 26(8):1307.
journal title abbreviation: Nat Med
publication date: 2020-08-01T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

A single-cell landscape of high-grade serous ovarian cancer.
PubMed Identifier: 32572264
author list: Izar B, Tirosh I, Stover EH, Wakiro I, Cuoco MS, Alter I, Rodman C, Leeson R, Su MJ, Shah P, Iwanicki M, Walker SR, Kanodia A, Melms JC, Mei S, Lin JR, Porter CBM, Slyper M, Waldman J, Jerby-Arnon L, Ashenberg O, Brinker TJ, Mills C, Rogava M, Vigneau S, Sorger PK, Garraway LA, Konstantinopoulos PA, Liu JF, Matulonis U, Johnson BE, Rozenblatt-Rosen O, Rotem A, Regev A
published in: Nature medicine
information resource reference: A single-cell landscape of high-grade serous ovarian cancer. Nat Med. 2020 08; 26(8):1271-1279.
journal title abbreviation: Nat Med
publication date: 2020-06-22T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1272436
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: Natural Language Processing to Ascertain Cancer Outcomes From Medical Oncologist Notes.

Natural Language Processing to Ascertain Cancer Outcomes From Medical Oncologist Notes.
PubMed Identifier: 32755459
author list: Kehl KL, Xu W, Lepisto E, Elmarakeby H, Hassett MJ, Van Allen EM, Johnson BE, Schrag D
published in: JCO clinical cancer informatics
information resource reference: Natural Language Processing to Ascertain Cancer Outcomes From Medical Oncologist Notes. JCO Clin Cancer Inform. 2020 08; 4:680-690.
journal title abbreviation: JCO Clin Cancer Inform
publication date: 2020-08-01T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 132191
type: Authorship
author rank in publication: 10
linked author: Johnson, Bruce
linked information resource: Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials.

Authorship 1287626
type: Authorship
author rank in publication: 25
linked author: Johnson, Bruce
linked information resource: Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials.

Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials.
PubMed Identifier: 32923853
author list: Exman P, Garrido-Castro AC, Hughes ME, Freedman RA, Li T, Trippa L, Bychkovsky BL, Barroso-Sousa R, Di Lascio S, Mackichan C, Lloyd MR, Krevalin M, Cerami E, Merrill MS, Santiago R, Crowley L, Kuhnly N, Files J, Lindeman NI, MacConaill LE, Kumari P, Tolaney SM, Krop IE, Bose R, Johnson BE, Ma CX, Dillon DA, Winer EP, Wagle N, Lin NU
published in: JCO precision oncology
information resource reference: Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials. JCO Precis Oncol. 2019; 3.
journal title abbreviation: JCO Precis Oncol
publication date: 2019-11-15T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1289748
type: Authorship
author rank in publication: 14
linked author: Johnson, Bruce
linked information resource: The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute.

The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute.
PubMed Identifier: 32959883
author list: Tolaney SM, Lydon CA, Li T, Dai J, Standring A, Legor KA, Caparrotta CM, Schenker MP, Glazer DI, Tayob N, DuBois SG, Meyerhardt JA, Taplin ME, Johnson BE
published in: Journal of the National Cancer Institute
information resource reference: The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute. J Natl Cancer Inst. 2021 11 02; 113(11):1453-1459.
journal title abbreviation: J Natl Cancer Inst
publication date: 2021-11-02T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1299963
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: Tumor volume dynamics and tumor growth rate in ALK-rearranged advanced non-small-cell lung cancer treated with crizotinib.

Tumor volume dynamics and tumor growth rate in ALK-rearranged advanced non-small-cell lung cancer treated with crizotinib.
PubMed Identifier: 33102632
author list: Nishino M, Hida T, Kravets S, Dahlberg SE, Lydon CA, Hatabu H, Johnson BE, Awad MM
published in: European journal of radiology open
information resource reference: Tumor volume dynamics and tumor growth rate in ALK-rearranged advanced non-small-cell lung cancer treated with crizotinib. Eur J Radiol Open. 2020; 7:100210.
journal title abbreviation: Eur J Radiol Open
publication date: 2020-01-28T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 203594
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Comprehensive genomic characterization of squamous cell lung cancers.

Genomic Characterization of de novo Metastatic Breast Cancer.
PubMed Identifier: 33293374
author list: Garrido-Castro AC, Spurr LF, Hughes ME, Li YY, Cherniack AD, Kumari P, Lloyd MR, Bychkovsky B, Barroso-Sousa R, Di Lascio S, Jain E, Files J, Mohammed-Abreu A, Krevalin M, MacKichan C, Barry WT, Guo H, Xia D, Cerami E, Rollins BJ, MacConaill LE, Lindeman NI, Krop IE, Johnson BE, Wagle N, Winer EP, Dillon DA, Lin NU
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Genomic Characterization of de novo Metastatic Breast Cancer. Clin Cancer Res. 2021 02 15; 27(4):1105-1118.
journal title abbreviation: Clin Cancer Res
publication date: 2020-12-08T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1312780
type: Authorship
author rank in publication: 24
linked author: Johnson, Bruce
linked information resource: Genomic Characterization of de novo Metastatic Breast Cancer.

Authorship 1323924
type: Authorship
author rank in publication: 33
linked author: Johnson, Bruce
linked information resource: Expansion sequencing: Spatially precise in situ transcriptomics in intact biological systems.

Expansion sequencing: Spatially precise in situ transcriptomics in intact biological systems.
PubMed Identifier: 33509999
author list: Alon S, Goodwin DR, Sinha A, Wassie AT, Chen F, Daugharthy ER, Bando Y, Kajita A, Xue AG, Marrett K, Prior R, Cui Y, Payne AC, Yao CC, Suk HJ, Wang R, Yu CJ, Tillberg P, Reginato P, Pak N, Liu S, Punthambaker S, Iyer EPR, Kohman RE, Miller JA, Lein ES, Lako A, Cullen N, Rodig S, Helvie K, Abravanel DL, Wagle N, Johnson BE, Klughammer J, Slyper M, Waldman J, Jané-Valbuena J, Rozenblatt-Rosen O, Regev A, Church GM, Marblestone AH, Boyden ES
published in: Science (New York, N.Y.)
information resource reference: Expansion sequencing: Spatially precise in situ transcriptomics in intact biological systems. Science. 2021 01 29; 371(6528).
journal title abbreviation: Science
publication date: 2021-01-29T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1335605
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: Association between Smoking History and Tumor Mutation Burden in Advanced Non-Small Cell Lung Cancer.

Authorship 1336465
type: Authorship
author rank in publication: 18
linked author: Johnson, Bruce
linked information resource: Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion.

Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion.
PubMed Identifier: 33649592
author list: Frangieh CJ, Melms JC, Thakore PI, Geiger-Schuller KR, Ho P, Luoma AM, Cleary B, Jerby-Arnon L, Malu S, Cuoco MS, Zhao M, Ager CR, Rogava M, Hovey L, Rotem A, Bernatchez C, Wucherpfennig KW, Johnson BE, Rozenblatt-Rosen O, Schadendorf D, Regev A, Izar B
published in: Nature genetics
information resource reference: Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion. Nat Genet. 2021 03; 53(3):332-341.
journal title abbreviation: Nat Genet
publication date: 2021-03-01T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Association between Smoking History and Tumor Mutation Burden in Advanced Non-Small Cell Lung Cancer.
PubMed Identifier: 33653773
author list: Wang X, Ricciuti B, Nguyen T, Li X, Rabin MS, Awad MM, Lin X, Johnson BE, Christiani DC
published in: Cancer research
information resource reference: Association between Smoking History and Tumor Mutation Burden in Advanced Non-Small Cell Lung Cancer. Cancer Res. 2021 05 01; 81(9):2566-2573.
journal title abbreviation: Cancer Res
publication date: 2021-03-02T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Professor of Radiology
is primary position: true
position in department: Radiology
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Professor of Radiology
position in organization: Brigham and Women's Hospital

Associate Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Hematology/Oncology
sort order: 1
type: Position
HR job title: Associate Professor of Medicine
position in organization: Massachusetts General Hospital

Authorship 1362869
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer.

Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer.
PubMed Identifier: 34115098
author list: Wang X, Ricciuti B, Alessi JV, Nguyen T, Awad MM, Lin X, Johnson BE, Christiani DC
published in: Journal of the National Cancer Institute
information resource reference: Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer. J Natl Cancer Inst. 2021 11 29; 113(12):1761-1769.
journal title abbreviation: J Natl Cancer Inst
publication date: 2021-11-29T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1370693
type: Authorship
author rank in publication: 5
linked author: Johnson, Bruce
linked information resource: Performance of a Machine Learning Algorithm Using Electronic Health Record Data to Identify and Estimate Survival in a Longitudinal Cohort of Patients With Lung Cancer.

Authorship 1371087
type: Authorship
author rank in publication: 4
linked author: Johnson, Bruce
linked information resource: Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-small Cell Lung Cancer.

Performance of a Machine Learning Algorithm Using Electronic Health Record Data to Identify and Estimate Survival in a Longitudinal Cohort of Patients With Lung Cancer.
PubMed Identifier: 34232304
author list: Yuan Q, Cai T, Hong C, Du M, Johnson BE, Lanuti M, Cai T, Christiani DC
published in: JAMA network open
information resource reference: Performance of a Machine Learning Algorithm Using Electronic Health Record Data to Identify and Estimate Survival in a Longitudinal Cohort of Patients With Lung Cancer. JAMA Netw Open. 2021 07 01; 4(7):e2114723.
journal title abbreviation: JAMA Netw Open
publication date: 2021-07-01T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-small Cell Lung Cancer.
PubMed Identifier: 34181954
author list: Fox AH, Jett JR, Roy UB, Johnson BE, King JC, Martin N, Osarogiagbon RU, Rivera MP, Rosenthal LS, Smith RA, Silvestri GA
published in: Chest
information resource reference: Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-small Cell Lung Cancer. Chest. 2021 12; 160(6):2293-2303.
journal title abbreviation: Chest
publication date: 2021-06-26T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 189597
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma.

Spatially organized multicellular immune hubs in human colorectal cancer.
PubMed Identifier: 34450029
author list: Pelka K, Hofree M, Chen JH, Sarkizova S, Pirl JD, Jorgji V, Bejnood A, Dionne D, Ge WH, Xu KH, Chao SX, Zollinger DR, Lieb DJ, Reeves JW, Fuhrman CA, Hoang ML, Delorey T, Nguyen LT, Waldman J, Klapholz M, Wakiro I, Cohen O, Albers J, Smillie CS, Cuoco MS, Wu J, Su MJ, Yeung J, Vijaykumar B, Magnuson AM, Asinovski N, Moll T, Goder-Reiser MN, Applebaum AS, Brais LK, DelloStritto LK, Denning SL, Phillips ST, Hill EK, Meehan JK, Frederick DT, Sharova T, Kanodia A, Todres EZ, Jané-Valbuena J, Biton M, Izar B, Lambden CD, Clancy TE, Bleday R, Melnitchouk N, Irani J, Kunitake H, Berger DL, Srivastava A, Hornick JL, Ogino S, Rotem A, Vigneau S, Johnson BE, Corcoran RB, Sharpe AH, Kuchroo VK, Ng K, Giannakis M, Nieman LT, Boland GM, Aguirre AJ, Anderson AC, Rozenblatt-Rosen O, Regev A, Hacohen N
published in: Cell
information resource reference: Spatially organized multicellular immune hubs in human colorectal cancer. Cell. 2021 09 02; 184(18):4734-4752.e20.
journal title abbreviation: Cell
publication date: 2021-08-26T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1388754
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: Response to Hopkins, Kichenadasse, Logan, et al.

Authorship 1388954
type: Authorship
author rank in publication: 60
linked author: Johnson, Bruce
linked information resource: Spatially organized multicellular immune hubs in human colorectal cancer.

Response to Hopkins, Kichenadasse, Logan, et al.
PubMed Identifier: 34450659
author list: Wang X, Ricciuti B, Alessi JV, Nguyen T, Awad MM, Lin X, Johnson BE, Christiani DC
published in: Journal of the National Cancer Institute
information resource reference: Response to Hopkins, Kichenadasse, Logan, et al. J Natl Cancer Inst. 2022 03 08; 114(3):477-478.
journal title abbreviation: J Natl Cancer Inst
publication date: 2022-03-08T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1391078
type: Authorship
author rank in publication: 17
linked author: Johnson, Bruce
linked information resource: Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis.

Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis.
PubMed Identifier: 34455067
author list: Planchard D, Besse B, Groen HJM, Hashemi SMS, Mazieres J, Kim TM, Quoix E, Souquet PJ, Barlesi F, Baik C, Villaruz LC, Kelly RJ, Zhang S, Tan M, Gasal E, Santarpia L, Johnson BE
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis. J Thorac Oncol. 2022 01; 17(1):103-115.
journal title abbreviation: J Thorac Oncol
publication date: 2021-08-26T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Prediction Model for Tumor Volume Nadir in EGFR -mutant NSCLC Patients Treated With EGFR Tyrosine Kinase Inhibitors.
PubMed Identifier: 34524205
author list: Nishino M, Lu J, Hino T, Vokes NI, Jänne PA, Hatabu H, Johnson BE
published in: Journal of thoracic imaging
information resource reference: Prediction Model for Tumor Volume Nadir in EGFR -mutant NSCLC Patients Treated With EGFR Tyrosine Kinase Inhibitors. J Thorac Imaging. 2023 Mar 01; 38(2):82-87.
journal title abbreviation: J Thorac Imaging
publication date: 2021-09-15T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1395016
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: Prediction Model for Tumor Volume Nadir in EGFR -mutant NSCLC Patients Treated With EGFR Tyrosine Kinase Inhibitors.

Authorship 189674
type: Authorship
author rank in publication: 3
linked author: Johnson, Bruce
linked information resource: Therapeutic targeting of multiple signaling pathways in malignant pleural mesothelioma.

Authorship 206328
type: Authorship
author rank in publication: 10
linked author: Johnson, Bruce
linked information resource: The impact of initial gefitinib or erlotinib versus chemotherapy on central nervous system progression in advanced non-small cell lung cancer with EGFR mutations.

Authorship 1410212
type: Authorship
author rank in publication: 5
linked author: Johnson, Bruce
linked information resource: Germline Testing Data Validate Inferences of Mutational Status for Variants Detected From Tumor-Only Sequencing.

Authorship 1415643
type: Authorship
author rank in publication: 4
linked author: Johnson, Bruce
linked information resource: Postdiagnosis BMI Change Is Associated with Non-Small Cell Lung Cancer Survival.

Postdiagnosis BMI Change Is Associated with Non-Small Cell Lung Cancer Survival.
PubMed Identifier: 34728470
author list: Yuan Q, Du M, Loehrer E, Johnson BE, Gainor JF, Lanuti M, Li Y, Christiani DC
published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
information resource reference: Postdiagnosis BMI Change Is Associated with Non-Small Cell Lung Cancer Survival. Cancer Epidemiol Biomarkers Prev. 2022 01; 31(1):262-268.
journal title abbreviation: Cancer Epidemiol Biomarkers Prev
publication date: 2021-11-02T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Germline Testing Data Validate Inferences of Mutational Status for Variants Detected From Tumor-Only Sequencing.
PubMed Identifier: 34820595
author list: Jalloul N, Gomy I, Stokes S, Gusev A, Johnson BE, Lindeman NI, Macconaill L, Ganesan S, Garber JE, Khiabanian H
published in: JCO precision oncology
information resource reference: Germline Testing Data Validate Inferences of Mutational Status for Variants Detected From Tumor-Only Sequencing. JCO Precis Oncol. 2021; 5.
journal title abbreviation: JCO Precis Oncol
publication date: 2021-11-17T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer.
PubMed Identifier: 34890551
author list: Raghavan S, Winter PS, Navia AW, Williams HL, DenAdel A, Lowder KE, Galvez-Reyes J, Kalekar RL, Mulugeta N, Kapner KS, Raghavan MS, Borah AA, Liu N, Väyrynen SA, Costa AD, Ng RWS, Wang J, Hill EK, Ragon DY, Brais LK, Jaeger AM, Spurr LF, Li YY, Cherniack AD, Booker MA, Cohen EF, Tolstorukov MY, Wakiro I, Rotem A, Johnson BE, McFarland JM, Sicinska ET, Jacks TE, Sullivan RJ, Shapiro GI, Clancy TE, Perez K, Rubinson DA, Ng K, Cleary JM, Crawford L, Manalis SR, Nowak JA, Wolpin BM, Hahn WC, Aguirre AJ, Shalek AK
published in: Cell
information resource reference: Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. Cell. 2021 12 09; 184(25):6119-6137.e26.
journal title abbreviation: Cell
publication date: 2021-12-09T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1417926
type: Authorship
author rank in publication: 30
linked author: Johnson, Bruce
linked information resource: Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer.

Authorship 1419543
type: Authorship
author rank in publication: 11
linked author: Johnson, Bruce
linked information resource: Defining comprehensive biomarker-related testing and treatment practices for advanced non-small-cell lung cancer: Results of a survey of U.S. oncologists.

Authorship 1420941
type: Authorship
author rank in publication: 11
linked author: Johnson, Bruce
linked information resource: Encorafenib plus binimetinib in patients with BRAFV600-mutant non-small cell lung cancer: phase II PHAROS study design.

Encorafenib plus binimetinib in patients with BRAFV600-mutant non-small cell lung cancer: phase II PHAROS study design.
PubMed Identifier: 34918546
author list: Riely GJ, Ahn MJ, Felip E, Ramalingam SS, Smit EF, Tsao AS, Alcasid A, Usari T, Wissel PS, Wilner KD, Johnson BE
published in: Future oncology (London, England)
information resource reference: Encorafenib plus binimetinib in patients with BRAFV600-mutant non-small cell lung cancer: phase II PHAROS study design. Future Oncol. 2022 Mar; 18(7):781-791.
journal title abbreviation: Future Oncol
publication date: 2021-12-17T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Defining comprehensive biomarker-related testing and treatment practices for advanced non-small-cell lung cancer: Results of a survey of U.S. oncologists.
PubMed Identifier: 34921524
author list: Mileham KF, Schenkel C, Bruinooge SS, Freeman-Daily J, Basu Roy U, Moore A, Smith RA, Garrett-Mayer E, Rosenthal L, Garon EB, Johnson BE, Osarogiagbon RU, Jalal S, Virani S, Weber Redman M, Silvestri GA
published in: Cancer medicine
information resource reference: Defining comprehensive biomarker-related testing and treatment practices for advanced non-small-cell lung cancer: Results of a survey of U.S. oncologists. Cancer Med. 2022 01; 11(2):530-538.
journal title abbreviation: Cancer Med
publication date: 2021-12-17T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1422181
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: Tumor Growth Rate After Nadir Is Associated With Survival in Patients With EGFR-Mutant Non-Small-Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor.

Tumor Growth Rate After Nadir Is Associated With Survival in Patients With EGFR-Mutant Non-Small-Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor.
PubMed Identifier: 34994646
author list: Nishino M, Lu J, Hino T, Vokes NI, Jänne PA, Hatabu H, Johnson BE
published in: JCO precision oncology
information resource reference: Tumor Growth Rate After Nadir Is Associated With Survival in Patients With EGFR-Mutant Non-Small-Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor. JCO Precis Oncol. 2021 11; 5:1603-1610.
journal title abbreviation: JCO Precis Oncol
publication date: 2021-11-01T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 191641
type: Authorship
author rank in publication: 11
linked author: Johnson, Bruce
linked information resource: Phase II neoadjuvant trial of paclitaxel by 96-hour continuous infusion (CIVI) in combination with cisplatin followed by chest radiotherapy for patients with stage III non-small-cell lung cancer.

Real-World Analysis of Off-Label Use of Molecularly Targeted Therapy in a Large Academic Medical Center Cohort.
PubMed Identifier: 35050710
author list: Upadhyay VA, Johnson BE, Landman AB, Hassett MJ
published in: JCO precision oncology
information resource reference: Real-World Analysis of Off-Label Use of Molecularly Targeted Therapy in a Large Academic Medical Center Cohort. JCO Precis Oncol. 2022 01; 6:e2100232.
journal title abbreviation: JCO Precis Oncol
publication date: 2022-01-01T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Clinical Pan-Cancer Assessment of Mismatch Repair Deficiency Using Tumor-Only, Targeted Next-Generation Sequencing.
PubMed Identifier: 35050773
author list: Albayrak A, Garrido-Castro AC, Giannakis M, Umeton R, Manam MD, Stover EH, Porter RL, Johnson BE, Liaw KL, Amonkar M, Church AJ, Janeway KA, Nowak JA, Sholl L, Lin NU, Johnson JM
published in: JCO precision oncology
information resource reference: Clinical Pan-Cancer Assessment of Mismatch Repair Deficiency Using Tumor-Only, Targeted Next-Generation Sequencing. JCO Precis Oncol. 2020 Nov; 4:1084-1097.
journal title abbreviation: JCO Precis Oncol
publication date: 2020-11-01T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1426846
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: Clinical Pan-Cancer Assessment of Mismatch Repair Deficiency Using Tumor-Only, Targeted Next-Generation Sequencing.

Authorship 1427337
type: Authorship
author rank in publication: 2
linked author: Johnson, Bruce
linked information resource: Real-World Analysis of Off-Label Use of Molecularly Targeted Therapy in a Large Academic Medical Center Cohort.

Authorship 1432209
type: Authorship
author rank in publication: 11
linked author: Johnson, Bruce
linked information resource: Outcomes by EGFR, KRAS, and ALK Genotype After Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.

Outcomes by EGFR, KRAS, and ALK Genotype After Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.
PubMed Identifier: 35135121
author list: Mak RH, Hermann G, Aerts HJ, Baldini EH, Chen AB, Kozono D, Rabin MS, Swanson SJ, Chen YH, Catalano P, Johnson BE, Jänne PA
published in: JCO precision oncology
information resource reference: Outcomes by EGFR, KRAS, and ALK Genotype After Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer. JCO Precis Oncol. 2018 Nov; 2:1-18.
journal title abbreviation: JCO Precis Oncol
publication date: 2018-11-01T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1437296
type: Authorship
author rank in publication: 19
linked author: Johnson, Bruce
linked information resource: Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program.

Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program.
PubMed Identifier: 35363308
author list: Bychkovsky BL, Li T, Sotelo J, Tayob N, Mercado J, Gomy I, Chittenden A, Kane S, Stokes S, Hughes ME, Kim JS, Umeton R, Awad MM, Konstantinopoulos PA, Yurgelun MB, Wolpin BM, Taplin ME, Newmark RE, Johnson BE, Lindeman NI, MacConaill LE, Garber JE, Lin NU
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program. Clin Cancer Res. 2022 06 01; 28(11):2349-2360.
journal title abbreviation: Clin Cancer Res
publication date: 2022-06-01T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center.
PubMed Identifier: 35413078
author list: Meyerhardt JA, Yue H, Nowak RP, Brais L, Ma C, Johnson S, Harrod J, Burman SSR, Hendrickson LM, Fischinger S, Alter G, Hahn W, Johnson BE, Fischer ES
published in: PloS one
information resource reference: Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center. PLoS One. 2022; 17(4):e0266791.
journal title abbreviation: PLoS One
publication date: 2022-04-12T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 290902
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions.

Authorship 294706
type: Authorship
author rank in publication: 2
linked author: Johnson, Bruce
linked information resource: Paraneoplastic syndromes associated with small cell lung cancer.

Authorship 1446058
type: Authorship
author rank in publication: 13
linked author: Johnson, Bruce
linked information resource: Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center.

Authorship 1452446
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Clinical Outcomes With Dabrafenib Plus Trametinib in a Clinical Trial Versus Real-World Standard of Care in Patients With BRAF-Mutated Advanced NSCLC.

Clinical Outcomes With Dabrafenib Plus Trametinib in a Clinical Trial Versus Real-World Standard of Care in Patients With BRAF-Mutated Advanced NSCLC.
PubMed Identifier: 35592617
author list: Johnson BE, Baik CS, Mazieres J, Groen HJM, Melosky B, Wolf J, Zadeh Vosta Kolaei FA, Wu WH, Knoll S, Ktiouet Dawson M, Johns A, Planchard D
published in: JTO clinical and research reports
information resource reference: Clinical Outcomes With Dabrafenib Plus Trametinib in a Clinical Trial Versus Real-World Standard of Care in Patients With BRAF-Mutated Advanced NSCLC. JTO Clin Res Rep. 2022 May; 3(5):100324.
journal title abbreviation: JTO Clin Res Rep
publication date: 2022-04-06T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 388428
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: Inhibition of the met receptor in mesothelioma.

Authorship 1464316
type: Authorship
author rank in publication: 4
linked author: Johnson, Bruce
linked information resource: State legislative trends related to biomarker testing.

State legislative trends related to biomarker testing.
PubMed Identifier: 35607821
author list: Sadigh G, Goeckner HG, Kazerooni EA, Johnson BE, Smith RA, Adams DV, Carlos RC
published in: Cancer
information resource reference: State legislative trends related to biomarker testing. Cancer. 2022 08 01; 128(15):2865-2870.
journal title abbreviation: Cancer
publication date: 2022-05-24T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 165409
type: Authorship
author rank in publication: 5
linked author: Johnson, Bruce
linked information resource: The Arg16Gly polymorphism of the beta2-adrenergic receptor and the natriuretic response to rapid saline infusion in humans.

Safety of image guided research biopsies in patients with thoracic malignancies.
PubMed Identifier: 36152477
author list: Soosman SK, Schenker MP, Mazzola E, Voligny E, Smokovich A, Bay C, Nguyen T, Michael K, Jänne PA, Rabin M, Glazer DI, Johnson BE, Luo J
published in: Lung cancer (Amsterdam, Netherlands)
information resource reference: Safety of image guided research biopsies in patients with thoracic malignancies. Lung Cancer. 2022 11; 173:53-57.
journal title abbreviation: Lung Cancer
publication date: 2022-09-17T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1481139
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial.

Authorship 1483808
type: Authorship
author rank in publication: 12
linked author: Johnson, Bruce
linked information resource: Safety of image guided research biopsies in patients with thoracic malignancies.

Authorship 1486320
type: Authorship
author rank in publication: 18
linked author: Johnson, Bruce
linked information resource: MatchMiner: an open-source platform for cancer precision medicine.

Authorship 1502068
type: Authorship
author rank in publication: 23
linked author: Johnson, Bruce
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/203409700

MatchMiner: an open-source platform for cancer precision medicine.
PubMed Identifier: 36202909
author list: Klein H, Mazor T, Siegel E, Trukhanov P, Ovalle A, Vecchio Fitz CD, Zwiesler Z, Kumari P, Van Der Veen B, Marriott E, Hansel J, Yu J, Albayrak A, Barry S, Keller RB, MacConaill LE, Lindeman N, Johnson BE, Rollins BJ, Do KT, Beardslee B, Shapiro G, Hector-Barry S, Methot J, Sholl L, Lindsay J, Hassett MJ, Cerami E
published in: NPJ precision oncology
information resource reference: MatchMiner: an open-source platform for cancer precision medicine. NPJ Precis Oncol. 2022 Oct 06; 6(1):69.
journal title abbreviation: NPJ Precis Oncol
publication date: 2022-10-06T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/203409700
PubMed Identifier: 36369159
author list: Rusch VW, Nicholas A, Patterson GA, Waqar SN, Toloza EM, Haura EB, Raz DJ, Reckamp KL, Merritt RE, Owen DH, Finley DJ, McNamee CJ, Blasberg JD, Garon EB, Mitchell JD, Doebele RC, Baciewicz F, Nagasaka M, Pass HI, Schulze K, Johnson A, Bunn PA, Johnson BE, Kris MG, Kwiatkowski DJ, Wistuba II, Chaft JE, Carbone DP, Lee JM
published in: The Journal of thoracic and cardiovascular surgery
information resource reference: Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2023 03; 165(3):828-839.e5.
journal title abbreviation: J Thorac Cardiovasc Surg
publication date: 2022-10-08T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non-small cell lung cancer.

Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial.
PubMed Identifier: 36097216
author list: Chaft JE, Oezkan F, Kris MG, Bunn PA, Wistuba II, Kwiatkowski DJ, Owen DH, Tang Y, Johnson BE, Lee JM, Lozanski G, Pietrzak M, Seweryn M, Byun WY, Schulze K, Nicholas A, Johnson A, Grindheim J, Hilz S, Shames DS, Rivard C, Toloza E, Haura EB, McNamee CJ, Patterson GA, Waqar SN, Rusch VW, Carbone DP
published in: Nature medicine
information resource reference: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial. Nat Med. 2022 10; 28(10):2155-2161.
journal title abbreviation: Nat Med
publication date: 2022-09-12T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1508133
type: Authorship
author rank in publication: 24
linked author: Johnson, Bruce
linked information resource: Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer.

Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer.
PubMed Identifier: 36446043
author list: Lazo De La Vega L, Comeau H, Sallan S, Al-Ibraheemi A, Gupta H, Li YY, Tsai HK, Kang W, Ward A, Church AJ, Kim A, Pinto NR, Macy ME, Maese LD, Sabnis AJ, Cherniack AD, Lindeman NI, Anderson ME, Cooney TM, Yeo KK, Reaman GH, DuBois SG, Collins NB, Johnson BE, Janeway KA, Forrest SJ
published in: JCO precision oncology
information resource reference: Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer. JCO Precis Oncol. 2022 11; 6:e2200390.
journal title abbreviation: JCO Precis Oncol
publication date: 2022-11-01T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1516053
type: Authorship
author rank in publication: 13
linked author: Johnson, Bruce
linked information resource: Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer.

Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer.
PubMed Identifier: 36647832
author list: Wang S, Rong R, Yang DM, Fujimoto J, Bishop JA, Yan S, Cai L, Behrens C, Berry LD, Wilhelm C, Aisner D, Sholl L, Johnson BE, Kwiatkowski DJ, Wistuba II, Bunn PA, Minna J, Xiao G, Kris MG, Xie Y
published in: The Journal of clinical investigation
information resource reference: Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer. J Clin Invest. 2023 01 17; 133(2).
journal title abbreviation: J Clin Invest
publication date: 2023-01-17T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC.
PubMed Identifier: 36775193
author list: Alessi JV, Elkrief A, Ricciuti B, Wang X, Cortellini A, Vaz VR, Lamberti G, Frias RL, Venkatraman D, Fulgenzi CAM, Pecci F, Recondo G, Di Federico A, Barrichello A, Park H, Nishino M, Hambelton GM, Egger JV, Ladanyi M, Digumarthy S, Johnson BE, Christiani DC, Lin X, Gainor JF, Lin JJ, Pinato DJ, Schoenfeld AJ, Awad MM
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC. J Thorac Oncol. 2023 06; 18(6):731-743.
journal title abbreviation: J Thorac Oncol
publication date: 2023-02-10T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1526182
type: Authorship
author rank in publication: 21
linked author: Johnson, Bruce
linked information resource: Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC.

Authorship 1523202
type: Authorship
author rank in publication: 23
linked author: Johnson, Bruce
linked information resource: Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarker.

Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarker.
PubMed Identifier: 36747644
author list: Taylor MS, Connie W, Fridy PC, Zhang SJ, Senussi Y, Wolters JC, Cheng WC, Heaps J, Miller BD, Mori K, Cohen L, Jiang H, Molloy KR, Norden BL, Chait BT, Goggins M, Bhan I, Franses JW, Yang X, Taplin ME, Wang X, Christiani DC, Johnson BE, Meyerson M, Uppaluri R, Egloff AM, Denault EN, Spring LM, Wang TL, Shih IM, Jung E, Arora KS, Zukerberg LR, Yilmaz OH, Chi G, Matulonis UA, Song Y, Nieman L, Parikh AR, Strickland M, Corcoran RB, Mustelin T, Eng G, Yilmaz ÃH, Skates SJ, Rueda BR, Drapkin R, Klempner SJ, Deshpande V, Ting DT, Rout MP, LaCava J, Walt DR, Burns KH
published in: bioRxiv : the preprint server for biology
information resource reference: Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarker. bioRxiv. 2023 Mar 17.
journal title abbreviation: bioRxiv
publication date: 2023-03-17T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1528227
type: Authorship
author rank in publication: 10
linked author: Johnson, Bruce
linked information resource: Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best-practice guide.

Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best-practice guide.
PubMed Identifier: 36859638
author list: Fox AH, Nishino M, Osarogiagbon RU, Rivera MP, Rosenthal LS, Smith RA, Farjah F, Sholl LM, Silvestri GA, Johnson BE
published in: CA: a cancer journal for clinicians
information resource reference: Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best-practice guide. CA Cancer J Clin. 2023 Jul-Aug; 73(4):358-375.
journal title abbreviation: CA Cancer J Clin
publication date: 2023-03-01T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1530510
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: Tumor Volume Nadir in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Treated With Alectinib.

Tumor Volume Nadir in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Treated With Alectinib.
PubMed Identifier: 36893377
author list: Nishino M, Wei Z, Mazzola E, Hino T, Tseng SC, Sanchez ME, Hatabu H, Johnson BE, Awad MM
published in: JCO precision oncology
information resource reference: Tumor Volume Nadir in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Treated With Alectinib. JCO Precis Oncol. 2023 03; 7:e2200603.
journal title abbreviation: JCO Precis Oncol
publication date: 2023-03-01T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC.
PubMed Identifier: 37247843
author list: Alessi JV, Wang X, Elkrief A, Ricciuti B, Li YY, Gupta H, Spurr LF, Rizvi H, Luo J, Pecci F, Lamberti G, Recondo G, Venkatraman D, Di Federico A, Gandhi MM, Vaz VR, Nishino M, Sholl LM, Cherniack AD, Ladanyi M, Price A, Richards AL, Donoghue M, Lindsay J, Sharma B, Turner MM, Pfaff KL, Felt KD, Rodig SJ, Lin X, Meyerson ML, Johnson BE, Christiani DC, Schoenfeld AJ, Awad MM
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC. J Thorac Oncol. 2023 11; 18(11):1524-1537.
journal title abbreviation: J Thorac Oncol
publication date: 2023-05-27T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC.
PubMed Identifier: 37454214
author list: Alessi JV, Ricciuti B, Wang X, Pecci F, Di Federico A, Lamberti G, Elkrief A, Rodig SJ, Lebow ES, Eicholz JE, Thor M, Rimner A, Schoenfeld AJ, Chaft JE, Johnson BE, Gomez DR, Awad MM, Shaverdian N
published in: Nature communications
information resource reference: Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC. Nat Commun. 2023 07 15; 14(1):4238.
journal title abbreviation: Nat Commun
publication date: 2023-07-15T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 276872
type: Authorship
author rank in publication: 12
linked author: Johnson, Bruce
linked information resource: Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma.

Authorship 1557521
type: Authorship
author rank in publication: 15
linked author: Johnson, Bruce
linked information resource: Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC.

Authorship 1568342
type: Authorship
author rank in publication: 22
linked author: Johnson, Bruce
linked information resource: A cellular and spatial atlas of TP53 -associated tissue remodeling in lung adenocarcinoma.

Authorship 1572040
type: Authorship
author rank in publication: 32
linked author: Johnson, Bruce
linked information resource: Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC.

Authorship 1553245
type: Authorship
author rank in publication: 25
linked author: Johnson, Bruce
linked information resource: Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With BRAFV600-Mutant Metastatic Non-Small-Cell Lung Cancer.

Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With BRAFV600-Mutant Metastatic Non-Small-Cell Lung Cancer.
PubMed Identifier: 37270692
author list: Riely GJ, Smit EF, Ahn MJ, Felip E, Ramalingam SS, Tsao A, Johnson M, Gelsomino F, Esper R, Nadal E, Offin M, Provencio M, Clarke J, Hussain M, Otterson GA, Dagogo-Jack I, Goldman JW, Morgensztern D, Alcasid A, Usari T, Wissel P, Wilner K, Pathan N, Tonkovyd S, Johnson BE
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With BRAFV600-Mutant Metastatic Non-Small-Cell Lung Cancer. J Clin Oncol. 2023 07 20; 41(21):3700-3711.
journal title abbreviation: J Clin Oncol
publication date: 2023-06-04T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

A cellular and spatial atlas of TP53 -associated tissue remodeling in lung adenocarcinoma.
PubMed Identifier: 37425718
author list: Zhao W, Kepecs B, Mahadevan NR, Segerstolpe A, Weirather JL, Besson NR, Giotti B, Soong BY, Li C, Vigneau S, Slyper M, Wakiro I, Jane-Valbuena J, Ashenberg O, Rotem A, Bueno R, Rozenblatt-Rosen O, Pfaff K, Rodig S, Hata AN, Regev A, Johnson BE, Tsankov AM
published in: bioRxiv : the preprint server for biology
information resource reference: A cellular and spatial atlas of TP53 -associated tissue remodeling in lung adenocarcinoma. bioRxiv. 2024 Feb 14.
journal title abbreviation: bioRxiv
publication date: 2024-02-14T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker.
PubMed Identifier: 37698949
author list: Taylor MS, Wu C, Fridy PC, Zhang SJ, Senussi Y, Wolters JC, Cajuso T, Cheng WC, Heaps JD, Miller BD, Mori K, Cohen L, Jiang H, Molloy KR, Chait BT, Goggins MG, Bhan I, Franses JW, Yang X, Taplin ME, Wang X, Christiani DC, Johnson BE, Meyerson M, Uppaluri R, Egloff AM, Denault EN, Spring LM, Wang TL, Shih IM, Fairman JE, Jung E, Arora KS, Yilmaz OH, Cohen S, Sharova T, Chi G, Norden BL, Song Y, Nieman LT, Pappas L, Parikh AR, Strickland MR, Corcoran RB, Mustelin T, Eng G, Yilmaz ÖH, Matulonis UA, Chan AT, Skates SJ, Rueda BR, Drapkin R, Klempner SJ, Deshpande V, Ting DT, Rout MP, LaCava J, Walt DR, Burns KH
published in: Cancer discovery
information resource reference: Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker. Cancer Discov. 2023 12 12; 13(12):2532-2547.
journal title abbreviation: Cancer Discov
publication date: 2023-12-12T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 352869
type: Authorship
author rank in publication: 10
linked author: Johnson, Bruce
linked information resource: Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome.

Authorship 1587622
type: Authorship
author rank in publication: 23
linked author: Johnson, Bruce
linked information resource: Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker.

Authorship 1596985
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial.

Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial.
PubMed Identifier: 37816821
author list: Chaft JE, Oezkan F, Kris MG, Bunn PA, Wistuba II, Kwiatkowski DJ, Owen DH, Tang Y, Johnson BE, Lee JM, Lozanski G, Pietrzak M, Seweryn M, Byun WY, Schulze K, Nicholas A, Johnson A, Grindheim J, Hilz S, Shames DS, Rivard C, Toloza E, Haura EB, McNamee CJ, Patterson GA, Waqar SN, Rusch VW, Carbone DP
published in: Nature medicine
information resource reference: Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial. Nat Med. 2024 Jan; 30(1):303.
journal title abbreviation: Nat Med
publication date: 2024-01-01T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer.
PubMed Identifier: 37914383
author list: Alessi JV, Price A, Richards AL, Ricciuti B, Wang X, Elkrief A, Pecci F, Di Federico A, Gandhi MM, Lebow ES, Santos PMG, Thor M, Rimner A, Schoenfeld AJ, Chaft JE, Johnson BE, Gomez DR, Awad MM, Shaverdian N
published in: Journal for immunotherapy of cancer
information resource reference: Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer. J Immunother Cancer. 2023 11; 11(11).
journal title abbreviation: J Immunother Cancer
publication date: 2023-11-01T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1599193
type: Authorship
author rank in publication: 16
linked author: Johnson, Bruce
linked information resource: Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer.

Authorship 17954
type: Authorship
author rank in publication: 16
linked author: Johnson, Bruce
linked information resource: The BATTLE trial: personalizing therapy for lung cancer.

Authorship 1608745
type: Authorship
author rank in publication: 23
linked author: Johnson, Bruce
linked information resource: Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial.

Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial.
PubMed Identifier: 38039427
author list: Tan DSW, Felip E, de Castro G, Solomon BJ, Greystoke A, Cho BC, Cobo M, Kim TM, Ganguly S, Carcereny E, Paz-Ares L, Bennouna J, Garassino MC, Schenker M, Kim SW, Brase JC, Bury-Maynard D, Passos VQ, Deudon S, Dharan B, Song Y, Caparica R, Johnson BE
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial. J Clin Oncol. 2024 Jan 10; 42(2):192-204.
journal title abbreviation: J Clin Oncol
publication date: 2023-12-01T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
PubMed Identifier: 37980405
author list: Tarantino P, Gupta H, Hughes ME, Files J, Strauss S, Kirkner G, Feeney AM, Li Y, Garrido-Castro AC, Barroso-Sousa R, Bychkovsky BL, DiLascio S, Sholl L, MacConaill L, Lindeman N, Johnson BE, Meyerson M, Jeselsohn R, Qiu X, Li R, Long H, Winer EP, Dillon D, Curigliano G, Cherniack AD, Tolaney SM, Lin NU
published in: Nature communications
information resource reference: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer. Nat Commun. 2023 11 18; 14(1):7496.
journal title abbreviation: Nat Commun
publication date: 2023-11-18T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1614669
type: Authorship
author rank in publication: 16
linked author: Johnson, Bruce
linked information resource: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.

Authorship 1613469
type: Authorship
author rank in publication: 20
linked author: Johnson, Bruce
linked information resource: Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study.

Authorship 1615736
type: Authorship
author rank in publication: 16
linked author: Johnson, Bruce
linked information resource: Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.

Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study.
PubMed Identifier: 38070597
author list: Dacic S, Travis WD, Giltnane JM, Kos F, Abel J, Hilz S, Fujimoto J, Sholl L, Ritter J, Khalil F, Liu Y, Taylor-Weiner A, Resnick M, Yu H, Hirsch FR, Bunn PA, Carbone DP, Rusch V, Kwiatkowski DJ, Johnson BE, Lee JM, Hennek SR, Wapinski I, Nicholas A, Johnson A, Schulze K, Kris MG, Wistuba II
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study. J Thorac Oncol. 2024 May; 19(5):719-731.
journal title abbreviation: J Thorac Oncol
publication date: 2023-12-07T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
PubMed Identifier: 38097580
author list: Tarantino P, Gupta H, Hughes ME, Files J, Strauss S, Kirkner G, Feeney AM, Li Y, Garrido-Castro AC, Barroso-Sousa R, Bychkovsky BL, DiLascio S, Sholl L, MacConaill L, Lindeman N, Johnson BE, Meyerson M, Jeselsohn R, Qiu X, Li R, Long H, Winer EP, Dillon D, Curigliano G, Cherniack AD, Tolaney SM, Lin NU
published in: Nature communications
information resource reference: Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer. Nat Commun. 2023 Dec 14; 14(1):8321.
journal title abbreviation: Nat Commun
publication date: 2023-12-14T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 51379
type: Authorship
author rank in publication: 47
linked author: Johnson, Bruce
linked information resource: Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.

Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer.
PubMed Identifier: 38207230
author list: Ricciuti B, Lamberti G, Puchala SR, Mahadevan NR, Lin JR, Alessi JV, Chowdhury A, Li YY, Wang X, Spurr L, Pecci F, Di Federico A, Venkatraman D, Barrichello AP, Gandhi M, Vaz VR, Pangilinan AJ, Haradon D, Lee E, Gupta H, Pfaff KL, Welsh EL, Nishino M, Cherniack AD, Johnson BE, Weirather JL, Dryg ID, Rodig SJ, Sholl LM, Sorger P, Santagata S, Umeton R, Awad MM
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer. J Clin Oncol. 2024 Apr 10; 42(11):1311-1321.
journal title abbreviation: J Clin Oncol
publication date: 2024-01-11T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1620622
type: Authorship
author rank in publication: 25
linked author: Johnson, Bruce
linked information resource: Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer.

Authorship 551340
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: Cost-effectiveness of computed tomography screening for lung cancer in the United States.

Authorship 1623146
type: Authorship
author rank in publication: 49
linked author: Johnson, Bruce
linked information resource: A spatial cell atlas of neuroblastoma reveals developmental, epigenetic and spatial axis of tumor heterogeneity.

A spatial cell atlas of neuroblastoma reveals developmental, epigenetic and spatial axis of tumor heterogeneity.
PubMed Identifier: 38260392
author list: Patel AG, Ashenberg O, Collins NB, Segerstolpe Å, Jiang S, Slyper M, Huang X, Caraccio C, Jin H, Sheppard H, Xu K, Chang TC, Orr BA, Shirinifard A, Chapple RH, Shen A, Clay MR, Tatevossian RG, Reilly C, Patel J, Lupo M, Cline C, Dionne D, Porter CBM, Waldman J, Bai Y, Zhu B, Barrera I, Murray E, Vigneau S, Napolitano S, Wakiro I, Wu J, Grimaldi G, Dellostritto L, Helvie K, Rotem A, Lako A, Cullen N, Pfaff KL, Karlström Å, Jané-Valbuena J, Todres E, Thorner A, Geeleher P, Rodig SJ, Zhou X, Stewart E, Johnson BE, Wu G, Chen F, Yu J, Goltsev Y, Nolan GP, Rozenblatt-Rosen O, Regev A, Dyer MA
published in: bioRxiv : the preprint server for biology
information resource reference: A spatial cell atlas of neuroblastoma reveals developmental, epigenetic and spatial axis of tumor heterogeneity. bioRxiv. 2024 Jan 16.
journal title abbreviation: bioRxiv
publication date: 2024-01-16T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1631478
type: Authorship
author rank in publication: 25
linked author: Johnson, Bruce
linked information resource: A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small-cell lung cancer.

A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small-cell lung cancer.
PubMed Identifier: 38357801
author list: Riely GJ, Smit EF, Ahn MJ, Felip E, Ramalingam SS, Tsao A, Johnson M, Gelsomino F, Esper R, Nadal E, Offin M, Provencio M, Clarke J, Hussein M, Otterson GA, Dagogo-Jack I, Goldman JW, Morgensztern D, Alcasid A, Usari T, Wissel P, Wilner K, Pathan N, Tonkovyd S, Johnson BE
published in: Future oncology (London, England)
information resource reference: A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small-cell lung cancer. Future Oncol. 2024; 20(16):1047-1055.
journal title abbreviation: Future Oncol
publication date: 2024-02-15T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Professor of Medicine, Emeritus
is primary position: true
position in department: Emeritus
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Professor of Medicine, Emeritus
position in organization: Harvard Medical School

Authorship 26275
type: Authorship
author rank in publication: 4
linked author: Johnson, Bruce
linked information resource: Submaximal exercise gas exchange is an important prognostic tool to predict adverse outcomes in heart failure.

Authorship 1647767
type: Authorship
author rank in publication: 22
linked author: Johnson, Bruce
linked information resource: Clinicogenomic characterization of inflammatory breast cancer.

Clinicogenomic characterization of inflammatory breast cancer.
PubMed Identifier: 38766070
author list: Priedigkeit N, Harrison B, Shue R, Hughes M, Li Y, Kirkner GJ, Spurr LF, Remolano MC, Strauss S, Files J, Feeney AM, Grant L, Mohammed-Abreu A, Garrido-Castro A, Sousa RB, Bychkovsky B, Nakhlis F, Bellon JR, King TA, Winer EP, Lindeman N, Johnson BE, Sholl L, Dillon D, Overmoyer B, Tolaney SM, Cherniack A, Lin NU, Lynce F
published in: bioRxiv : the preprint server for biology
information resource reference: Clinicogenomic characterization of inflammatory breast cancer. bioRxiv. 2024 May 10.
journal title abbreviation: bioRxiv
publication date: 2024-05-10T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1660261
type: Authorship
author rank in publication: 12
linked author: Johnson, Bruce
linked information resource: Additional impact of genetic ancestry over race/ethnicity to prevalence of KRAS mutations and allele-specific subtypes in non-small cell lung cancer.

Additional impact of genetic ancestry over race/ethnicity to prevalence of KRAS mutations and allele-specific subtypes in non-small cell lung cancer.
PubMed Identifier: 38902927
author list: Wang X, Hou K, Ricciuti B, Alessi JV, Li X, Pecci F, Dey R, Luo J, Awad MM, Gusev A, Lin X, Johnson BE, Christiani DC
published in: HGG advances
information resource reference: Additional impact of genetic ancestry over race/ethnicity to prevalence of KRAS mutations and allele-specific subtypes in non-small cell lung cancer. HGG Adv. 2024 Jul 18; 5(3):100320.
journal title abbreviation: HGG Adv
publication date: 2024-06-19T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 359625
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.

Authorship 1665927
type: Authorship
author rank in publication: 30
linked author: Johnson, Bruce
linked information resource: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.

Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.
PubMed Identifier: 38992034
author list: Forrest SJ, Gupta H, Ward A, Li YY, Doan D, Al-Ibraheemi A, Alexandrescu S, Bandopadhayay P, Shusterman S, Mullen EA, Collins NB, Chi SN, Wright KD, Kumari P, Mazor T, Ligon KL, Shivdasani P, Manam M, MacConaill LE, Ceca E, Benich SN, London WB, Schilsky RL, Bruinooge SS, Guidry Auvil JM, Cerami E, Rollins BJ, Meyerson ML, Lindeman NI, Johnson BE, Cherniack AD, Church AJ, Janeway KA
published in: Nature communications
information resource reference: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer. Nat Commun. 2024 Jul 11; 15(1):5837.
journal title abbreviation: Nat Commun
publication date: 2024-07-11T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1666625
type: Authorship
author rank in publication: 16
linked author: Johnson, Bruce
linked information resource: Calls to action on lung cancer management and research.

Calls to action on lung cancer management and research.
PubMed Identifier: 39002167
author list: Meyer ML, Hirsch FR, Bunn PA, Ujhazy P, Fredrickson D, Berg CD, Carbone DP, Halmos B, Singh H, Borghaei H, Ferris A, Langer C, Dacic S, Mok TS, Peters S, Johnson BE
published in: The oncologist
information resource reference: Calls to action on lung cancer management and research. Oncologist. 2024 Dec 06; 29(12):e1634-e1645.
journal title abbreviation: Oncologist
publication date: 2024-12-06T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Authorship 435679
type: Authorship
author rank in publication: 3
linked author: Johnson, Bruce
linked information resource: Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development.

Authorship 1687544
type: Authorship
author rank in publication: 30
linked author: Johnson, Bruce
linked information resource: Author Correction: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.

Author Correction: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.
PubMed Identifier: 39174503
author list: Forrest SJ, Gupta H, Ward A, Li YY, Doan D, Al-Ibraheemi A, Alexandrescu S, Bandopadhayay P, Shusterman S, Mullen EA, Collins NB, Chi SN, Wright KD, Kumari P, Mazor T, Ligon KL, Shivdasani P, Manam M, MacConaill LE, Ceca E, Benich SN, London WB, Schilsky RL, Bruinooge SS, Guidry Auvil JM, Cerami E, Rollins BJ, Meyerson ML, Lindeman NI, Johnson BE, Cherniack AD, Church AJ, Janeway KA
published in: Nature communications
information resource reference: Author Correction: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer. Nat Commun. 2024 Aug 22; 15(1):7218.
journal title abbreviation: Nat Commun
publication date: 2024-08-22T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 338949
type: Authorship
author rank in publication: 10
linked author: Johnson, Bruce
linked information resource: Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agents.

Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.
PubMed Identifier: 23833300
author list: Cardarella S, Ogino A, Nishino M, Butaney M, Shen J, Lydon C, Yeap BY, Sholl LM, Johnson BE, Jänne PA
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer. Clin Cancer Res. 2013 Aug 15; 19(16):4532-40.
journal title abbreviation: Clin Cancer Res
publication date: 2013-07-05T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

RECIST 1.1 in NSCLC patients with EGFR mutations treated with EGFR tyrosine kinase inhibitors: comparison with RECIST 1.0.
PubMed Identifier: 23789698
author list: Nishino M, Cardarella S, Jackman DM, Ramaiya NH, Rabin MS, Hatabu H, Jänne PA, Johnson BE
published in: AJR. American journal of roentgenology
information resource reference: RECIST 1.1 in NSCLC patients with EGFR mutations treated with EGFR tyrosine kinase inhibitors: comparison with RECIST 1.0. AJR Am J Roentgenol. 2013 Jul; 201(1):W64-71.
journal title abbreviation: AJR Am J Roentgenol
publication date: 2013-07-01T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/25818066
PubMed Identifier: 23922022
author list: Nishino M, Dahlberg SE, Cardarella S, Jackman DM, Rabin MS, Ramaiya NH, Hatabu H, Jänne PA, Johnson BE
published in: Cancer
information resource reference: Volumetric tumor growth in advanced non-small cell lung cancer patients with EGFR mutations during EGFR-tyrosine kinase inhibitor therapy: developing criteria to continue therapy beyond RECIST progression. Cancer. 2013 Nov 01; 119(21):3761-8.
journal title abbreviation: Cancer
publication date: 2013-08-06T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Volumetric tumor growth in advanced non-small cell lung cancer patients with EGFR mutations during EGFR-tyrosine kinase inhibitor therapy: developing criteria to continue therapy beyond RECIST progression.

Tumor volume decrease at 8 weeks is associated with longer survival in EGFR-mutant advanced non-small-cell lung cancer patients treated with EGFR TKI.
PubMed Identifier: 23787800
author list: Nishino M, Dahlberg SE, Cardarella S, Jackman DM, Rabin MS, Hatabu H, Jänne PA, Johnson BE
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Tumor volume decrease at 8 weeks is associated with longer survival in EGFR-mutant advanced non-small-cell lung cancer patients treated with EGFR TKI. J Thorac Oncol. 2013 Aug; 8(8):1059-68.
journal title abbreviation: J Thorac Oncol
publication date: 2013-08-01T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 352933
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Rationale for a phase I trial of erlotinib and the mammalian target of rapamycin inhibitor everolimus (RAD001) for patients with relapsed non small cell lung cancer.

Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer.
PubMed Identifier: 23564469
author list: Zhu J, Sharma DB, Chen AB, Johnson BE, Weeks JC, Schrag D
published in: Cancer
information resource reference: Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer. Cancer. 2013 Jun 01; 119(11):2048-60.
journal title abbreviation: Cancer
publication date: 2013-04-05T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Meta-analysis of EGFR kinase inhibitors: not always greater than the sum of its parts.
PubMed Identifier: 23594425
author list: Cardarella S, Johnson BE
published in: Journal of the National Cancer Institute
information resource reference: Meta-analysis of EGFR kinase inhibitors: not always greater than the sum of its parts. J Natl Cancer Inst. 2013 May 01; 105(9):589-90.
journal title abbreviation: J Natl Cancer Inst
publication date: 2013-04-17T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1700293
type: Authorship
author rank in publication: 5
linked author: Johnson, Bruce
linked information resource: The American Cancer Society National Lung Cancer Roundtable strategic plan: Advancing comprehensive biomarker testing in non-small cell lung cancer.

Authorship 1700291
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: The American Cancer Society National Lung Cancer Roundtable strategic plan: Methods for improving turnaround time of comprehensive biomarker testing in non-small cell lung cancer.

The American Cancer Society National Lung Cancer Roundtable strategic plan: Methods for improving turnaround time of comprehensive biomarker testing in non-small cell lung cancer.
PubMed Identifier: 39347608
author list: Roy-Chowdhuri S, Mani H, Fox AH, Tsao A, Sholl LM, Farjah F, Johnson BE, Osarogiagbon RU, Rivera MP, Silvestri GA, Smith RA, Wistuba II
published in: Cancer
information resource reference: The American Cancer Society National Lung Cancer Roundtable strategic plan: Methods for improving turnaround time of comprehensive biomarker testing in non-small cell lung cancer. Cancer. 2024 Dec 15; 130(24):4200-4212.
journal title abbreviation: Cancer
publication date: 2024-09-30T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

The American Cancer Society National Lung Cancer Roundtable strategic plan: Advancing comprehensive biomarker testing in non-small cell lung cancer.
PubMed Identifier: 39347617
author list: Fox AH, Osarogiagbon RU, Farjah F, Jett JR, Johnson BE, Rivera MP, Smith RA, Wistuba II, Silvestri GA
published in: Cancer
information resource reference: The American Cancer Society National Lung Cancer Roundtable strategic plan: Advancing comprehensive biomarker testing in non-small cell lung cancer. Cancer. 2024 Dec 15; 130(24):4188-4199.
journal title abbreviation: Cancer
publication date: 2024-09-30T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1703300
type: Authorship
author rank in publication: 57
linked author: Johnson, Bruce
linked information resource: A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features.

A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features.
PubMed Identifier: 39478111
author list: Klughammer J, Abravanel DL, Segerstolpe Å, Blosser TR, Goltsev Y, Cui Y, Goodwin DR, Sinha A, Ashenberg O, Slyper M, Vigneau S, Jané-Valbuena J, Alon S, Caraccio C, Chen J, Cohen O, Cullen N, DelloStritto LK, Dionne D, Files J, Frangieh A, Helvie K, Hughes ME, Inga S, Kanodia A, Lako A, MacKichan C, Mages S, Moriel N, Murray E, Napolitano S, Nguyen K, Nitzan M, Ortiz R, Patel M, Pfaff KL, Porter CBM, Rotem A, Strauss S, Strasser R, Thorner AR, Turner M, Wakiro I, Waldman J, Wu J, Gómez Tejeda Zañudo J, Zhang D, Lin NU, Tolaney SM, Winer EP, Boyden ES, Chen F, Nolan GP, Rodig SJ, Zhuang X, Rozenblatt-Rosen O, Johnson BE, Regev A, Wagle N
published in: Nature medicine
information resource reference: A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features. Nat Med. 2024 Nov; 30(11):3236-3249.
journal title abbreviation: Nat Med
publication date: 2024-10-30T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Alectinib combined with cobimetinib in ALK-Rearranged lung Cancer: A phase IB study.
PubMed Identifier: 39615410
author list: Dagogo-Jack I, Cooper AJ, Johnson BE, Gainor JF, Lin JJ, Sequist LV, Piotrowska Z, Digumarthy SR, Mino-Kenudson M, Muzikansky A, Shaw AT
published in: Lung cancer (Amsterdam, Netherlands)
information resource reference: Alectinib combined with cobimetinib in ALK-Rearranged lung Cancer: A phase IB study. Lung Cancer. 2025 Jan; 199:108003.
journal title abbreviation: Lung Cancer
publication date: 2024-11-01T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1710275
type: Authorship
author rank in publication: 3
linked author: Johnson, Bruce
linked information resource: Alectinib combined with cobimetinib in ALK-Rearranged lung Cancer: A phase IB study.

Authorship 523907
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Farnesyl transferase inhibitors for patients with lung cancer.

Authorship 543358
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: Phase I study of the c-raf-1 antisense oligonucleotide ISIS 5132 in combination with carboplatin and paclitaxel in patients with previously untreated, advanced non-small cell lung cancer.

Authorship 545268
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry.

Authorship 548510
type: Authorship
author rank in publication: 4
linked author: Johnson, Bruce
linked information resource: Prospective study of palliative hypofractionated radiotherapy (8.5 Gy x 2) for patients with symptomatic non-small-cell lung cancer.

Authorship 1723991
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: A phase II study of ramucirumab and somatostatin analog therapy in patients with advanced neuroendocrine tumors.

A phase II study of ramucirumab and somatostatin analog therapy in patients with advanced neuroendocrine tumors.
PubMed Identifier: 39834129
author list: Perez K, Kulke MH, Zheng H, Allen J, Clark J, Enzinger AC, Enzinger PC, Johnson BE, McCleary NJ, Parikh A, Patel A, Rubinson D, Yurgelun MB, Ramsey K, Johnson E, Graham C, Chan JA
published in: The oncologist
information resource reference: A phase II study of ramucirumab and somatostatin analog therapy in patients with advanced neuroendocrine tumors. Oncologist. 2025 Jan 17; 30(1).
journal title abbreviation: Oncologist
publication date: 2025-01-17T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1725384
type: Authorship
author rank in publication: 13
linked author: Johnson, Bruce
linked information resource: Gene Copy Deletion of STK11, KEAP1, and SMARCA4: Clinicopathologic Features and Association With the Outcomes of Immunotherapy With or Without Chemotherapy in Nonsquamous NSCLC.

Gene Copy Deletion of STK11, KEAP1, and SMARCA4: Clinicopathologic Features and Association With the Outcomes of Immunotherapy With or Without Chemotherapy in Nonsquamous NSCLC.
PubMed Identifier: 39864548
author list: Gandhi MM, Elkrief A, Moore CG, Ricciuti B, Alessi JV, Richards AL, Tischfield S, Williams J, Lamberti G, Pecci F, Di Federico A, Makarem M, Johnson BE, Nishino M, Sholl LM, Schoenfeld AJ, Awad MM
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Gene Copy Deletion of STK11, KEAP1, and SMARCA4: Clinicopathologic Features and Association With the Outcomes of Immunotherapy With or Without Chemotherapy in Nonsquamous NSCLC. J Thorac Oncol. 2025 Jun; 20(6):725-738.
journal title abbreviation: J Thorac Oncol
publication date: 2025-01-27T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Treatment-related toxicities in a phase II trial of dasatinib in patients with squamous cell carcinoma of the lung.
PubMed Identifier: 24128713
author list: Brunner AM, Costa DB, Heist RS, Garcia E, Lindeman NI, Sholl LM, Oxnard GR, Johnson BE, Hammerman PS
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Treatment-related toxicities in a phase II trial of dasatinib in patients with squamous cell carcinoma of the lung. J Thorac Oncol. 2013 Nov; 8(11):1434-7.
journal title abbreviation: J Thorac Oncol
publication date: 2013-11-01T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

The impact of genomic changes on treatment of lung cancer.
PubMed Identifier: 23841470
author list: Cardarella S, Johnson BE
published in: American journal of respiratory and critical care medicine
information resource reference: The impact of genomic changes on treatment of lung cancer. Am J Respir Crit Care Med. 2013 Oct 01; 188(7):770-5.
journal title abbreviation: Am J Respir Crit Care Med
publication date: 2013-10-01T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 681076
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/25818066

Authorship 681471
type: Authorship
author rank in publication: 2
linked author: Johnson, Bruce
linked information resource: Meta-analysis of EGFR kinase inhibitors: not always greater than the sum of its parts.

Authorship 681580
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: The Intermountain Risk Score, based on common laboratory tests, was highly predictive of short-term mortality.

Authorship 681597
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Preoperative evaluation of the gynecologic patient: considerations for improved outcomes.

Authorship 681003
type: Authorship
author rank in publication: 2
linked author: Johnson, Bruce
linked information resource: Family medicine practice in rural any-country.

Authorship 681040
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Oestrogen did not improve health related quality of life in postmenopausal women with hysterectomy.

Authorship 681093
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Dietary supplements containing red clover extracts were no better than placebo for hot flashes in menopause.

Authorship 681111
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Herbal supplements did not relieve vasomotor symptoms of menopause.

Authorship 681133
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: ACP Journal Club. Estrogen plus progestin increased lung cancer mortality but not incidence in postmenopausal women.

Authorship 681613
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Herbal supplements did not relieve vasomotor symptoms of menopause in women.

Authorship 681355
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: Tumor volume decrease at 8 weeks is associated with longer survival in EGFR-mutant advanced non-small-cell lung cancer patients treated with EGFR TKI.

Authorship 681829
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Sunburn and swelling: the edema of erythema.

Authorship 681088
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: ACP Journal Club. Review: teriparatide reduces fractures in postmenopausal women with osteoporosis.

Authorship 681042
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.

Authorship 681345
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: Treatment-related toxicities in a phase II trial of dasatinib in patients with squamous cell carcinoma of the lung.

Authorship 681444
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: A once yearly IV infusion of zoledronic acid prevented fractures in postmenopausal women with osteoporosis.

Authorship 681506
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: RECIST 1.1 in NSCLC patients with EGFR mutations treated with EGFR tyrosine kinase inhibitors: comparison with RECIST 1.0.

Authorship 681614
type: Authorship
author rank in publication: 4
linked author: Johnson, Bruce
linked information resource: Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer.

Authorship 681615
type: Authorship
author rank in publication: 6
linked author: Johnson, Bruce
linked information resource: Virginia Tech Carilion School of Medicine and Research Institute.

Authorship 681827
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Review: prophylactic use of Vitamin D reduces falls in older persons.

Authorship 681315
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Statistic on life expectancy challenged.

Authorship 681004
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: A once-yearly IV infusion of zoledronic acid prevented fractures in postmenopausal women with osteoporosis.

Authorship 681776
type: Authorship
author rank in publication: 2
linked author: Johnson, Bruce
linked information resource: The impact of genomic changes on treatment of lung cancer.

Authorship 681492
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: ACP Journal Club. Postmenopausal hormone therapy was cost-effective when started at age 50 years but not at 65 years.

ACP Journal Club. Postmenopausal hormone therapy was cost-effective when started at age 50 years but not at 65 years.
PubMed Identifier: 19528560
author list: Johnson BE, Johnson CA
published in: Annals of internal medicine
information resource reference: ACP Journal Club. Postmenopausal hormone therapy was cost-effective when started at age 50 years but not at 65 years. Ann Intern Med. 2009 Jun 16; 150(12):JC6-15.
journal title abbreviation: Ann Intern Med
publication date: 2009-06-16T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Preoperative evaluation of the gynecologic patient: considerations for improved outcomes.
PubMed Identifier: 18448753
author list: Johnson BE, Porter J
published in: Obstetrics and gynecology
information resource reference: Preoperative evaluation of the gynecologic patient: considerations for improved outcomes. Obstet Gynecol. 2008 May; 111(5):1183-94.
journal title abbreviation: Obstet Gynecol
publication date: 2008-05-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

ACP Journal Club. Estrogen plus progestin increased lung cancer mortality but not incidence in postmenopausal women.
PubMed Identifier: 20157132
author list: Johnson BE, Johnson CA
published in: Annals of internal medicine
information resource reference: ACP Journal Club. Estrogen plus progestin increased lung cancer mortality but not incidence in postmenopausal women. Ann Intern Med. 2010 Feb 16; 152(4):JC-28.
journal title abbreviation: Ann Intern Med
publication date: 2010-02-16T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Dietary supplements containing red clover extracts were no better than placebo for hot flashes in menopause.
PubMed Identifier: 15122867
author list: Johnson BE
published in: ACP journal club
information resource reference: Dietary supplements containing red clover extracts were no better than placebo for hot flashes in menopause. ACP J Club. 2004 Mar-Apr; 140(2):47.
journal title abbreviation: ACP J Club
publication date: 2004-03-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

The Intermountain Risk Score, based on common laboratory tests, was highly predictive of short-term mortality.
PubMed Identifier: 19949188
author list: Johnson BE
published in: Evidence-based medicine
information resource reference: The Intermountain Risk Score, based on common laboratory tests, was highly predictive of short-term mortality. Evid Based Med. 2009 Dec; 14(6):186.
journal title abbreviation: Evid Based Med
publication date: 2009-12-01T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Virginia Tech Carilion School of Medicine and Research Institute.
PubMed Identifier: 20736637
author list: Vari RC, Workman TF, Harrington DP, Johnson TA, Sherman JM, Johnson BE, Trinkle DB, Means DE, Johnson CA
published in: Academic medicine : journal of the Association of American Medical Colleges
information resource reference: Virginia Tech Carilion School of Medicine and Research Institute. Acad Med. 2010 Sep; 85(9 Suppl):S582-5.
journal title abbreviation: Acad Med
publication date: 2010-09-01T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Review: prophylactic use of Vitamin D reduces falls in older persons.
PubMed Identifier: 15518450
author list: Johnson BE
published in: ACP journal club
information resource reference: Review: prophylactic use of Vitamin D reduces falls in older persons. ACP J Club. 2004 Nov-Dec; 141(3):66.
journal title abbreviation: ACP J Club
publication date: 2004-11-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Statistic on life expectancy challenged.
PubMed Identifier: 16201301
author list: Johnson BE
published in: Postgraduate medicine
information resource reference: Statistic on life expectancy challenged. Postgrad Med. 2005 Sep; 118(3):1; author reply 1-2.
journal title abbreviation: Postgrad Med
publication date: 2005-09-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Sunburn and swelling: the edema of erythema.
PubMed Identifier: 16004178
author list: Johnson BE
published in: Southern medical journal
information resource reference: Sunburn and swelling: the edema of erythema. South Med J. 2005 Jun; 98(6):672.
journal title abbreviation: South Med J
publication date: 2005-06-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Oestrogen did not improve health related quality of life in postmenopausal women with hysterectomy.
PubMed Identifier: 17213098
author list: Johnson BE
published in: Evidence-based medicine
information resource reference: Oestrogen did not improve health related quality of life in postmenopausal women with hysterectomy. Evid Based Med. 2006 Jun; 11(3):76.
journal title abbreviation: Evid Based Med
publication date: 2006-06-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

A once yearly IV infusion of zoledronic acid prevented fractures in postmenopausal women with osteoporosis.
PubMed Identifier: 17909236
author list: Johnson BE
published in: Evidence-based medicine
information resource reference: A once yearly IV infusion of zoledronic acid prevented fractures in postmenopausal women with osteoporosis. Evid Based Med. 2007 Oct; 12(5):145.
journal title abbreviation: Evid Based Med
publication date: 2007-10-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Herbal supplements did not relieve vasomotor symptoms of menopause.
PubMed Identifier: 17474674
author list: Johnson BE
published in: ACP journal club
information resource reference: Herbal supplements did not relieve vasomotor symptoms of menopause. ACP J Club. 2007 May-Jun; 146(3):65.
journal title abbreviation: ACP J Club
publication date: 2007-05-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Family medicine practice in rural any-country.
PubMed Identifier: 18172800
author list: Johnson CA, Johnson BE
published in: Family medicine
information resource reference: Family medicine practice in rural any-country. Fam Med. 2008 Jan; 40(1):55-6.
journal title abbreviation: Fam Med
publication date: 2008-01-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Herbal supplements did not relieve vasomotor symptoms of menopause in women.
PubMed Identifier: 17537886
author list: Johnson BE
published in: Evidence-based medicine
information resource reference: Herbal supplements did not relieve vasomotor symptoms of menopause in women. Evid Based Med. 2007 Jun; 12(3):78.
journal title abbreviation: Evid Based Med
publication date: 2007-06-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

A once-yearly IV infusion of zoledronic acid prevented fractures in postmenopausal women with osteoporosis.
PubMed Identifier: 17764122
author list: Johnson BE
published in: ACP journal club
information resource reference: A once-yearly IV infusion of zoledronic acid prevented fractures in postmenopausal women with osteoporosis. ACP J Club. 2007 Sep-Oct; 147(2):31.
journal title abbreviation: ACP J Club
publication date: 2007-09-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

ACP Journal Club. Review: teriparatide reduces fractures in postmenopausal women with osteoporosis.
PubMed Identifier: 22986396
author list: Johnson BE
published in: Annals of internal medicine
information resource reference: ACP Journal Club. Review: teriparatide reduces fractures in postmenopausal women with osteoporosis. Ann Intern Med. 2012 Sep 18; 157(6):JC3-4.
journal title abbreviation: Ann Intern Med
publication date: 2012-09-18T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 250138
type: Authorship
author rank in publication: 12
linked author: Johnson, Bruce
linked information resource: Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations.

Authorship 686460
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/27752497

https://connects.catalyst.harvard.edu/Profiles/profile/27752497
PubMed Identifier: 24101054
author list: Johnson BE, Kabbinavar F, Fehrenbacher L, Hainsworth J, Kasubhai S, Kressel B, Lin CY, Marsland T, Patel T, Polikoff J, Rubin M, White L, Yang JC, Bowden C, Miller V
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: ATLAS: randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancer. J Clin Oncol. 2013 Nov 01; 31(31):3926-34.
journal title abbreviation: J Clin Oncol
publication date: 2013-10-07T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource
label: ATLAS: randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancer.

Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non-Small Cell Lung Cancer.
PubMed Identifier: 40247431
author list: Pecci F, Thummalapalli R, Alden SL, Ricciuti B, Alessi JV, Elkrief A, Rizvi H, Wang X, Jeng M, Egger JV, Vaz VR, Barrichello A, Lamberti G, Di Federico A, Santo V, Rossato de Almeida G, Gandhi M, Clark P, Nishino M, Johnson BE, Hellmann M, Schoenfeld AJ, Awad MM
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non-Small Cell Lung Cancer. Clin Cancer Res. 2025 Jun 13; 31(12):2413-2425.
journal title abbreviation: Clin Cancer Res
publication date: 2025-06-13T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerization.
PubMed Identifier: 24063894
author list: Cho J, Chen L, Sangji N, Okabe T, Yonesaka K, Francis JM, Flavin RJ, Johnson W, Kwon J, Yu S, Greulich H, Johnson BE, Eck MJ, Jänne PA, Wong KK, Meyerson M
published in: Cancer research
information resource reference: Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerization. Cancer Res. 2013 Nov 15; 73(22):6770-9.
journal title abbreviation: Cancer Res
publication date: 2013-09-24T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1737057
type: Authorship
author rank in publication: 22
linked author: Johnson, Bruce
linked information resource: Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (=50%) Patients.

Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (=50%) Patients.
PubMed Identifier: 40021433
author list: Barrichello APC, Elkrief A, Ricciuti B, Ganta T, Marron TU, Wang X, Lotter W, Lindsay J, Santo V, Cortellini A, Sharma B, Felt K, Pfaff K, Lamberti G, Pecci F, Federico AD, Makarem M, Gandhi MM, Nguyen T, Haradon D, Vaz VR, Johnson BE, Debnath N, Wang Y, Kuang AG, Saeed A, Radford M, Lovly CM, Nebhan CA, Pinato DJ, Rodig SJ, Schoenfeld AJ, Awad MM, Alessi JV, Naqash AR
published in: Clinical lung cancer
information resource reference: Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (=50%) Patients. Clin Lung Cancer. 2025 Jun; 26(4):288-298.e8.
journal title abbreviation: Clin Lung Cancer
publication date: 2025-02-04T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 693786
type: Authorship
author rank in publication: 12
linked author: Johnson, Bruce
linked information resource: Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerization.

Anne E. Dyson Professor in Women's Cancers, Emeritus
is primary position: true
position in department: Emeritus
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Anne E. Dyson Professor in Women's Cancers, Emeritus
position in organization: Harvard Medical School

Jerome and Nancy Kohlberg Professor of Medicine, Emeritus
is primary position: true
position in department: Emeritus
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Jerome and Nancy Kohlberg Professor of Medicine, Emeritus
position in organization: Harvard Medical School

Professor of Pediatrics, Emeritus
is primary position: true
position in department: Emeritus
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Professor of Pediatrics, Emeritus
position in organization: Harvard Medical School

Professor of Pathology, Emeritus
is primary position: true
position in department: Emeritus
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Professor of Pathology, Emeritus
position in organization: Harvard Medical School

William Rosenberg Professor of Medicine, Emeritus
is primary position: true
position in department: Emeritus
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: William Rosenberg Professor of Medicine, Emeritus
position in organization: Harvard Medical School

Authorship 1739454
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: The Impact of the Tumor Microenvironment on the Effect of IL-1ß Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials.

Authorship 1743043
type: Authorship
author rank in publication: 57
linked author: Johnson, Bruce
linked information resource: Author Correction: A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features.

Authorship 1746445
type: Authorship
author rank in publication: 23
linked author: Johnson, Bruce
linked information resource: Clinicogenomic Characterization of Inflammatory Breast Cancer.

Authorship 1750311
type: Authorship
author rank in publication: 20
linked author: Johnson, Bruce
linked information resource: Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non-Small Cell Lung Cancer.

Clinicogenomic Characterization of Inflammatory Breast Cancer.
PubMed Identifier: 40378057
author list: Priedigkeit N, Harrison B, Shue R, Hughes ME, Li Y, Lebrón-Torres A, Kirkner GJ, Spurr LF, Remolano MC, Strauss S, Files J, Feeney AM, Grant L, Mohammed-Abreu A, Garrido-Castro A, Barroso-Sousa R, Bychkovsky B, Nakhlis F, Bellon JR, King TA, Winer EP, Lindeman N, Johnson BE, Sholl L, Dillon D, Overmoyer B, Tolaney SM, Cherniack AD, Lin NU, Lynce F
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Clinicogenomic Characterization of Inflammatory Breast Cancer. Clin Cancer Res. 2025 Jul 15; 31(14):3072-3083.
journal title abbreviation: Clin Cancer Res
publication date: 2025-07-15T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Author Correction: A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features.
PubMed Identifier: 40155562
author list: Klughammer J, Abravanel DL, Segerstolpe Å, Blosser TR, Goltsev Y, Cui Y, Goodwin DR, Sinha A, Ashenberg O, Slyper M, Vigneau S, Jané-Valbuena J, Alon S, Caraccio C, Chen J, Cohen O, Cullen N, DelloStritto LK, Dionne D, Files J, Frangieh A, Helvie K, Hughes ME, Inga S, Kanodia A, Lako A, MacKichan C, Mages S, Moriel N, Murray E, Napolitano S, Nguyen K, Nitzan M, Ortiz R, Patel M, Pfaff KL, Porter CBM, Rotem A, Strauss S, Strasser R, Thorner AR, Turner M, Wakiro I, Waldman J, Wu J, Gómez Tejeda Zañudo J, Zhang D, Lin NU, Tolaney SM, Winer EP, Boyden ES, Chen F, Nolan GP, Rodig SJ, Zhuang X, Rozenblatt-Rosen O, Johnson BE, Regev A, Wagle N
published in: Nature medicine
information resource reference: Author Correction: A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features. Nat Med. 2025 May; 31(5):1713.
journal title abbreviation: Nat Med
publication date: 2025-05-01T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

The Impact of the Tumor Microenvironment on the Effect of IL-1ß Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials.
PubMed Identifier: 40116353
author list: Solomon BJ, Tan DSW, de Castro G, Cobo M, Garassino MC, Zhang J, Johnson BE, Lee JM, Garrido P, Butler AA, Pelletier MR, Savchenko A, Ji L, Brase JC, Caparica R, Demanse D, Wu J, Bossen C, Mok T
published in: Cancer research communications
information resource reference: The Impact of the Tumor Microenvironment on the Effect of IL-1ß Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials. Cancer Res Commun. 2025 04 01; 5(4):632-646.
journal title abbreviation: Cancer Res Commun
publication date: 2025-04-01T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 170344
type: Authorship
author rank in publication: 28
linked author: Johnson, Bruce
linked information resource: LKB1 modulates lung cancer differentiation and metastasis.

Authorship 268785
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer.

Professor of Pathology
is primary position: true
position in department: Pathology
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Professor of Pathology
position in organization: Brigham and Women's Hospital

Clinical Implementation of Matched Tumor/Germline Sequencing Improves Accuracy of Tumor Genomic Profiling and Therapeutic Recommendations.
PubMed Identifier: 40706989
author list: Manning DK, Ananda G, Eifert C, Rojas-Rudilla V, Swanton W, Keefe S, Garcia EP, D'Eletto M, Holdmore E, Mishra S, Borziak K, Lukasse P, Davineni P, Manam MD, Shivdasani P, Ghazani AA, Wang AL, Bastepe M, Beltran H, Janeway KA, Church A, Pollaci A, Chittenden AB, Koeller DR, Schwartz Levine A, Garber JE, Johnson BE, Lindeman NI, Nowak JA, Sholl LM, MacConaill LE
published in: The Journal of molecular diagnostics : JMD
information resource reference: Clinical Implementation of Matched Tumor/Germline Sequencing Improves Accuracy of Tumor Genomic Profiling and Therapeutic Recommendations. J Mol Diagn. 2025 Oct; 27(10):969-988.
journal title abbreviation: J Mol Diagn
publication date: 2025-07-22T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 67964
type: Authorship
author rank in publication: 2
linked author: Johnson, Bruce
linked information resource: Small-cell lung cancer.

Authorship 429739
type: Authorship
author rank in publication: 2
linked author: Johnson, Bruce
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/822099

Authorship 440619
type: Authorship
author rank in publication: 5
linked author: Johnson, Bruce
linked information resource: TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.

Authorship 79331
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Selecting patients for epidermal growth factor receptor inhibitor treatment: A FISH story or a tale of mutations?

Authorship 470697
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: Long-term outcome of lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension.

Authorship 206319
type: Authorship
author rank in publication: 18
linked author: Johnson, Bruce
linked information resource: First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations.

Authorship 333259
type: Authorship
author rank in publication: 6
linked author: Johnson, Bruce
linked information resource: Right ventricular function with hypoxic exercise: effects of sildenafil.

Authorship 711955
type: Authorship
author rank in publication: 3
linked author: Johnson, Bruce
linked information resource: State of the art: Response assessment in lung cancer in the era of genomic medicine.

State of the art: Response assessment in lung cancer in the era of genomic medicine.
PubMed Identifier: 24661292
author list: Nishino M, Hatabu H, Johnson BE, McLoud TC
published in: Radiology
information resource reference: State of the art: Response assessment in lung cancer in the era of genomic medicine. Radiology. 2014 Apr; 271(1):6-27.
journal title abbreviation: Radiology
publication date: 2014-04-01T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 322621
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Adjuvant chemotherapy for non-small-cell lung cancer: the end of the beginning.

Authorship 327982
type: Authorship
author rank in publication: 15
linked author: Johnson, Bruce
linked information resource: Epidermal growth factor receptor mutation testing in the care of lung cancer patients.

George P. Canellos, MD, and Jean S. Canellos Professor of Medicine Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: George P. Canellos, MD, and Jean S. Canellos Professor of Medicine Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Authorship 284518
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: Development of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic EGFR mutations treated with gefitinib or erlotinib.

Authorship 288750
type: Authorship
author rank in publication: 36
linked author: Johnson, Bruce
linked information resource: International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Authorship 165668
type: Authorship
author rank in publication: 2
linked author: Johnson, Bruce
linked information resource: Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer.

Professor of Medicine
is primary position: true
position in department: Medicine
position in division: DF Thoracic Onc
sort order: 1
type: Position
HR job title: Professor of Medicine
position in organization: Beth Israel Deaconess Medical Center

DF Thoracic Onc
type: Division
type: Organization

TTF-1 Expression in Lung Adenocarcinoma: Clinicopathologic, Genomic, and Immunophenotypic Correlates and Outcomes to Immunotherapy-Based Treatments and KRASG12C Inhibitors.
PubMed Identifier: 41690367
author list: Di Federico A, Hong L, Elkrief A, Thummalapalli R, Cooper AJ, Ricciuti B, Digumarthy S, Alessi JV, Gogia P, Hambelton GM, Pecci F, Makarem M, Gandhi MM, Garbo E, De Giglio A, Gagliano A, Sperandi F, Gelsomino F, Scalera S, Cipriani L, Marinelli D, Lamberti G, Shaverdian N, Haradon J, Nguyen T, Voligny E, Ladanyi M, Zhang J, Gibbons DL, Heymach JV, Nishino M, Rodig SJ, Pfaff K, Wang X, Rekhtman N, Sholl LM, Luo J, Johnson BE, Janne PA, Arvind R, Gainor JF, Maugeri-Saccà M, Ardizzoni A, Heist RS, Arbour KC, Schoenfeld AJ, Vokes NI, Awad MM
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: TTF-1 Expression in Lung Adenocarcinoma: Clinicopathologic, Genomic, and Immunophenotypic Correlates and Outcomes to Immunotherapy-Based Treatments and KRASG12C Inhibitors. J Thorac Oncol. 2026 Feb 12; 103610.
journal title abbreviation: J Thorac Oncol
publication date: 2026-02-12T00:00:00
year: 2026
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 233698
type: Authorship
author rank in publication: 18
linked author: Johnson, Bruce
linked information resource: Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial.

Authorship 729282
type: Authorship
author rank in publication: 2
linked author: Johnson, Bruce
linked information resource: Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.

Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.
PubMed Identifier: 24846037
author list: Kris MG, Johnson BE, Berry LD, Kwiatkowski DJ, Iafrate AJ, Wistuba II, Varella-Garcia M, Franklin WA, Aronson SL, Su PF, Shyr Y, Camidge DR, Sequist LV, Glisson BS, Khuri FR, Garon EB, Pao W, Rudin C, Schiller J, Haura EB, Socinski M, Shirai K, Chen H, Giaccone G, Ladanyi M, Kugler K, Minna JD, Bunn PA
published in: JAMA
information resource reference: Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA. 2014 May 21; 311(19):1998-2006.
journal title abbreviation: JAMA
publication date: 2014-05-21T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 180432
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy.

Authorship 1780525
type: Authorship
author rank in publication: 27
linked author: Johnson, Bruce
linked information resource: Clinical Implementation of Matched Tumor/Germline Sequencing Improves Accuracy of Tumor Genomic Profiling and Therapeutic Recommendations.

Authorship 1781651
type: Authorship
author rank in publication: 38
linked author: Johnson, Bruce
linked information resource: TTF-1 Expression in Lung Adenocarcinoma: Clinicopathologic, Genomic, and Immunophenotypic Correlates and Outcomes to Immunotherapy-Based Treatments and KRASG12C Inhibitors.

Authorship 1793526
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: Updated Overall Survival Analysis From the Phase II PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer.

Authorship 1812708
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: Editor's Note: Identification of Existing Drugs That Effectively Target NTRK1 and ROS1 Rearrangements in Lung Cancer.

Authorship 1813056
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: Biomarker Testing for Non-Small Cell Lung Cancer in Community Practices Operated by an Academic Cancer Center.

Authorship 1817810
type: Authorship
author rank in publication: 4
linked author: Johnson, Bruce
linked information resource: Patterns of lung cancer incidence in adults diagnosed under age 50 in the United States, 2000-2021.

Authorship 1844373
type: Authorship
author rank in publication: 27
linked author: Johnson, Bruce
linked information resource: Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC-A Brief Report.

Authorship 1848389
type: Authorship
author rank in publication: 42
linked author: Johnson, Bruce
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/323017159

Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC-A Brief Report.
PubMed Identifier: 40480428
author list: Riely GJ, Ahn MJ, Clarke JM, Dagogo-Jack I, Esper R, Felip E, Gelsomino F, Goldman JW, Hussein M, Johnson M, Marrone KA, Morgensztern D, Nadal E, Negrao MV, Offin M, Provencio M, Ramalingam SS, Roof L, Sanborn RE, Smit EF, Tsao A, Usari T, Alcasid A, Wilner K, Tonkovyd S, Zhang X, Johnson BE
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC-A Brief Report. J Thorac Oncol. 2025 Oct; 20(10):1538-1547.
journal title abbreviation: J Thorac Oncol
publication date: 2025-06-04T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/323017159
PubMed Identifier: 41038185
author list: Di Federico A, Wang K, Chen MF, Barsouk AA, Pagliaro A, Chen LN, Ogliari FR, Stockhammer P, Thawani R, Raslan S, Gariazzo E, Fusco F, Hambelton GM, Citarella F, Meyer D, Aldea M, De Giglio A, Alessi JV, Pecci F, Gelsomino F, Corassa M, Vokes NI, Wang X, de Biase D, Abu Rous F, Areesawangkit P, Elghawy O, Cortellini A, Metro G, Ferrara R, Awad MM, Pabani A, Murray JC, Cappuzzo F, Garassino MC, Dagogo-Jack I, Riely G, Grant M, Herzberg BO, Ardizzoni A, Planchard D, Johnson BE, Langer CJ, Offin M, Negrao MV, Ricciuti B
published in: The Lancet. Oncology
information resource reference: First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study. Lancet Oncol. 2025 Oct; 26(10):1357-1369.
journal title abbreviation: Lancet Oncol
publication date: 2025-10-01T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource
label: First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study.

Editor's Note: Identification of Existing Drugs That Effectively Target NTRK1 and ROS1 Rearrangements in Lung Cancer.
PubMed Identifier: 41088890
author list: Chong CR, Bahcall M, Capelletti M, Kosaka T, Ercan D, Sim T, Sholl LM, Nishino M, Johnson BE, Gray NS, Jänne PA
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Editor's Note: Identification of Existing Drugs That Effectively Target NTRK1 and ROS1 Rearrangements in Lung Cancer. Clin Cancer Res. 2025 Oct 15; 31(20):4384.
journal title abbreviation: Clin Cancer Res
publication date: 2025-10-15T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Updated Overall Survival Analysis From the Phase II PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer.
PubMed Identifier: 41109959
author list: Johnson ML, Smit EF, Felip E, Ramalingam SS, Ahn MJ, Tsao A, Johnson BE, Offin M, Hussein M, Dagogo-Jack I, Goldman JW, Clarke JM, Negrao MV, Sanborn RE, Morgensztern D, Usari T, Wilner K, Alejandro L, Rifi N, Zhang X, Riely GJ
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Updated Overall Survival Analysis From the Phase II PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer. J Clin Oncol. 2025 Dec 10; 43(35):3706-3713.
journal title abbreviation: J Clin Oncol
publication date: 2025-10-19T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Patterns of lung cancer incidence in adults diagnosed under age 50 in the United States, 2000-2021.
PubMed Identifier: 41442233
author list: LoPiccolo J, Tramontano AC, Florez N, Johnson BE, Gusev A, Christiani DC, Jänne PA
published in: Cancer
information resource reference: Patterns of lung cancer incidence in adults diagnosed under age 50 in the United States, 2000-2021. Cancer. 2026 Jan 01; 132(1):e70217.
journal title abbreviation: Cancer
publication date: 2026-01-01T00:00:00
year: 2026
type: Academic Article
type: Article
type: Document
type: Information Resource

Biomarker Testing for Non-Small Cell Lung Cancer in Community Practices Operated by an Academic Cancer Center.
PubMed Identifier: 41213102
author list: Farhat K, Paul MA, Roby L, Roberts T, Landry L, Hossaini C, Sulieman R, Lathan C, Johnson BE, Kehl KL
published in: JCO oncology practice
information resource reference: Biomarker Testing for Non-Small Cell Lung Cancer in Community Practices Operated by an Academic Cancer Center. JCO Oncol Pract. 2025 Nov 10; OP2500280.
journal title abbreviation: JCO Oncol Pract
publication date: 2025-11-10T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 737276
type: Authorship
author rank in publication: 4
linked author: Johnson, Bruce
linked information resource: Evaluation of statistical designs in phase I expansion cohorts: the Dana-Farber/Harvard Cancer Center experience.

Authorship 737511
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer.

Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer.
PubMed Identifier: 24867533
author list: Parikh RB, Cronin AM, Kozono DE, Oxnard GR, Mak RH, Jackman DM, Lo PC, Baldini EH, Johnson BE, Chen AB
published in: International journal of radiation oncology, biology, physics
information resource reference: Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):880-7.
journal title abbreviation: Int J Radiat Oncol Biol Phys
publication date: 2014-05-24T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Evaluation of statistical designs in phase I expansion cohorts: the Dana-Farber/Harvard Cancer Center experience.
PubMed Identifier: 24963024
author list: Dahlberg SE, Shapiro GI, Clark JW, Johnson BE
published in: Journal of the National Cancer Institute
information resource reference: Evaluation of statistical designs in phase I expansion cohorts: the Dana-Farber/Harvard Cancer Center experience. J Natl Cancer Inst. 2014 Jul; 106(7).
journal title abbreviation: J Natl Cancer Inst
publication date: 2014-06-24T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Adolescent Medicine
type: Division
type: Organization

Authorship 388018
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Civic norms and etiquettes regarding marijuana use in public settings in New York City.

Authorship 406064
type: Authorship
author rank in publication: 26
linked author: Johnson, Bruce
linked information resource: Characterizing the cancer genome in lung adenocarcinoma.

Authorship 42462
type: Authorship
author rank in publication: 5
linked author: Johnson, Bruce
linked information resource: Unsuspected pulmonary embolism in lung cancer patients: comparison of clinical characteristics and outcome with suspected pulmonary embolism.

Authorship 31800
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Imatinib for small cell lung cancer, aiming for a target in vivo.

Elkan Blout Professor of Environmental Genetics
is primary position: true
position in department: Environmental Health
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Elkan Blout Professor of Environmental Genetics
position in organization: Harvard T.H. Chan School of Public Health

Associate Professor of Pediatrics
is primary position: true
position in department: Pediatrics
position in division: Adolescent Medicine
sort order: 1
type: Position
HR job title: Associate Professor of Pediatrics
position in organization: Boston Children's Hospital

Authorship 447820
type: Authorship
author rank in publication: 6
linked author: Johnson, Bruce
linked information resource: The pulmonary status of patients with limited-stage small cell lung cancer 15 years after treatment with chemotherapy and chest irradiation.

Authorship 363966
type: Authorship
author rank in publication: 2
linked author: Johnson, Bruce
linked information resource: Effects of beta-blocker therapy on ventilatory responses to exercise in patients with heart failure.

Authorship 747302
type: Authorship
author rank in publication: 14
linked author: Johnson, Bruce
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/34238799

Authorship 752244
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: Realizing the potential of plasma genotyping in an age of genotype-directed therapies.

Realizing the potential of plasma genotyping in an age of genotype-directed therapies.
PubMed Identifier: 25106647
author list: Luke JJ, Oxnard GR, Paweletz CP, Camidge DR, Heymach JV, Solit DB, Johnson BE
published in: Journal of the National Cancer Institute
information resource reference: Realizing the potential of plasma genotyping in an age of genotype-directed therapies. J Natl Cancer Inst. 2014 Aug; 106(8).
journal title abbreviation: J Natl Cancer Inst
publication date: 2014-08-08T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/34238799
PubMed Identifier: 25122437
author list: Kabbinavar F, Fehrenbacher L, Hainsworth J, Kasubhai S, Kressel B, Marsland T, Patel T, Rubin M, White L, Yang JC, Klughammer B, Colburn D, Miller V, Johnson BE
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of advanced non-small-cell lung cancer (ATLAS). J Thorac Oncol. 2014 Sep; 9(9):1411-7.
journal title abbreviation: J Thorac Oncol
publication date: 2014-09-01T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of advanced non-small-cell lung cancer (ATLAS).

Authorship 62478
type: Authorship
author rank in publication: 4
linked author: Johnson, Bruce
linked information resource: Haplotypes of estrogen receptor-beta and risk of non-small cell lung cancer in women.

Authorship 773635
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: Chemotherapy for locally advanced and metastatic pulmonary carcinoid tumors.

Chemotherapy for locally advanced and metastatic pulmonary carcinoid tumors.
PubMed Identifier: 25218177
author list: Chong CR, Wirth LJ, Nishino M, Chen AB, Sholl LM, Kulke MH, McNamee CJ, Jänne PA, Johnson BE
published in: Lung cancer (Amsterdam, Netherlands)
information resource reference: Chemotherapy for locally advanced and metastatic pulmonary carcinoid tumors. Lung Cancer. 2014 Nov; 86(2):241-6.
journal title abbreviation: Lung Cancer
publication date: 2014-08-27T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 571744
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines.

Authorship 55973
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Rationale for a phase II trial of pertuzumab, a HER-2 dimerization inhibitor, in patients with non-small cell lung cancer.

Authorship 295876
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a Phase I study.

Authorship 61605
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.

Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung cancer patients are associated with shorter survival.
PubMed Identifier: 25726730
author list: Nishino M, Cardarella S, Dahlberg SE, Araki T, Lydon C, Jackman DM, Rabin MS, Hatabu H, Johnson BE
published in: European journal of radiology
information resource reference: Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung cancer patients are associated with shorter survival. Eur J Radiol. 2015 May; 84(5):998-1004.
journal title abbreviation: Eur J Radiol
publication date: 2015-02-07T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 390090
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Small cell lung cancer clinical practice guidelines in oncology.

Authorship 382741
type: Authorship
author rank in publication: 5
linked author: Johnson, Bruce
linked information resource: Long-term mortality with multiple treadmill exercise test abnormalities: comparison between patients with and without cardiovascular disease.

Authorship 173427
type: Authorship
author rank in publication: 3
linked author: Johnson, Bruce
linked information resource: Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study.

Authorship 221093
type: Authorship
author rank in publication: 4
linked author: Johnson, Bruce
linked information resource: Parity and risk of lung cancer in women.

Authorship 364627
type: Authorship
author rank in publication: 17
linked author: Johnson, Bruce
linked information resource: MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Authorship 473658
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

Authorship 570328
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America.

Authorship 226771
type: Authorship
author rank in publication: 4
linked author: Johnson, Bruce
linked information resource: Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.

Authorship 94703
type: Authorship
author rank in publication: 6
linked author: Johnson, Bruce
linked information resource: A metabolic study of patients with lung cancer and hyponatremia of malignancy.

Authorship 556649
type: Authorship
author rank in publication: 3
linked author: Johnson, Bruce
linked information resource: Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting.

Authorship 223362
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.

Authorship 25169
type: Authorship
author rank in publication: 3
linked author: Johnson, Bruce
linked information resource: Beta2-adrenergic receptor genotype and pulmonary function in patients with heart failure.

Authorship 186775
type: Authorship
author rank in publication: 15
linked author: Johnson, Bruce
linked information resource: Efficacy and safety of single-agent pertuzumab, a human epidermal receptor dimerization inhibitor, in patients with non small cell lung cancer.

Authorship 369697
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: Tumoral cavitation in patients with non-small-cell lung cancer treated with antiangiogenic therapy using bevacizumab.

Authorship 385784
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: Radiographic assessment and therapeutic decisions at RECIST progression in EGFR-mutant NSCLC treated with EGFR tyrosine kinase inhibitors.

Authorship 282072
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: Autocrine production of amphiregulin predicts sensitivity to both gefitinib and cetuximab in EGFR wild-type cancers.

Authorship 346122
type: Authorship
author rank in publication: 2
linked author: Johnson, Bruce
linked information resource: Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.

Authorship 35798
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: Prospective study of the airways and pulmonary parenchyma of patients at risk for a second lung cancer.

Authorship 419298
type: Authorship
author rank in publication: 3
linked author: Johnson, Bruce
linked information resource: A model to select regimens for phase III trials for patients with advanced-stage non-small cell lung cancer.

Authorship 443489
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.

Authorship 27369
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: Small cell lung cancer.

Authorship 287335
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma.

Authorship 300383
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: Phase I trial of the matrix metalloproteinase inhibitor marimastat combined with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.

Authorship 442026
type: Authorship
author rank in publication: 3
linked author: Johnson, Bruce
linked information resource: Gefitinib for recurrent non-small-cell lung cancer: all things are not created equal.

Authorship 272834
type: Authorship
author rank in publication: 10
linked author: Johnson, Bruce
linked information resource: Integration of molecular profiling into the lung cancer clinic.

Authorship 313413
type: Authorship
author rank in publication: 2
linked author: Johnson, Bruce
linked information resource: Adjuvant chemotherapy for surgically resected non-small cell lung cancer.

Authorship 354428
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Basic treatment considerations using chemotherapy for patients with small cell lung cancer.

Authorship 403599
type: Authorship
author rank in publication: 6
linked author: Johnson, Bruce
linked information resource: A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma.

Authorship 406059
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: Novel agents in the treatment of lung cancer: Fourth Cambridge Conference.

Authorship 406241
type: Authorship
author rank in publication: 15
linked author: Johnson, Bruce
linked information resource: Randomized phase II study of vandetanib alone or with paclitaxel and carboplatin as first-line treatment for advanced non-small-cell lung cancer.

Authorship 450253
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.

Authorship 531339
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Management of small cell lung cancer.

Authorship 563527
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement.

Authorship 275676
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Phase II study of imatinib in patients with small cell lung cancer.

Authorship 464084
type: Authorship
author rank in publication: 10
linked author: Johnson, Bruce
linked information resource: The introduction of systematic genomic testing for patients with non-small-cell lung cancer.

Authorship 323305
type: Authorship
author rank in publication: 6
linked author: Johnson, Bruce
linked information resource: Arginine 16 glycine beta2-adrenoceptor polymorphism and cardiovascular structure and function in patients with heart failure.

Authorship 344716
type: Authorship
author rank in publication: 19
linked author: Johnson, Bruce
linked information resource: Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance.

Authorship 457749
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Epidermal growth factor receptor mutations in patients with non-small cell lung cancer.

Authorship 514373
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: Novel agents in the treatment of lung cancer: conference summary statement.

Authorship 553799
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: Sensitivity of non-small-cell lung cancer cell lines established from patients treated with prolonged infusions of Paclitaxel.

Authorship 804885
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung cancer patients are associated with shorter survival.

Authorship 790073
type: Authorship
author rank in publication: 5
linked author: Johnson, Bruce
linked information resource: Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.

Authorship 805957
type: Authorship
author rank in publication: 11
linked author: Johnson, Bruce
linked information resource: A phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer.

Authorship 793061
type: Authorship
author rank in publication: 14
linked author: Johnson, Bruce
linked information resource: Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience.

Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience.
PubMed Identifier: 25738220
author list: Sholl LM, Aisner DL, Varella-Garcia M, Berry LD, Dias-Santagata D, Wistuba II, Chen H, Fujimoto J, Kugler K, Franklin WA, Iafrate AJ, Ladanyi M, Kris MG, Johnson BE, Bunn PA, Minna JD, Kwiatkowski DJ
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience. J Thorac Oncol. 2015 May; 10(5):768-777.
journal title abbreviation: J Thorac Oncol
publication date: 2015-05-01T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

A phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer.
PubMed Identifier: 25784657
author list: Jackman DM, Cioffredi LA, Jacobs L, Sharmeen F, Morse LK, Lucca J, Plotkin SR, Marcoux PJ, Rabin MS, Lynch TJ, Johnson BE, Kesari S
published in: Oncotarget
information resource reference: A phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer. Oncotarget. 2015 Feb 28; 6(6):4527-36.
journal title abbreviation: Oncotarget
publication date: 2015-02-28T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.
PubMed Identifier: 25273224
author list: Villaruz LC, Socinski MA, Abberbock S, Berry LD, Johnson BE, Kwiatkowski DJ, Iafrate AJ, Varella-Garcia M, Franklin WA, Camidge DR, Sequist LV, Haura EB, Ladanyi M, Kurland BF, Kugler K, Minna JD, Bunn PA, Kris MG
published in: Cancer
information resource reference: Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium. Cancer. 2015 Feb 01; 121(3):448-56.
journal title abbreviation: Cancer
publication date: 2014-10-01T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 91464
type: Authorship
author rank in publication: 4
linked author: Johnson, Bruce
linked information resource: A pulmonary hypertension gas exchange severity (PH-GXS) score to assist with the assessment and monitoring of pulmonary arterial hypertension.

Authorship 245225
type: Authorship
author rank in publication: 14
linked author: Johnson, Bruce
linked information resource: Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib.

Authorship 316933
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: Patient-reported receipt of and interest in smoking-cessation interventions after a diagnosis of cancer.

Authorship 416125
type: Authorship
author rank in publication: 60
linked author: Johnson, Bruce
linked information resource: Somatic mutations affect key pathways in lung adenocarcinoma.

Authorship 503685
type: Authorship
author rank in publication: 18
linked author: Johnson, Bruce
linked information resource: Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models.

Authorship 503779
type: Authorship
author rank in publication: 5
linked author: Johnson, Bruce
linked information resource: Leptin, a novel predictor of lung function in heart failure.

Authorship 817489
type: Authorship
author rank in publication: 4
linked author: Johnson, Bruce
linked information resource: Delay of treatment change after objective progression on first-line erlotinib in epidermal growth factor receptor-mutant lung cancer.

Delay of treatment change after objective progression on first-line erlotinib in epidermal growth factor receptor-mutant lung cancer.
PubMed Identifier: 25876525
author list: Lo PC, Dahlberg SE, Nishino M, Johnson BE, Sequist LV, Jackman DM, Jänne PA, Oxnard GR
published in: Cancer
information resource reference: Delay of treatment change after objective progression on first-line erlotinib in epidermal growth factor receptor-mutant lung cancer. Cancer. 2015 Aug 01; 121(15):2570-7.
journal title abbreviation: Cancer
publication date: 2015-04-15T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 458008
type: Authorship
author rank in publication: 10
linked author: Johnson, Bruce
linked information resource: Human phenylethanolamine N-methyltransferase genetic polymorphisms and exercise-induced epinephrine release.

Authorship 516447
type: Authorship
author rank in publication: 4
linked author: Johnson, Bruce
linked information resource: Predictive value of heart rate recovery and peak oxygen consumption for long-term mortality in patients with coronary heart disease.

Authorship 564743
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma.

Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.
PubMed Identifier: 26410082
author list: Brastianos PK, Carter SL, Santagata S, Cahill DP, Taylor-Weiner A, Jones RT, Van Allen EM, Lawrence MS, Horowitz PM, Cibulskis K, Ligon KL, Tabernero J, Seoane J, Martinez-Saez E, Curry WT, Dunn IF, Paek SH, Park SH, McKenna A, Chevalier A, Rosenberg M, Barker FG, Gill CM, Van Hummelen P, Thorner AR, Johnson BE, Hoang MP, Choueiri TK, Signoretti S, Sougnez C, Rabin MS, Lin NU, Winer EP, Stemmer-Rachamimov A, Meyerson M, Garraway L, Gabriel S, Lander ES, Beroukhim R, Batchelor TT, Baselga J, Louis DN, Getz G, Hahn WC
published in: Cancer discovery
information resource reference: Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. Cancer Discov. 2015 Nov; 5(11):1164-1177.
journal title abbreviation: Cancer Discov
publication date: 2015-09-26T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 843543
type: Authorship
author rank in publication: 26
linked author: Johnson, Bruce
linked information resource: Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.

Authorship 480677
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/1170781

Authorship 512991
type: Authorship
author rank in publication: 5
linked author: Johnson, Bruce
linked information resource: Imaging of lung cancer in the era of molecular medicine.

Authorship 534214
type: Authorship
author rank in publication: 13
linked author: Johnson, Bruce
linked information resource: A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening.

Volumetric Tumor Response and Progression in EGFR-mutant NSCLC Patients Treated with Erlotinib or Gefitinib.
PubMed Identifier: 26776293
author list: Nishino M, Dahlberg SE, Fulton LE, Digumarthy SR, Hatabu H, Johnson BE, Sequist LV
published in: Academic radiology
information resource reference: Volumetric Tumor Response and Progression in EGFR-mutant NSCLC Patients Treated with Erlotinib or Gefitinib. Acad Radiol. 2016 Mar; 23(3):329-36.
journal title abbreviation: Acad Radiol
publication date: 2016-01-08T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 85711
type: Authorship
author rank in publication: 4
linked author: Johnson, Bruce
linked information resource: Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapy.

Authorship 88166
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, "Iressa") on an expanded access study.

Authorship 869815
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium.

Authorship 862867
type: Authorship
author rank in publication: 17
linked author: Johnson, Bruce
linked information resource: Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses.

Authorship 867676
type: Authorship
author rank in publication: 16
linked author: Johnson, Bruce
linked information resource: Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.

Authorship 867918
type: Authorship
author rank in publication: 6
linked author: Johnson, Bruce
linked information resource: Volumetric Tumor Response and Progression in EGFR-mutant NSCLC Patients Treated with Erlotinib or Gefitinib.

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.
PubMed Identifier: 26883990
author list: Koyama S, Akbay EA, Li YY, Herter-Sprie GS, Buczkowski KA, Richards WG, Gandhi L, Redig AJ, Rodig SJ, Asahina H, Jones RE, Kulkarni MM, Kuraguchi M, Palakurthi S, Fecci PE, Johnson BE, Janne PA, Engelman JA, Gangadharan SP, Costa DB, Freeman GJ, Bueno R, Hodi FS, Dranoff G, Wong KK, Hammerman PS
published in: Nature communications
information resource reference: Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints. Nat Commun. 2016 Feb 17; 7:10501.
journal title abbreviation: Nat Commun
publication date: 2016-02-17T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses.
PubMed Identifier: 26446944
author list: Sundaresan TK, Sequist LV, Heymach JV, Riely GJ, Jänne PA, Koch WH, Sullivan JP, Fox DB, Maher R, Muzikansky A, Webb A, Tran HT, Giri U, Fleisher M, Yu HA, Wei W, Johnson BE, Barber TA, Walsh JR, Engelman JA, Stott SL, Kapur R, Maheswaran S, Toner M, Haber DA
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses. Clin Cancer Res. 2016 Mar 01; 22(5):1103-10.
journal title abbreviation: Clin Cancer Res
publication date: 2015-10-07T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium.
PubMed Identifier: 26695526
author list: Steuer CE, Behera M, Berry L, Kim S, Rossi M, Sica G, Owonikoko TK, Johnson BE, Kris MG, Bunn PA, Khuri FR, Garon EB, Ramalingam SS
published in: Cancer
information resource reference: Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium. Cancer. 2016 Mar 01; 122(5):766-72.
journal title abbreviation: Cancer
publication date: 2015-12-22T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 90584
type: Authorship
author rank in publication: 2
linked author: Johnson, Bruce
linked information resource: Update: NCCN small cell and non-small cell lung cancer Clinical Practice Guidelines.

Authorship 342816
type: Authorship
author rank in publication: 34
linked author: Johnson, Bruce
linked information resource: Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.

Authorship 874948
type: Authorship
author rank in publication: 7
linked author: Johnson, Bruce
linked information resource: Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs.

Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs.
PubMed Identifier: 26724471
author list: Lin JJ, Cardarella S, Lydon CA, Dahlberg SE, Jackman DM, Jänne PA, Johnson BE
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs. J Thorac Oncol. 2016 Apr; 11(4):556-65.
journal title abbreviation: J Thorac Oncol
publication date: 2015-12-25T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 389978
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: Response to treatment and survival of patients with non-small cell lung cancer undergoing somatic EGFR mutation testing.

Authorship 876539
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Emerging gene mutation targets in lung cancer.

Emerging gene mutation targets in lung cancer.
PubMed Identifier: 27058846
author list: Johnson BE
published in: Clinical advances in hematology & oncology : H&O
information resource reference: Emerging gene mutation targets in lung cancer. Clin Adv Hematol Oncol. 2015 Dec; 13(12):812-4.
journal title abbreviation: Clin Adv Hematol Oncol
publication date: 2015-12-01T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 877648
type: Authorship
author rank in publication: 13
linked author: Johnson, Bruce
linked information resource: KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI Vandetanib.

KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI Vandetanib.
PubMed Identifier: 26578684
author list: Nilsson MB, Giri U, Gudikote J, Tang X, Lu W, Tran H, Fan Y, Koo A, Diao L, Tong P, Wang J, Herbst R, Johnson BE, Ryan A, Webster A, Rowe P, Wistuba II, Heymach JV
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI Vandetanib. Clin Cancer Res. 2016 Apr 15; 22(8):1940-50.
journal title abbreviation: Clin Cancer Res
publication date: 2015-11-17T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 450119
type: Authorship
author rank in publication: 8
linked author: Johnson, Bruce
linked information resource: High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines.

Authorship 531122
type: Authorship
author rank in publication: 3
linked author: Johnson, Bruce
linked information resource: Pulmonary function changes associated with cardiomegaly in chronic heart failure.

Authorship 887233
type: Authorship
author rank in publication: 19
linked author: Johnson, Bruce
linked information resource: Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial.

Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial.
PubMed Identifier: 27080216
author list: Planchard D, Kim TM, Mazieres J, Quoix E, Riely G, Barlesi F, Souquet PJ, Smit EF, Groen HJ, Kelly RJ, Cho BC, Socinski MA, Pandite L, Nase C, Ma B, D'Amelio A, Mookerjee B, Curtis CM, Johnson BE
published in: The Lancet. Oncology
information resource reference: Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial. Lancet Oncol. 2016 05; 17(5):642-50.
journal title abbreviation: Lancet Oncol
publication date: 2016-04-11T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 75024
type: Authorship
author rank in publication: 3
linked author: Johnson, Bruce
linked information resource: Factors associated with smoking abstinence among smokers and recent-quitters with lung and head and neck cancer.

A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial.
PubMed Identifier: 27281561
author list: Yanagita M, Redig AJ, Paweletz CP, Dahlberg SE, O'Connell A, Feeney N, Taibi M, Boucher D, Oxnard GR, Johnson BE, Costa DB, Jackman DM, Jänne PA
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial. Clin Cancer Res. 2016 Dec 15; 22(24):6010-6020.
journal title abbreviation: Clin Cancer Res
publication date: 2016-06-08T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Assistant Professor
sort order: 2
type: Faculty Rank

Associate Professor
sort order: 1
type: Faculty Rank

Full Professor
sort order: 0
type: Faculty Rank

Authorship 90553
type: Authorship
author rank in publication: 18
linked author: Johnson, Bruce
linked information resource: The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies.

Prospective Study of Repeated Biopsy Feasibility and Acquired Resistance at Disease Progression in Patients With Advanced EGFR Mutant Lung Cancer Treated With Erlotinib in a Phase 2 Trial.
PubMed Identifier: 27387964
author list: Redig AJ, Costa DB, Taibi M, Boucher D, Johnson BE, Jänne PA, Jackman DM
published in: JAMA oncology
information resource reference: Prospective Study of Repeated Biopsy Feasibility and Acquired Resistance at Disease Progression in Patients With Advanced EGFR Mutant Lung Cancer Treated With Erlotinib in a Phase 2 Trial. JAMA Oncol. 2016 Sep 01; 2(9):1240-2.
journal title abbreviation: JAMA Oncol
publication date: 2016-09-01T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 891983
type: Authorship
author rank in publication: 16
linked author: Johnson, Bruce
linked information resource: Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial.

Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial.
PubMed Identifier: 27283860
author list: Planchard D, Besse B, Groen HJM, Souquet PJ, Quoix E, Baik CS, Barlesi F, Kim TM, Mazieres J, Novello S, Rigas JR, Upalawanna A, D'Amelio AM, Zhang P, Mookerjee B, Johnson BE
published in: The Lancet. Oncology
information resource reference: Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial. Lancet Oncol. 2016 Jul; 17(7):984-993.
journal title abbreviation: Lancet Oncol
publication date: 2016-06-06T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 86353
type: Authorship
author rank in publication: 2
linked author: Johnson, Bruce
linked information resource: Left atrial index is a predictor of exercise capacity in patients with hypertrophic cardiomyopathy.

Authorship 9710
type: Authorship
author rank in publication: 16
linked author: Johnson, Bruce
linked information resource: EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Authorship 485686
type: Authorship
author rank in publication: 6
linked author: Johnson, Bruce
linked information resource: Heart rate recovery and prognosis in heart failure patients.

EGFR Mutations in Non-Small Cell Lung Cancer
end date: 2019-04-30
principal investigator name: JOHNSON, BRUCE E.
start date: 2005-04-01
type: Grant
sponsor award id: R01CA114465

General Clinical Research Center
end date: 2009-11-30
principal investigator name: RIZZA, ROBERT A.
start date: 1976-12-01
type: Grant
sponsor award id: M01RR000585

Clinical implementation of single cell tumor transcriptome analysis
end date: 2020-04-30
principal investigator name: GOLUB, TODD R.
start date: 2016-05-12
type: Grant
sponsor award id: R33CA202820

SPORE in Lung Cancer
end date: 2008-06-30
principal investigator name: JOHNSON, BRUCE E.
start date: 2003-09-19
type: Grant
sponsor award id: P20CA090578

Dana-Farber/Harvard Cancer Center SPORE in Lung Cancer
end date: 2015-06-30
principal investigator name: JOHNSON, BRUCE E.
start date: 2001-04-01
type: Grant
sponsor award id: P50CA090578

Principal Investigator
type: Researcher Role
researcher role of: Johnson, Bruce
contributes to: Dana-Farber/Harvard Cancer Center SPORE in Lung Cancer

Co-Principal Investigator
type: Researcher Role
researcher role of: Johnson, Bruce
contributes to: General Clinical Research Center

Co-Principal Investigator
type: Researcher Role
researcher role of: Johnson, Bruce
contributes to: EGFR Mutations in Non-Small Cell Lung Cancer

Principal Investigator
type: Researcher Role
researcher role of: Johnson, Bruce
contributes to: SPORE in Lung Cancer

Authorship 912895
type: Authorship
author rank in publication: 5
linked author: Johnson, Bruce
linked information resource: Prospective Study of Repeated Biopsy Feasibility and Acquired Resistance at Disease Progression in Patients With Advanced EGFR Mutant Lung Cancer Treated With Erlotinib in a Phase 2 Trial.

Identification of Existing Drugs That Effectively Target NTRK1 and ROS1 Rearrangements in Lung Cancer.
PubMed Identifier: 27370605
author list: Chong CR, Bahcall M, Capelletti M, Kosaka T, Ercan D, Sim T, Sholl LM, Nishino M, Johnson BE, Gray NS, Jänne PA
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Identification of Existing Drugs That Effectively Target NTRK1 and ROS1 Rearrangements in Lung Cancer. Clin Cancer Res. 2017 Jan 01; 23(1):204-213.
journal title abbreviation: Clin Cancer Res
publication date: 2016-07-01T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 388091
type: Authorship
author rank in publication: 3
linked author: Johnson, Bruce
linked information resource: Expression of bcl-2 protein is associated with shorter survival in nonsmall cell lung carcinoma.

Authorship 922917
type: Authorship
author rank in publication: 1
linked author: Johnson, Bruce
linked information resource: Divide and Conquer to Treat Lung Cancer.

Divide and Conquer to Treat Lung Cancer.
PubMed Identifier: 27718875
author list: Johnson BE
published in: The New England journal of medicine
information resource reference: Divide and Conquer to Treat Lung Cancer. N Engl J Med. 2016 11 10; 375(19):1892-1893.
journal title abbreviation: N Engl J Med
publication date: 2016-10-08T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 432484
type: Authorship
author rank in publication: 10
linked author: Johnson, Bruce
linked information resource: Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib.

Authorship 932479
type: Authorship
author rank in publication: 10
linked author: Johnson, Bruce
linked information resource: A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial.

Authorship 933832
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: Identification of Existing Drugs That Effectively Target NTRK1 and ROS1 Rearrangements in Lung Cancer.

Authorship 60494
type: Authorship
author rank in publication: 5
linked author: Johnson, Bruce
linked information resource: Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255.

Authorship 938088
type: Authorship
author rank in publication: 34
linked author: Johnson, Bruce
linked information resource: Institutional implementation of clinical tumor profiling on an unselected cancer population.

Institutional implementation of clinical tumor profiling on an unselected cancer population.
PubMed Identifier: 27882345
author list: Sholl LM, Do K, Shivdasani P, Cerami E, Dubuc AM, Kuo FC, Garcia EP, Jia Y, Davineni P, Abo RP, Pugh TJ, van Hummelen P, Thorner AR, Ducar M, Berger AH, Nishino M, Janeway KA, Church A, Harris M, Ritterhouse LL, Campbell JD, Rojas-Rudilla V, Ligon AH, Ramkissoon S, Cleary JM, Matulonis U, Oxnard GR, Chao R, Tassell V, Christensen J, Hahn WC, Kantoff PW, Kwiatkowski DJ, Johnson BE, Meyerson M, Garraway LA, Shapiro GI, Rollins BJ, Lindeman NI, MacConaill LE
published in: JCI insight
information resource reference: Institutional implementation of clinical tumor profiling on an unselected cancer population. JCI Insight. 2016 11 17; 1(19):e87062.
journal title abbreviation: JCI Insight
publication date: 2016-11-17T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 252291
type: Authorship
author rank in publication: 11
linked author: Johnson, Bruce
linked information resource: Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and/or chemotherapy in patients with non-small-cell lung cancer.

Authorship 263511
type: Authorship
author rank in publication: 6
linked author: Johnson, Bruce
linked information resource: Everolimus and erlotinib as second- or third-line therapy in patients with advanced non-small-cell lung cancer.

Authorship 273451
type: Authorship
author rank in publication: 12
linked author: Johnson, Bruce
linked information resource: Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria.

Authorship 369330
type: Authorship
author rank in publication: 3
linked author: Johnson, Bruce
linked information resource: Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening.

Authorship 438156
type: Authorship
author rank in publication: 15
linked author: Johnson, Bruce
linked information resource: Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancer.

Authorship 547735
type: Authorship
author rank in publication: 13
linked author: Johnson, Bruce
linked information resource: Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.

Authorship 954016
type: Authorship
author rank in publication: 10
linked author: Johnson, Bruce
linked information resource: Clinical trial enrollment expansion to the community.

Clinical trial enrollment expansion to the community.
PubMed Identifier: 28152731
author list: Zerillo JA, Kruse A, Sinclair NF, Patrick M, McGovern L, Fuller F, O'Neil K, Hixon N, Weeks K, Johnson BE, Krop IE, Savoie J, Daftary F, Constantine M, Kaddis MS, Rossi HA, Tahir N, Norden AD
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Clinical trial enrollment expansion to the community. J Clin Oncol. 2016 Mar; 34(7_suppl):112.
journal title abbreviation: J Clin Oncol
publication date: 2016-03-01T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 81023
type: Authorship
author rank in publication: 10
linked author: Johnson, Bruce
linked information resource: CT tumor volume measurement in advanced non-small-cell lung cancer: Performance characteristics of an emerging clinical tool.

Authorship 958410
type: Authorship
author rank in publication: 12
linked author: Johnson, Bruce
linked information resource: An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC).

An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC).
PubMed Identifier: 28212994
author list: Awad MM, Chu QS, Gandhi L, Stephenson JJ, Govindan R, Bradford DS, Bonomi PD, Ellison DM, Eaton KD, Fritsch H, Munzert G, Johnson BE, Socinski MA
published in: Lung cancer (Amsterdam, Netherlands)
information resource reference: An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC). Lung Cancer. 2017 02; 104:126-130.
journal title abbreviation: Lung Cancer
publication date: 2016-12-30T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations.
PubMed Identifier: 16106023
author list: Mukohara T, Engelman JA, Hanna NH, Yeap BY, Kobayashi S, Lindeman N, Halmos B, Pearlberg J, Tsuchihashi Z, Cantley LC, Tenen DG, Johnson BE, Jänne PA
published in: Journal of the National Cancer Institute
information resource reference: Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations. J Natl Cancer Inst. 2005 Aug 17; 97(16):1185-94.
journal title abbreviation: J Natl Cancer Inst
publication date: 2005-08-17T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 958890
type: Authorship
author rank in publication: 3
linked author: Johnson, Bruce
linked information resource: Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.

Authorship 964317
type: Authorship
author rank in publication: 9
linked author: Johnson, Bruce
linked information resource: Co-clinical quantitative tumor volume imaging in ALK-rearranged NSCLC treated with crizotinib.

Co-clinical quantitative tumor volume imaging in ALK-rearranged NSCLC treated with crizotinib.
PubMed Identifier: 28189201
author list: Nishino M, Sacher AG, Gandhi L, Chen Z, Akbay E, Fedorov A, Westin CF, Hatabu H, Johnson BE, Hammerman P, Wong KK
published in: European journal of radiology
information resource reference: Co-clinical quantitative tumor volume imaging in ALK-rearranged NSCLC treated with crizotinib. Eur J Radiol. 2017 Mar; 88:15-20.
journal title abbreviation: Eur J Radiol
publication date: 2016-12-26T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Novel agents in the treatment of lung cancer: Fourth Cambridge Conference.
PubMed Identifier: 17671145
author list: Lynch TJ, Bonomi PD, Butts C, Davies AM, Engelman J, Govindan R, Herbst RS, Heymach JV, Johnson BE, Martins RG, Perez-Soler R, Riely GJ, Sandler AB, Sequist LV, Socinski MA, Wong KK, Hart CS
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Novel agents in the treatment of lung cancer: Fourth Cambridge Conference. Clin Cancer Res. 2007 Aug 01; 13(15 Pt 2):s4583-8.
journal title abbreviation: Clin Cancer Res
publication date: 2007-08-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Parity and risk of lung cancer in women.
PubMed Identifier: 20123687
author list: Paulus JK, Asomaning K, Kraft P, Johnson BE, Lin X, Christiani DC
published in: American journal of epidemiology
information resource reference: Parity and risk of lung cancer in women. Am J Epidemiol. 2010 Mar 01; 171(5):557-63.
journal title abbreviation: Am J Epidemiol
publication date: 2010-01-31T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Basic treatment considerations using chemotherapy for patients with small cell lung cancer.
PubMed Identifier: 15094173
author list: Johnson BE, Jänne PA
published in: Hematology/oncology clinics of North America
information resource reference: Basic treatment considerations using chemotherapy for patients with small cell lung cancer. Hematol Oncol Clin North Am. 2004 Apr; 18(2):309-22.
journal title abbreviation: Hematol Oncol Clin North Am
publication date: 2004-04-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase I trial of the matrix metalloproteinase inhibitor marimastat combined with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
PubMed Identifier: 15867243
author list: Goffin JR, Anderson IC, Supko JG, Eder JP, Shapiro GI, Lynch TJ, Shipp M, Johnson BE, Skarin AT
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Phase I trial of the matrix metalloproteinase inhibitor marimastat combined with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer. Clin Cancer Res. 2005 May 01; 11(9):3417-24.
journal title abbreviation: Clin Cancer Res
publication date: 2005-05-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Rationale for a phase II trial of pertuzumab, a HER-2 dimerization inhibitor, in patients with non-small cell lung cancer.
PubMed Identifier: 16857824
author list: Johnson BE, Jänne PA
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Rationale for a phase II trial of pertuzumab, a HER-2 dimerization inhibitor, in patients with non-small cell lung cancer. Clin Cancer Res. 2006 Jul 15; 12(14 Pt 2):4436s-4440s.
journal title abbreviation: Clin Cancer Res
publication date: 2006-07-15T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

The Arg16Gly polymorphism of the beta2-adrenergic receptor and the natriuretic response to rapid saline infusion in humans.
PubMed Identifier: 16728452
author list: Snyder EM, Turner ST, Joyner MJ, Eisenach JH, Johnson BD
published in: The Journal of physiology
information resource reference: The Arg16Gly polymorphism of the beta2-adrenergic receptor and the natriuretic response to rapid saline infusion in humans. J Physiol. 2006 Aug 01; 574(Pt 3):947-54.
journal title abbreviation: J Physiol
publication date: 2006-05-25T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a Phase I study.
PubMed Identifier: 12738723
author list: Wirth LJ, Lucca J, Ostler P, Fidias P, Lynch C, Jänne PA, Herbst RS, Johnson BE, Sugarbaker DJ, Mathisen DJ, Lukanich JM, Choi NC, Berman SM, Skarin AT
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a Phase I study. Clin Cancer Res. 2003 May; 9(5):1698-704.
journal title abbreviation: Clin Cancer Res
publication date: 2003-05-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

Effects of beta-blocker therapy on ventilatory responses to exercise in patients with heart failure.
PubMed Identifier: 15948082
author list: Wolk R, Johnson BD, Somers VK, Allison TG, Squires RW, Gau GT, Olson LJ
published in: Journal of cardiac failure
information resource reference: Effects of beta-blocker therapy on ventilatory responses to exercise in patients with heart failure. J Card Fail. 2005 Jun; 11(5):333-9.
journal title abbreviation: J Card Fail
publication date: 2005-06-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Civic norms and etiquettes regarding marijuana use in public settings in New York City.
PubMed Identifier: 18570024
author list: Johnson BD, Ream GL, Dunlap E, Sifaneck SJ
published in: Substance use & misuse
information resource reference: Civic norms and etiquettes regarding marijuana use in public settings in New York City. Subst Use Misuse. 2008; 43(7):895-918.
journal title abbreviation: Subst Use Misuse
publication date: 2008-01-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Small-cell lung cancer.
PubMed Identifier: 16226617
author list: Jackman DM, Johnson BE
published in: Lancet (London, England)
information resource reference: Small-cell lung cancer. Lancet. 2005 Oct 15-21; 366(9494):1385-96.
journal title abbreviation: Lancet
publication date: 2005-10-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Integration of molecular profiling into the lung cancer clinic.
PubMed Identifier: 19706816
author list: Pao W, Kris MG, Iafrate AJ, Ladanyi M, Jänne PA, Wistuba II, Miake-Lye R, Herbst RS, Carbone DP, Johnson BE, Lynch TJ
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Integration of molecular profiling into the lung cancer clinic. Clin Cancer Res. 2009 Sep 01; 15(17):5317-22.
journal title abbreviation: Clin Cancer Res
publication date: 2009-08-25T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Left atrial index is a predictor of exercise capacity in patients with hypertrophic cardiomyopathy.
PubMed Identifier: 16376769
author list: Kjaergaard J, Johnson BD, Pellikka PA, Cha SS, Oh JK, Ommen SR
published in: Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
information resource reference: Left atrial index is a predictor of exercise capacity in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2005 Dec; 18(12):1373-80.
journal title abbreviation: J Am Soc Echocardiogr
publication date: 2005-12-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase II neoadjuvant trial of paclitaxel by 96-hour continuous infusion (CIVI) in combination with cisplatin followed by chest radiotherapy for patients with stage III non-small-cell lung cancer.
PubMed Identifier: 12040286
author list: Breathnach OS, Kasturi V, Kaye F, Herscher L, Georgiadis MS, Edison M, Schuler BS, Pizzella P, Steinberg SM, O'Neil K, Johnson BE
published in: American journal of clinical oncology
information resource reference: Phase II neoadjuvant trial of paclitaxel by 96-hour continuous infusion (CIVI) in combination with cisplatin followed by chest radiotherapy for patients with stage III non-small-cell lung cancer. Am J Clin Oncol. 2002 Jun; 25(3):269-73.
journal title abbreviation: Am J Clin Oncol
publication date: 2002-06-01T00:00:00
year: 2002
type: Academic Article
type: Article
type: Document
type: Information Resource

Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.
PubMed Identifier: 12234991
author list: Jänne PA, Taffaro ML, Salgia R, Johnson BE
published in: Cancer research
information resource reference: Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma. Cancer Res. 2002 Sep 15; 62(18):5242-7.
journal title abbreviation: Cancer Res
publication date: 2002-09-15T00:00:00
year: 2002
type: Academic Article
type: Article
type: Document
type: Information Resource

High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines.
PubMed Identifier: 15048096
author list: Jänne PA, Li C, Zhao X, Girard L, Chen TH, Minna J, Christiani DC, Johnson BE, Meyerson M
published in: Oncogene
information resource reference: High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines. Oncogene. 2004 Apr 08; 23(15):2716-26.
journal title abbreviation: Oncogene
publication date: 2004-04-08T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.
PubMed Identifier: 15118125
author list: Paez JG, Jänne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE, Meyerson M
published in: Science (New York, N.Y.)
information resource reference: EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 2004 Jun 04; 304(5676):1497-500.
journal title abbreviation: Science
publication date: 2004-04-29T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/822099
PubMed Identifier: 16043828
author list: Eberhard DA, Johnson BE, Amler LC, Goddard AD, Heldens SL, Herbst RS, Ince WL, Jänne PA, Januario T, Johnson DH, Klein P, Miller VA, Ostland MA, Ramies DA, Sebisanovic D, Stinson JA, Zhang YR, Seshagiri S, Hillan KJ
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. J Clin Oncol. 2005 Sep 01; 23(25):5900-9.
journal title abbreviation: J Clin Oncol
publication date: 2005-07-25T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib.

TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.
PubMed Identifier: 16043829
author list: Herbst RS, Prager D, Hermann R, Fehrenbacher L, Johnson BE, Sandler A, Kris MG, Tran HT, Klein P, Li X, Ramies D, Johnson DH, Miller VA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol. 2005 Sep 01; 23(25):5892-9.
journal title abbreviation: J Clin Oncol
publication date: 2005-07-25T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement.
PubMed Identifier: 16000599
author list: Lynch TJ, Bogart JA, Curran WJ, DeCamp MM, Gandara DR, Goss G, Henschke CI, Jett JR, Johnson BE, Kelly KL, Le Chevalier T, Mulshine JL, Scagliotti GV, Schiller JH, Shaw A, Thatcher N, Vokes EE, Wood DE, Hart C
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement. Clin Cancer Res. 2005 Jul 01; 11(13 Pt 2):4981s-4983s.
journal title abbreviation: Clin Cancer Res
publication date: 2005-07-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agents.
PubMed Identifier: 16857812
author list: Lynch TJ, Adjei AA, Bunn PA, Eisen TG, Engelman J, Goss GD, Haber DA, Heymach JV, Jänne PA, Johnson BE, Johnson DH, Lilenbaum RC, Meyerson M, Sandler AB, Sequist LV, Settleman J, Wong KK, Hart CS
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agents. Clin Cancer Res. 2006 Jul 15; 12(14 Pt 2):4365s-4371s.
journal title abbreviation: Clin Cancer Res
publication date: 2006-07-15T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Arginine 16 glycine beta2-adrenoceptor polymorphism and cardiovascular structure and function in patients with heart failure.
PubMed Identifier: 17336757
author list: Wolk R, Snyder EM, Somers VK, Turner ST, Olson LJ, Johnson BD
published in: Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
information resource reference: Arginine 16 glycine beta2-adrenoceptor polymorphism and cardiovascular structure and function in patients with heart failure. J Am Soc Echocardiogr. 2007 Mar; 20(3):290-7.
journal title abbreviation: J Am Soc Echocardiogr
publication date: 2007-03-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Rationale for a phase I trial of erlotinib and the mammalian target of rapamycin inhibitor everolimus (RAD001) for patients with relapsed non small cell lung cancer.
PubMed Identifier: 17671154
author list: Johnson BE, Jackman D, Jänne PA
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Rationale for a phase I trial of erlotinib and the mammalian target of rapamycin inhibitor everolimus (RAD001) for patients with relapsed non small cell lung cancer. Clin Cancer Res. 2007 Aug 01; 13(15 Pt 2):s4628-31.
journal title abbreviation: Clin Cancer Res
publication date: 2007-08-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Efficacy and safety of single-agent pertuzumab, a human epidermal receptor dimerization inhibitor, in patients with non small cell lung cancer.
PubMed Identifier: 17947484
author list: Herbst RS, Davies AM, Natale RB, Dang TP, Schiller JH, Garland LL, Miller VA, Mendelson D, Van den Abbeele AD, Melenevsky Y, de Vries DJ, Eberhard DA, Lyons B, Lutzker SG, Johnson BE
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Efficacy and safety of single-agent pertuzumab, a human epidermal receptor dimerization inhibitor, in patients with non small cell lung cancer. Clin Cancer Res. 2007 Oct 15; 13(20):6175-81.
journal title abbreviation: Clin Cancer Res
publication date: 2007-10-15T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Characterizing the cancer genome in lung adenocarcinoma.
PubMed Identifier: 17982442
author list: Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R, Lin WM, Province MA, Kraja A, Johnson LA, Shah K, Sato M, Thomas RK, Barletta JA, Borecki IB, Broderick S, Chang AC, Chiang DY, Chirieac LR, Cho J, Fujii Y, Gazdar AF, Giordano T, Greulich H, Hanna M, Johnson BE, Kris MG, Lash A, Lin L, Lindeman N, Mardis ER, McPherson JD, Minna JD, Morgan MB, Nadel M, Orringer MB, Osborne JR, Ozenberger B, Ramos AH, Robinson J, Roth JA, Rusch V, Sasaki H, Shepherd F, Sougnez C, Spitz MR, Tsao MS, Twomey D, Verhaak RG, Weinstock GM, Wheeler DA, Winckler W, Yoshizawa A, Yu S, Zakowski MF, Zhang Q, Beer DG, Wistuba II, Watson MA, Garraway LA, Ladanyi M, Travis WD, Pao W, Rubin MA, Gabriel SB, Gibbs RA, Varmus HE, Wilson RK, Lander ES, Meyerson M
published in: Nature
information resource reference: Characterizing the cancer genome in lung adenocarcinoma. Nature. 2007 Dec 06; 450(7171):893-8.
journal title abbreviation: Nature
publication date: 2007-11-04T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma.
PubMed Identifier: 18720359
author list: Saad AG, Yeap BY, Thunnissen FB, Pinkus GS, Pinkus JL, Loda M, Sugarbaker DJ, Johnson BE, Chirieac LR
published in: Cancer
information resource reference: Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma. Cancer. 2008 Oct 15; 113(8):2129-38.
journal title abbreviation: Cancer
publication date: 2008-10-15T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Somatic mutations affect key pathways in lung adenocarcinoma.
PubMed Identifier: 18948947
author list: Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan MB, Fulton L, Fulton RS, Zhang Q, Wendl MC, Lawrence MS, Larson DE, Chen K, Dooling DJ, Sabo A, Hawes AC, Shen H, Jhangiani SN, Lewis LR, Hall O, Zhu Y, Mathew T, Ren Y, Yao J, Scherer SE, Clerc K, Metcalf GA, Ng B, Milosavljevic A, Gonzalez-Garay ML, Osborne JR, Meyer R, Shi X, Tang Y, Koboldt DC, Lin L, Abbott R, Miner TL, Pohl C, Fewell G, Haipek C, Schmidt H, Dunford-Shore BH, Kraja A, Crosby SD, Sawyer CS, Vickery T, Sander S, Robinson J, Winckler W, Baldwin J, Chirieac LR, Dutt A, Fennell T, Hanna M, Johnson BE, Onofrio RC, Thomas RK, Tonon G, Weir BA, Zhao X, Ziaugra L, Zody MC, Giordano T, Orringer MB, Roth JA, Spitz MR, Wistuba II, Ozenberger B, Good PJ, Chang AC, Beer DG, Watson MA, Ladanyi M, Broderick S, Yoshizawa A, Travis WD, Pao W, Province MA, Weinstock GM, Varmus HE, Gabriel SB, Lander ES, Gibbs RA, Meyerson M, Wilson RK
published in: Nature
information resource reference: Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008 Oct 23; 455(7216):1069-75.
journal title abbreviation: Nature
publication date: 2008-10-23T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Adjuvant chemotherapy for non-small-cell lung cancer: the end of the beginning.
PubMed Identifier: 14519741
author list: Johnson BE
published in: Journal of the National Cancer Institute
information resource reference: Adjuvant chemotherapy for non-small-cell lung cancer: the end of the beginning. J Natl Cancer Inst. 2003 Oct 01; 95(19):1422-4.
journal title abbreviation: J Natl Cancer Inst
publication date: 2003-10-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib.
PubMed Identifier: 16983123
author list: Jackman DM, Holmes AJ, Lindeman N, Wen PY, Kesari S, Borras AM, Bailey C, de Jong F, Jänne PA, Johnson BE
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib. J Clin Oncol. 2006 Sep 20; 24(27):4517-20.
journal title abbreviation: J Clin Oncol
publication date: 2006-09-20T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Right ventricular function with hypoxic exercise: effects of sildenafil.
PubMed Identifier: 17909844
author list: Kjaergaard J, Snyder EM, Hassager C, Olson TP, Oh JK, Johnson BD, Frantz RP
published in: European journal of applied physiology
information resource reference: Right ventricular function with hypoxic exercise: effects of sildenafil. Eur J Appl Physiol. 2007 Dec; 102(1):87-95.
journal title abbreviation: Eur J Appl Physiol
publication date: 2007-10-02T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Imatinib for small cell lung cancer, aiming for a target in vivo.
PubMed Identifier: 15161675
author list: Johnson BE
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Imatinib for small cell lung cancer, aiming for a target in vivo. Clin Cancer Res. 2004 May 15; 10(10):3235-6.
journal title abbreviation: Clin Cancer Res
publication date: 2004-05-15T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer.
PubMed Identifier: 17285598
author list: Gandhi L, Harding MW, Neubauer M, Langer CJ, Moore M, Ross HJ, Johnson BE, Lynch TJ
published in: Cancer
information resource reference: A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer. Cancer. 2007 Mar 01; 109(5):924-32.
journal title abbreviation: Cancer
publication date: 2007-03-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.
PubMed Identifier: 11839685
author list: Maulik G, Kijima T, Ma PC, Ghosh SK, Lin J, Shapiro GI, Schaefer E, Tibaldi E, Johnson BE, Salgia R
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer. Clin Cancer Res. 2002 Feb; 8(2):620-7.
journal title abbreviation: Clin Cancer Res
publication date: 2002-02-01T00:00:00
year: 2002
type: Academic Article
type: Article
type: Document
type: Information Resource

Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer.
PubMed Identifier: 19447868
author list: Hanrahan EO, Ryan AJ, Mann H, Kennedy SJ, Langmuir P, Natale RB, Herbst RS, Johnson BE, Heymach JV
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer. Clin Cancer Res. 2009 May 15; 15(10):3600-9.
journal title abbreviation: Clin Cancer Res
publication date: 2009-05-15T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study.
PubMed Identifier: 18458247
author list: McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Kuntz KM, Shepard JA, Swensen SJ, Gazelle GS
published in: Radiology
information resource reference: Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology. 2008 Jul; 248(1):278-87.
journal title abbreviation: Radiology
publication date: 2008-05-05T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance.
PubMed Identifier: 19447865
author list: Naumov GN, Nilsson MB, Cascone T, Briggs A, Straume O, Akslen LA, Lifshits E, Byers LA, Xu L, Wu HK, Jänne P, Kobayashi S, Halmos B, Tenen D, Tang XM, Engelman J, Yeap B, Folkman J, Johnson BE, Heymach JV
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance. Clin Cancer Res. 2009 May 15; 15(10):3484-94.
journal title abbreviation: Clin Cancer Res
publication date: 2009-05-15T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Haplotypes of estrogen receptor-beta and risk of non-small cell lung cancer in women.
PubMed Identifier: 20655613
author list: Paulus JK, Zhou W, Kraft P, Johnson BE, Lin X, Christiani DC
published in: Lung cancer (Amsterdam, Netherlands)
information resource reference: Haplotypes of estrogen receptor-beta and risk of non-small cell lung cancer in women. Lung Cancer. 2011 Mar; 71(3):258-63.
journal title abbreviation: Lung Cancer
publication date: 2010-07-23T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Imaging of lung cancer in the era of molecular medicine.
PubMed Identifier: 21277232
author list: Nishino M, Jackman DM, Hatabu H, Jänne PA, Johnson BE, Van den Abbeele AD
published in: Academic radiology
information resource reference: Imaging of lung cancer in the era of molecular medicine. Acad Radiol. 2011 Apr; 18(4):424-36.
journal title abbreviation: Acad Radiol
publication date: 2011-01-28T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
PubMed Identifier: 14559814
author list: Ma PC, Kijima T, Maulik G, Fox EA, Sattler M, Griffin JD, Johnson BE, Salgia R
published in: Cancer research
information resource reference: c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions. Cancer Res. 2003 Oct 01; 63(19):6272-81.
journal title abbreviation: Cancer Res
publication date: 2003-10-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

LKB1 modulates lung cancer differentiation and metastasis.
PubMed Identifier: 17676035
author list: Ji H, Ramsey MR, Hayes DN, Fan C, McNamara K, Kozlowski P, Torrice C, Wu MC, Shimamura T, Perera SA, Liang MC, Cai D, Naumov GN, Bao L, Contreras CM, Li D, Chen L, Krishnamurthy J, Koivunen J, Chirieac LR, Padera RF, Bronson RT, Lindeman NI, Christiani DC, Lin X, Shapiro GI, Jänne PA, Johnson BE, Meyerson M, Kwiatkowski DJ, Castrillon DH, Bardeesy N, Sharpless NE, Wong KK
published in: Nature
information resource reference: LKB1 modulates lung cancer differentiation and metastasis. Nature. 2007 Aug 16; 448(7155):807-10.
journal title abbreviation: Nature
publication date: 2007-08-05T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry.
PubMed Identifier: 20179225
author list: Mino-Kenudson M, Chirieac LR, Law K, Hornick JL, Lindeman N, Mark EJ, Cohen DW, Johnson BE, Jänne PA, Iafrate AJ, Rodig SJ
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry. Clin Cancer Res. 2010 Mar 01; 16(5):1561-71.
journal title abbreviation: Clin Cancer Res
publication date: 2010-02-23T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Comprehensive genomic characterization of squamous cell lung cancers.
PubMed Identifier: 22960745
published in: Nature
information resource reference: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27; 489(7417):519-25.
journal title abbreviation: Nature
publication date: 2012-09-09T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Leptin, a novel predictor of lung function in heart failure.
PubMed Identifier: 18403666
author list: Sierra-Johnson J, Romero-Corral A, Somers VK, Olson LJ, Johnson BD
published in: Chest
information resource reference: Leptin, a novel predictor of lung function in heart failure. Chest. 2008 Aug; 134(2):346-350.
journal title abbreviation: Chest
publication date: 2008-04-10T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Autocrine production of amphiregulin predicts sensitivity to both gefitinib and cetuximab in EGFR wild-type cancers.
PubMed Identifier: 18980991
author list: Yonesaka K, Zejnullahu K, Lindeman N, Homes AJ, Jackman DM, Zhao F, Rogers AM, Johnson BE, Jänne PA
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Autocrine production of amphiregulin predicts sensitivity to both gefitinib and cetuximab in EGFR wild-type cancers. Clin Cancer Res. 2008 Nov 01; 14(21):6963-73.
journal title abbreviation: Clin Cancer Res
publication date: 2008-11-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

CT tumor volume measurement in advanced non-small-cell lung cancer: Performance characteristics of an emerging clinical tool.
PubMed Identifier: 21036632
author list: Nishino M, Guo M, Jackman DM, DiPiro PJ, Yap JT, Ho TK, Hatabu H, Jänne PA, Van den Abbeele AD, Johnson BE
published in: Academic radiology
information resource reference: CT tumor volume measurement in advanced non-small-cell lung cancer: Performance characteristics of an emerging clinical tool. Acad Radiol. 2011 Jan; 18(1):54-62.
journal title abbreviation: Acad Radiol
publication date: 2010-10-30T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions.
PubMed Identifier: 23328547
author list: Oxnard GR, Lo PC, Nishino M, Dahlberg SE, Lindeman NI, Butaney M, Jackman DM, Johnson BE, Jänne PA
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions. J Thorac Oncol. 2013 Feb; 8(2):179-84.
journal title abbreviation: J Thorac Oncol
publication date: 2013-02-01T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Submaximal exercise gas exchange is an important prognostic tool to predict adverse outcomes in heart failure.
PubMed Identifier: 21036777
author list: Woods PR, Bailey KR, Wood CM, Johnson BD
published in: European journal of heart failure
information resource reference: Submaximal exercise gas exchange is an important prognostic tool to predict adverse outcomes in heart failure. Eur J Heart Fail. 2011 Mar; 13(3):303-10.
journal title abbreviation: Eur J Heart Fail
publication date: 2010-10-29T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Co-Principal Investigator
type: Researcher Role
researcher role of: Johnson, Bruce
contributes to: Clinical implementation of single cell tumor transcriptome analysis

Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy.
PubMed Identifier: 16077423
author list: McCurry KR, Iacono A, Zeevi A, Yousem S, Girnita A, Husain S, Zaldonis D, Johnson B, Hattler BG, Starzl TE
published in: The Journal of thoracic and cardiovascular surgery
information resource reference: Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy. J Thorac Cardiovasc Surg. 2005 Aug; 130(2):528-37.
journal title abbreviation: J Thorac Cardiovasc Surg
publication date: 2005-08-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Epidermal growth factor receptor mutations in patients with non-small cell lung cancer.
PubMed Identifier: 16140912
author list: Johnson BE, Jänne PA
published in: Cancer research
information resource reference: Epidermal growth factor receptor mutations in patients with non-small cell lung cancer. Cancer Res. 2005 Sep 01; 65(17):7525-9.
journal title abbreviation: Cancer Res
publication date: 2005-09-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

A metabolic study of patients with lung cancer and hyponatremia of malignancy.
PubMed Identifier: 16467103
author list: Chute JP, Taylor E, Williams J, Kaye F, Venzon D, Johnson BE
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: A metabolic study of patients with lung cancer and hyponatremia of malignancy. Clin Cancer Res. 2006 Feb 01; 12(3 Pt 1):888-96.
journal title abbreviation: Clin Cancer Res
publication date: 2006-02-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

450 Brookline Ave
type: Address
address line 1: Dana-Farber Cancer Institute
address line 2: Adult Oncology
address line 3: 450 Brookline Ave
city: Boston
postal code: 02215
state or province: MA

Prospective study of the airways and pulmonary parenchyma of patients at risk for a second lung cancer.
PubMed Identifier: 14676115
author list: Means-Markwell M, Linnoila RI, Williams J, Jänne PA, Kaye F, O'Neil K, Johnson BE
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Prospective study of the airways and pulmonary parenchyma of patients at risk for a second lung cancer. Clin Cancer Res. 2003 Dec 01; 9(16 Pt 1):5915-21.
journal title abbreviation: Clin Cancer Res
publication date: 2003-12-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapy.
PubMed Identifier: 15084386
author list: Wirth LJ, Carter MR, Jänne PA, Johnson BE
published in: Lung cancer (Amsterdam, Netherlands)
information resource reference: Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapy. Lung Cancer. 2004 May; 44(2):213-20.
journal title abbreviation: Lung Cancer
publication date: 2004-05-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.
PubMed Identifier: 15728811
author list: Kobayashi S, Boggon TJ, Dayaram T, Jänne PA, Kocher O, Meyerson M, Johnson BE, Eck MJ, Tenen DG, Halmos B
published in: The New England journal of medicine
information resource reference: EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N Engl J Med. 2005 Feb 24; 352(8):786-92.
journal title abbreviation: N Engl J Med
publication date: 2005-02-24T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines.
PubMed Identifier: 15731348
author list: Engelman JA, Jänne PA, Mermel C, Pearlberg J, Mukohara T, Fleet C, Cichowski K, Johnson BE, Cantley LC
published in: Proceedings of the National Academy of Sciences of the United States of America
information resource reference: ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines. Proc Natl Acad Sci U S A. 2005 Mar 08; 102(10):3788-93.
journal title abbreviation: Proc Natl Acad Sci U S A
publication date: 2005-02-24T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Inhibition of the met receptor in mesothelioma.
PubMed Identifier: 16299245
author list: Mukohara T, Civiello G, Davis IJ, Taffaro ML, Christensen J, Fisher DE, Johnson BE, Jänne PA
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Inhibition of the met receptor in mesothelioma. Clin Cancer Res. 2005 Nov 15; 11(22):8122-30.
journal title abbreviation: Clin Cancer Res
publication date: 2005-11-15T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1012783
type: Authorship
author rank in publication: 11
linked author: Johnson, Bruce
linked information resource: Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial.

Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial.
PubMed Identifier: 28919011
author list: Planchard D, Smit EF, Groen HJM, Mazieres J, Besse B, Helland Å, Giannone V, D'Amelio AM, Zhang P, Mookerjee B, Johnson BE
published in: The Lancet. Oncology
information resource reference: Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial. Lancet Oncol. 2017 10; 18(10):1307-1316.
journal title abbreviation: Lancet Oncol
publication date: 2017-09-11T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Randomized phase II study of vandetanib alone or with paclitaxel and carboplatin as first-line treatment for advanced non-small-cell lung cancer.
PubMed Identifier: 18936474
author list: Heymach JV, Paz-Ares L, De Braud F, Sebastian M, Stewart DJ, Eberhardt WE, Ranade AA, Cohen G, Trigo JM, Sandler AB, Bonomi PD, Herbst RS, Krebs AD, Vasselli J, Johnson BE
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Randomized phase II study of vandetanib alone or with paclitaxel and carboplatin as first-line treatment for advanced non-small-cell lung cancer. J Clin Oncol. 2008 Nov 20; 26(33):5407-15.
journal title abbreviation: J Clin Oncol
publication date: 2008-10-20T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Cost-effectiveness of computed tomography screening for lung cancer in the United States.
PubMed Identifier: 21892105
author list: McMahon PM, Kong CY, Bouzan C, Weinstein MC, Cipriano LE, Tramontano AC, Johnson BE, Weeks JC, Gazelle GS
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol. 2011 Nov; 6(11):1841-8.
journal title abbreviation: J Thorac Oncol
publication date: 2011-11-01T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Unsuspected pulmonary embolism in lung cancer patients: comparison of clinical characteristics and outcome with suspected pulmonary embolism.
PubMed Identifier: 22959241
author list: Shinagare AB, Okajima Y, Oxnard GR, Dipiro PJ, Johnson BE, Hatabu H, Nishino M
published in: Lung cancer (Amsterdam, Netherlands)
information resource reference: Unsuspected pulmonary embolism in lung cancer patients: comparison of clinical characteristics and outcome with suspected pulmonary embolism. Lung Cancer. 2012 Nov; 78(2):161-6.
journal title abbreviation: Lung Cancer
publication date: 2012-09-07T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Therapeutic targeting of multiple signaling pathways in malignant pleural mesothelioma.
PubMed Identifier: 16020981
author list: Mukohara T, Civiello G, Johnson BE, Janne PA
published in: Oncology
information resource reference: Therapeutic targeting of multiple signaling pathways in malignant pleural mesothelioma. Oncology. 2005; 68(4-6):500-10.
journal title abbreviation: Oncology
publication date: 2005-07-13T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
PubMed Identifier: 16326753
author list: Herbst RS, Bajorin DF, Bleiberg H, Blum D, Hao D, Johnson BE, Ozols RF, Demetri GD, Ganz PA, Kris MG, Levin B, Markman M, Raghavan D, Reaman GH, Sawaya R, Schuchter LM, Sweetenham JW, Vahdat LT, Vokes EE, Winn RJ, Mayer RJ
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J Clin Oncol. 2006 Jan 01; 24(1):190-205.
journal title abbreviation: J Clin Oncol
publication date: 2005-12-02T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Sensitivity of non-small-cell lung cancer cell lines established from patients treated with prolonged infusions of Paclitaxel.
PubMed Identifier: 12759538
author list: Fujishita T, Loda M, Turner RE, Gentler M, Kashii T, Breathnach OS, Johnson BE
published in: Oncology
information resource reference: Sensitivity of non-small-cell lung cancer cell lines established from patients treated with prolonged infusions of Paclitaxel. Oncology. 2003; 64(4):399-406.
journal title abbreviation: Oncology
publication date: 2003-01-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

Prospective study of palliative hypofractionated radiotherapy (8.5 Gy x 2) for patients with symptomatic non-small-cell lung cancer.
PubMed Identifier: 15001250
author list: Cross CK, Berman S, Buswell L, Johnson B, Baldini EH
published in: International journal of radiation oncology, biology, physics
information resource reference: Prospective study of palliative hypofractionated radiotherapy (8.5 Gy x 2) for patients with symptomatic non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004 Mar 15; 58(4):1098-105.
journal title abbreviation: Int J Radiat Oncol Biol Phys
publication date: 2004-03-15T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, "Iressa") on an expanded access study.
PubMed Identifier: 15084387
author list: Jänne PA, Gurubhagavatula S, Yeap BY, Lucca J, Ostler P, Skarin AT, Fidias P, Lynch TJ, Johnson BE
published in: Lung cancer (Amsterdam, Netherlands)
information resource reference: Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, "Iressa") on an expanded access study. Lung Cancer. 2004 May; 44(2):221-30.
journal title abbreviation: Lung Cancer
publication date: 2004-05-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1018690
type: Authorship
author rank in publication: 6
linked author: Johnson, Bruce
linked information resource: HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium.

HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium.
PubMed Identifier: 28743157
author list: Pillai RN, Behera M, Berry LD, Rossi MR, Kris MG, Johnson BE, Bunn PA, Ramalingam SS, Khuri FR
published in: Cancer
information resource reference: HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium. Cancer. 2017 Nov 01; 123(21):4099-4105.
journal title abbreviation: Cancer
publication date: 2017-07-25T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma.
PubMed Identifier: 15886315
author list: Travis WD, Garg K, Franklin WA, Wistuba II, Sabloff B, Noguchi M, Kakinuma R, Zakowski M, Ginsberg M, Padera R, Jacobson F, Johnson BE, Hirsch F, Brambilla E, Flieder DB, Geisinger KR, Thunnisen F, Kerr K, Yankelevitz D, Franks TJ, Galvin JR, Henderson DW, Nicholson AG, Hasleton PS, Roggli V, Tsao MS, Cappuzzo F, Vazquez M
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol. 2005 May 10; 23(14):3279-87.
journal title abbreviation: J Clin Oncol
publication date: 2005-05-10T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase I study of the c-raf-1 antisense oligonucleotide ISIS 5132 in combination with carboplatin and paclitaxel in patients with previously untreated, advanced non-small cell lung cancer.
PubMed Identifier: 19704336
author list: Fidias P, Pennell NA, Boral AL, Shapiro GI, Skarin AT, Eder JP, Kwoh TJ, Geary RS, Johnson BE, Lynch TJ, Supko JG
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Phase I study of the c-raf-1 antisense oligonucleotide ISIS 5132 in combination with carboplatin and paclitaxel in patients with previously untreated, advanced non-small cell lung cancer. J Thorac Oncol. 2009 Sep; 4(9):1156-62.
journal title abbreviation: J Thorac Oncol
publication date: 2009-09-01T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Development of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic EGFR mutations treated with gefitinib or erlotinib.
PubMed Identifier: 21030498
author list: Heon S, Yeap BY, Britt GJ, Costa DB, Rabin MS, Jackman DM, Johnson BE
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Development of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic EGFR mutations treated with gefitinib or erlotinib. Clin Cancer Res. 2010 Dec 01; 16(23):5873-82.
journal title abbreviation: Clin Cancer Res
publication date: 2010-10-28T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Socioeconomic marginality and health services utilization among Central Harlem substance users.
PubMed Identifier: 15002944
author list: Van Ness PH, Davis WR, Johnson BD
published in: Substance use & misuse
information resource reference: Socioeconomic marginality and health services utilization among Central Harlem substance users. Subst Use Misuse. 2004 Jan; 39(1):61-85.
journal title abbreviation: Subst Use Misuse
publication date: 2004-01-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/923964
PubMed Identifier: 15867254
author list: Beaudry P, Force J, Naumov GN, Wang A, Baker CH, Ryan A, Soker S, Johnson BE, Folkman J, Heymach JV
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity. Clin Cancer Res. 2005 May 01; 11(9):3514-22.
journal title abbreviation: Clin Cancer Res
publication date: 2005-05-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity.

Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer.
PubMed Identifier: 16906227
author list: Engelman JA, Mukohara T, Zejnullahu K, Lifshits E, Borrás AM, Gale CM, Naumov GN, Yeap BY, Jarrell E, Sun J, Tracy S, Zhao X, Heymach JV, Johnson BE, Cantley LC, Jänne PA
published in: The Journal of clinical investigation
information resource reference: Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer. J Clin Invest. 2006 Oct; 116(10):2695-706.
journal title abbreviation: J Clin Invest
publication date: 2006-08-10T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Pulmonary function changes associated with cardiomegaly in chronic heart failure.
PubMed Identifier: 17395049
author list: Olson TP, Beck KC, Johnson BD
published in: Journal of cardiac failure
information resource reference: Pulmonary function changes associated with cardiomegaly in chronic heart failure. J Card Fail. 2007 Mar; 13(2):100-7.
journal title abbreviation: J Card Fail
publication date: 2007-03-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria.
PubMed Identifier: 17409995
author list: Travis WD, Garg K, Franklin WA, Wistuba II, Sabloff B, Noguchi M, Kakinuma R, Zakowski M, Ginsberg M, Padera R, Jacobson F, Johnson BE, Hirsch F, Brambilla E, Flieder DB, Geisinger KR, Thunnissen F, Kerr K, Yankelevitz D, Franks TJ, Galvin JR, Henderson DW, Nicholson AG, Hasleton PS, Roggli V, Tsao MS, Cappuzzo F, Vazquez M
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria. J Thorac Oncol. 2006 Nov; 1(9 Suppl):S13-9.
journal title abbreviation: J Thorac Oncol
publication date: 2006-11-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Molecular biology, genomics, and proteomics in bronchioloalveolar carcinoma.
PubMed Identifier: 17410000
author list: Wislez M, Beer DG, Wistuba I, Cadranel J, Saijo N, Johnson BE
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Molecular biology, genomics, and proteomics in bronchioloalveolar carcinoma. J Thorac Oncol. 2006 Nov; 1(9 Suppl):S8-12.
journal title abbreviation: J Thorac Oncol
publication date: 2006-11-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and/or chemotherapy in patients with non-small-cell lung cancer.
PubMed Identifier: 19949019
author list: Hanrahan EO, Lin HY, Kim ES, Yan S, Du DZ, McKee KS, Tran HT, Lee JJ, Ryan AJ, Langmuir P, Johnson BE, Heymach JV
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and/or chemotherapy in patients with non-small-cell lung cancer. J Clin Oncol. 2010 Jan 10; 28(2):193-201.
journal title abbreviation: J Clin Oncol
publication date: 2009-11-30T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Imatinib in small cell lung cancer.
PubMed Identifier: 12867062
author list: Soria JC, Johnson BE, Chevalier TL
published in: Lung cancer (Amsterdam, Netherlands)
information resource reference: Imatinib in small cell lung cancer. Lung Cancer. 2003 Aug; 41 Suppl 1:S49-53.
journal title abbreviation: Lung Cancer
publication date: 2003-08-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
PubMed Identifier: 22298894
author list: Parkinson DR, Johnson BE, Sledge GW
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics. Clin Cancer Res. 2012 Feb 01; 18(3):619-24.
journal title abbreviation: Clin Cancer Res
publication date: 2012-02-01T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

The pulmonary status of patients with limited-stage small cell lung cancer 15 years after treatment with chemotherapy and chest irradiation.
PubMed Identifier: 16304271
author list: Myers JN, O'neil KM, Walsh TE, Hoffmeister KJ, Venzon DJ, Johnson BE
published in: Chest
information resource reference: The pulmonary status of patients with limited-stage small cell lung cancer 15 years after treatment with chemotherapy and chest irradiation. Chest. 2005 Nov; 128(5):3261-8.
journal title abbreviation: Chest
publication date: 2005-11-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer.
PubMed Identifier: 17878479
author list: Heymach JV, Johnson BE, Prager D, Csada E, Roubec J, Pesek M, Spásová I, Belani CP, Bodrogi I, Gadgeel S, Kennedy SJ, Hou J, Herbst RS
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer. J Clin Oncol. 2007 Sep 20; 25(27):4270-7.
journal title abbreviation: J Clin Oncol
publication date: 2007-09-20T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Long-term outcome of lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension.
PubMed Identifier: 18805144
author list: Toyoda Y, Thacker J, Santos R, Nguyen D, Bhama J, Bermudez C, Kormos R, Johnson B, Crespo M, Pilewski J, Teuteberg J, Alvarez R, Mathier M, McNamara D, McCurry K, Zenati M, Hattler B
published in: The Annals of thoracic surgery
information resource reference: Long-term outcome of lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension. Ann Thorac Surg. 2008 Oct; 86(4):1116-22.
journal title abbreviation: Ann Thorac Surg
publication date: 2008-10-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1030942
type: Authorship
author rank in publication: 23
linked author: Johnson, Bruce
linked information resource: The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2).

The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2).
PubMed Identifier: 29217530
author list: Aisner DL, Sholl LM, Berry LD, Rossi MR, Chen H, Fujimoto J, Moreira AL, Ramalingam SS, Villaruz LC, Otterson GA, Haura E, Politi K, Glisson B, Cetnar J, Garon EB, Schiller J, Waqar SN, Sequist LV, Brahmer J, Shyr Y, Kugler K, Wistuba II, Johnson BE, Minna JD, Kris MG, Bunn PA, Kwiatkowski DJ
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2). Clin Cancer Res. 2018 03 01; 24(5):1038-1047.
journal title abbreviation: Clin Cancer Res
publication date: 2017-12-07T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.
PubMed Identifier: 20008850
author list: Hammerman PS, Jänne PA, Johnson BE
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer. Clin Cancer Res. 2009 Dec 15; 15(24):7502-7509.
journal title abbreviation: Clin Cancer Res
publication date: 2009-12-15T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Small cell lung cancer.
PubMed Identifier: 18377848
author list: Kalemkerian GP, Akerley W, Downey RJ, Ettinger DS, Fossella F, Grecula JC, Jahan T, Johnson BE, Kessinger A, Koczywas M, Langer CJ, Martins R, Niell HB, Pan CC, Ramnath N, Ready N, Robert F, Williams CC
published in: Journal of the National Comprehensive Cancer Network : JNCCN
information resource reference: Small cell lung cancer. J Natl Compr Canc Netw. 2008 Mar; 6(3):294-314.
journal title abbreviation: J Natl Compr Canc Netw
publication date: 2008-03-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma.
PubMed Identifier: 19185169
author list: Zellos L, Richards WG, Capalbo L, Jaklitsch MT, Chirieac LR, Johnson BE, Bueno R, Sugarbaker DJ
published in: The Journal of thoracic and cardiovascular surgery
information resource reference: A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2009 Feb; 137(2):453-8.
journal title abbreviation: J Thorac Cardiovasc Surg
publication date: 2009-02-01T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 106631
type: Authorship
author rank in publication: 6
linked author: Johnson, Bruce
linked information resource: Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period.

The introduction of systematic genomic testing for patients with non-small-cell lung cancer.
PubMed Identifier: 23154547
author list: Cardarella S, Ortiz TM, Joshi VA, Butaney M, Jackman DM, Kwiatkowski DJ, Yeap BY, Jänne PA, Lindeman NI, Johnson BE
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: The introduction of systematic genomic testing for patients with non-small-cell lung cancer. J Thorac Oncol. 2012 Dec; 7(12):1767-1774.
journal title abbreviation: J Thorac Oncol
publication date: 2012-12-01T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.
PubMed Identifier: 12414661
author list: Kijima T, Maulik G, Ma PC, Tibaldi EV, Turner RE, Rollins B, Sattler M, Johnson BE, Salgia R
published in: Cancer research
information resource reference: Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. Cancer Res. 2002 Nov 01; 62(21):6304-11.
journal title abbreviation: Cancer Res
publication date: 2002-11-01T00:00:00
year: 2002
type: Academic Article
type: Article
type: Document
type: Information Resource